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Abstract
The Hermansky-Pudlak syndrome (HPS) is a rare autosomally recessive 
genetic disorder characterised by defective lysosome-related organelles (LROs) first 
described in 1959. Patients exhibit a triad of phenotypes including tyrosinase-positive 
oculocutaneous albinism, bleeding tendency and ceroid-lipofuscin lysosomal storage 
disease. The most common form of HPS is caused by a mutation in the HPS1 gene, 
which encodes a 79kDa protein of unknown function.
A monoclonal antibody specific to the human HPS1 protein was generated 
using recombinant HPS1 protein expressed in E.Coli. Transiently over expressed 
epitope tagged HPS1 protein was localised using polyclonal antisera against the HPS1 
protein in addition to the monoclonal in both non-melanocytic and melanocytic cell 
lines by immunofluorescence analysis. The protein distribution pattern was partially 
aggregated, partially cytosolic and localised to punctate vesicles distributed 
throughout the cytosol in both types of cell lines. These punctate structures closely 
associated with microtubule filaments. Drug treatment using vincristine and 
nocodazole to depolymerise the microtubule filaments caused the HPS1 protein to 
redistribute from punctate vesicles to a more cytosolic localisation. Together with 
subcellular fractionation data this supported a role for the HPS1 protein in 
microtubule-mediated transport.
Immunofluorescence analysis in polynuclear CHRF megakaryocyte cells 
demonstrated that endogenous HPS1 protein was present in punctate structures 
throughout the cell. The punctate structures colocalised to a large extent with the 
small GTPase Rab27, which has an unknown function in these megakaryocytes. C 
terminal truncations of the HPS1 protein were transiently over expressed in both non- 
melanocytic and melanocytic cell lines to assess the role of the C terminus in HPS1 
localisation. Loss of the C terminus resulted in the HPS1 protein becoming more 
aggregated when over expressed in melanocytic cell lines. It is speculated that this 
portion of the protein may play a role in the formation of the HPS1 containing BLOC- 
3 complex or its membrane association.
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Eukaryotic cells are divided into discrete compartments termed organelles 
which all perform specific roles. Christian de Duve first identified lysosomes in 1949 
using cell fractionation techniques. He described these organelles as being 
responsible for cellular degradation processes (Bainton, 1981). Lysosomes are 
membrane bound organelles to which endogenous and exogenous macromolecules 
are delivered, from both the endocytic and biosynthetic pathways within the cell 
(Dell’Angelica et al., 2000a). They are found in all cell types and for optimal activity 
all the enzymes contained within them require an acid environment. The lysosome 
provides this environment using transmembrane proton pumps to maintain a pH of 
4.6-5.0. In electron micrographs lysosomes are typically ~0.5jim in diameter with 
electron dense cores. Lysosomes contain about 40 different types of hydrolytic 
enzymes, including proteases, nucleases, glycosidases, lipases, phospholipases, 
phosphatases and sulfatases. The limiting membrane of the lysosome contains a set 
of highly glycosylated, lysosomal-associated membrane proteins (LAMPs) whose 
function is unknown. The high level of glycosylation of these proteins is thought to 
help protect them from the lysosomal proteases within the lumen of the organelle. 
Lysosomes are often morphologically heterogenous resembling other organelles of 
the endocytic pathway. They are currently distinguished on a functional basis defined 
as membrane-bound organelles containing acid hydrolases and LAMPs but lacking 
mannose 6-phosphate receptors.
The mechanism of biogenesis of the lysosome and how material is 
transported to it from the endocytic pathway is currently the subject of intense 
investigation. One model proposes that the late endosome, an endocytic 
compartment, can fuse with end stage lysosomes for the transfer of material 
(Mullock et al., 1998). Several mechanisms have been suggested for late endosome 
and lysosome fusion events. The first proposed that the formation involves a number 
of fusion events termed ‘kiss-and-run’. This model proposed that late endosomes and 
lysosomes undergo a series of fusion and fission events (Storrie and Desjardins,














Fig. 1.1 Schematic representation of kiss-and-run fusion proposed to operate 
between donor and target intracellular compartments (adapted from Marks and 
Seabra, 2001).
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An alternative model proposes direct fusion of late endosomes to lysosomes, 
which has been characterised using a rat liver cell free system. Immunoprecipitation 
products of content mixing between late endosomes and lysosomes are present in a 
membrane bound organelle whose density is intermediate between late endosomes 
and lysosomes (Mullock et al., 1998). This organelle is termed a late endosome- 
lysosome hybrid organelle and contains protein markers from both lysosomes and 
endosomes. The final model suggests that lysosomes repeatedly fused with 
lysosomes to form hybrid organelles in which digestion occurs and from which 
lysosomes are reformed (Luzio et al., 2000).
Proteins reach lysosomes by one of two routes, either via the endocytic or 
biosynthetic pathways. Integral membrane proteins are generally sorted by signals 
that are present in their cytoplasmic tails and are recognised by components of the 
sorting machinery. This leads to the proteins being recruited into budding vesicles for 
onward trafficking (Blott and Griffiths, 2002). Soluble lysosomal proteins such as the 
resident hydrolase enzymes have no signal sequence. Instead these proteins are 
modified during the biosynthetic process with the addition of a mannose-6-phosphate 
(M6P) moiety. This is then recognised by mannose-6-phosphate receptors (M6PR), 
which cycle between the TGN and late endosomes carrying proteins to the lysosome 
(Griffiths et al., 1998). Examples of lysosomal hydrolases containing these signals 
include cathepsins and granzymes. In addition to the M6P receptor utilised by 
soluble lysosomal hydrolases there are a number of different sorting signals present 
in lysosomal proteins required for their correct targeting. These include tyrosine- 
based signals of the form YXX$ (where Y is tyrosine, X is any amino acid and $  is 
a bulky hydrophobic amino acid) for example in the LAMP1 protein trafficking to 
lysosomes (Honing et al., 1996).
1.2 Lysosome-related organelles
As well as containing lysosomes some cells also contain cell type specific 
modifications of these organelles termed lysosome-related organelles (LROs). These 
organelles share some common characteristics with lysosomes. In addition to having 
a specific content or membrane protein marker found in lysosomes, LROs may show 
other common characteristics with lysosomes such as a low pH or accessibility from 
the cell surface. These points may strengthen the status of an organelle to an LRO
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but the classification of an LRO has not yet been completely defined. These LROs 
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Destruction of virally 
infected or cancerous 
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(Peters et al., 1991a)
MIIC (Major 
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complex class II 
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CD4+ T lymphocytes for 
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(Peters et al., 
1991b)
Basophilic granules Basophils, mast cells
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histamines, other 
inflammatory agents
(Marone et al., 
1997)
Azurophilic granules Neutrophils, eosinophils
Release of microbial and 
inflammatory agents
(Gullberg et al., 
1997)
Osteoclast granules Osteoclasts
Bone resorption and 
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Maturation and regulated 
release of von Willebrand 
factor into blood
(Hannah et al., 
2002)
Platelet a  granules
Platelets,
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Fibrinogen and von 
Willebrand factor release 
for platelet adhesion and 
blood clotting
(White et al., 1985)
Table 1.1 Lysosome related organelles, cell type location and function (Adapted 
from Marks and Seabra, 2001).
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An additional important characteristic of LROs is that they can respond to 
physiological stimulation and many LROs may in fact be termed storage organelles 
(Cutler, 2002). The function of these storage organelles involves fusion of the LRO 
with the plasma membrane and contents release. This storage and contents release is 
not however true of all LROs, for example the melanosome, which is released from 
melanocytes as an entire organelle. The relationship between LROs and lysosomes 
might be very distant for example; Weibel-Palade bodies contain only one lysosomal 
protein, CD63. The ability of the protein CD63 to reach Weibel-Palade bodies 
directly from the endocytic pathway is a characteristic of both lysosomes and LROs.
If cells generate separate populations of lysosomes and LROs within a single 
cell than a sorting mechanism must exist to ensure the differential targeting of 
proteins to either organelle. Observations suggest that although the pathways leading 
to formation of lysosomes and LROs may be shared to a large extent there must be 
divergence in some cell types. The relationship of LROs to lysosomes suggests the 
endosomal system plays a key role in the biogenesis of these organelles, with protein 
segregation occurring presumably in a late endosomal compartment. This process 
would rely on specific protein sorting signals and recognition systems. These sorting 
signals include tyrosine-based signals of the type used in the trafficking of LAMPs to 
lysosomes (Ohno et al., 1996) and in addition di-leucine based signals. These di­
leucine signals contain two consecutive leucine residues and are required for the 
correct sorting of tyrosinase related protein-1 (TRP-1) to the melanosome (Jimbow et 
al., 1997).
The fusion and contents release process defined lysosome-related organelles 
as being different from lysosomes as lysosomes were thought not to have any fusion 
and contents release capability (Cutler, 2002). Recent studies have established that 
not only LROs but also lysosomes themselves can fuse with the plasma membrane. 
The studies were performed using the invasion of a protozoan parasite Trypanosoma 
cruzi into fibroblasts. The organism was thought originally to have a phagocytic 
invasion mechanism. Imaging studies have however revealed the accumulation of 
lysosomes at the entry site of the organism (Tardieux et al., 1992). Subsequent 
studies showed that the accumulated lysosomes fused with the plasma membrane 
with the whole process triggered by raised levels of intracellular calcium (Burleigh 
and Andrews, 1998). It is thought that this fusion reaction is a possible plasma 
membrane repair mechanism (Andrews, 2002).
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1.3 Secretory lysosomes
The majority of LROs can also be termed secretory lysosomes. In a 
small number of cell types the lysosome is used as a regulated secretory organelle. 
These cells package additional secretory products into the lysosomes, which respond 
to extracellular stimuli and fuse with the plasma membrane. Morphological and 
biochemical studies reveal these secretory lysosomes combine many of the 
characteristics of conventional lysosomes and secretory granules in a single structure. 
Identification of the molecular machinery involved in secretory lysosome exocytosis 
demonstrated that some components are expressed exclusively in cells containing 
secretory lysosomes. This suggests that secretory and conventional lysosomes may 
differ in the mechanism of secretion. These unique components therefore provide 
molecular markers to distinguish between secretory and conventional lysosomes. The 
best-studied models of the actual biogenesis of the structure of secretory lysosomes 
are in the formation of lytic granules in cytotoxic T cells (Stinchcombe et al., 2000), 
melanosomes in melanocytes (Raposo et al., 2001) and dense granules in platelets 
(King and Reed, 2002).
Virtually all immune cells which use specialised regulated secretory granules 
to function seem to use secretory lysosomes. The majority o f cells containing 
secretory lysosomes are derived from the hemopoietic lineage but some are not. 
Secretory lysosomes are not lineage specific therefore it has been proposed that this 
system may provide evidence of a primitive mechanism of secretion. This 
mechanism has therefore been maintained or separately derived in a number of 
different lineages as cells have become specialized.
Conventional lysosomes are usually multivesicular and contain internal 
vesicles that bud off from the limiting membrane. Secretory lysosomes tend to have a 
much more diverse type of structure with some having dense cores for example 
dense granules within platelets whilst others are multilaminar or have completely 
unique structures. There are clearly also contents differences between the two 
organelles with both containing degradative enzymes such as lysosomal acid 
hydrolases and other resident membrane proteins for example; LAMPs (Blott and 
Griffiths, 2002). Secretory lysosomes however contain a specific cell-type dependent 
set of secreted components and differences exist in the secretion capabilities of 
secretory and conventional lysosomes.
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1.3.1 Regulated exocytosis of secretory lysosomes
Regulated exocytosis of secretory lysosomes involves several distinct steps. 
Firstly, a signal, such as the binding of ligand to a cell surface receptor is required to 
initiate the exocytosis process. This stimulation results in an increase in intracellular 
Ca levels signalling to the granule to mobilize and be transported to the site of 
stimulation (Lyubchenko et al., 2001). This mobilization over long-range distances 
probably occurs with the aid of microtubule networks. Once these long-range 
movements are completed short-range movements occur on peripheral actin 
networks. Secretory lysosomes appear to use a number of components to achieve 
exocytosis some of which are common to other secretory granules and others that are 
unique. Some of these components include synaptotagmins that are important in 
regulated exocytosis and SNAREs, which facilitate fusion of secretory lysosomes 
with the plasma membrane. Studies in RBL-2H3 cells, which are derived from mast 
cells and degranulate upon IgE stimulation, demonstrated that the overexpression of 
the SNARE protein syntaxin 4 inhibited degranulation confirming the importance of 
SNARE proteins in this process (Paumet et al., 2000).
1.3.2 Genetic disorders with defective lysosome-like organelles
Several human disorders result from selective dysfunction o f secretory 
lysosomes in a small number of cell types. This is most clearly shown in a number of 
autosomally recessive single gene disorders. These are listed in table 1.2.
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Human disease Human gene Mouse mutation Reference
Chediak-Higashi 
syndrome (CHS)








ADTB3A pearl (DelTAngelica et al., 
1999)ADTA mocha
PA pallid (Huang et al., 1999)




HPS3 cocoa (Anikster et al., 2001)
Griscelli’s
syndrome
RAB27A ashen (Wilson et al., 2000)
ND leaden (Matesic et al., 2001)
MyoVa dilute (Pastural et al., 1997)
Table 1.2 Genetic disorders in humans, which have defects in secretory lysosomes.
All of these disorders are characterised by platelet defects and resultant 
increases in bleeding times. The genetic disorders appeared to cause defects in the 
dense granules present within the platelets. In addition both the human and mouse 
genetic disorders are characterised by reduced pigmentation of the skin and eye due 
to defects in the melanosomes, pigmented organelles contained in melanocytic cells. 
A detailed analysis of both these genetic disorders has enabled molecular 
characterisation o f the genes mutated in these human and mouse disorders.
1.4 Biogenesis of lysosomes and dense granules in platelets
The major purpose of the anucleate platelet cell is to protect the integrity of 
the vascular system by contributing to haemostatic reactions in a very controlled 
manner. The cells adhere to and spread over exposed subendothelium at the site of 
vascular injury and prevent blood loss. Subcellular fractionation and transmission 
electron microscopy has identified three major types of storage organelles within
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platelets. Most numerous are a  granules whose protein constituents include P 
thromoglobulin, von Willebrand factor and platelet derived growth factor (PDGF). 
These granules show moderate electron density in osmium stained thin sections. The 
less numerous but highly osmophilic granules are termed dense granules. They are 
the storage sites for serotonin, calcium, pyrophosphate and a non-metabolic storage 
pool of ATP and ADP. In addition to these components dense granules contain 
membrane proteins typically found in lysosomes such as CD63 (Nishibori et al., 
1993), LAMP2 (Israels et al., 1996) and LAMP1 (Febbraio and Silverstein, 1990). 
The presence of these lysosomal proteins characterises these organelles as being 
LROs. Platelets also contain a few lysosomes that store acid hydrolases and 
microperoxisomes with catalase activity (White, 1985).
Dense granules are electron opaque on unfixed, unstained whole mount 
preparations due to their high heavy metal and calcium content. Dense granules can 
be detected by their high affinity for uranyl ions (uranaffin reaction) (Payne, 1984). 
This reaction is thought to be selective for polyphosphates associated with the 
granule membrane. Dense granules also show the ability to accumulate the 
fluorescent dye, mepacrine, which localises to dense granules due to its high affinity 
for ATP (Lorez et al., 1977). Uranaffin labelled granules have been shown to appear 
near the trans face of the Golgi apparatus in immature megakaryocytes, increasing in 
size and number during maturation (Diamon and David, 1983).
Platelets are formed from the terminal differentiation of megakaryocytes 
within bone marrow. The mechanisms underlying this process are poorly understood 
in part due to the rarity o f megakaryocytes in normal bone marrow where they make 
up less than 0.1% of the total cells. Each mature megakaryocyte produces and 
releases hundreds of platelets into circulation. Recent electron microscopy data has 
provided a much greater understanding as to how a  and dense granules found in 
platelets are formed in megakaryocytes. The multivesicular body appears to be a 
developmental stage in a  granule maturation (Heijen et al., 1998). Further work on 
immature megakaryocytes using an antibody to granulophysin, a specific protein 
resident in dense granules, demonstrated the appearance of dense granules at a very 
early developmental stage. 80% of labelling with this antibody was present on 
internal vesicles of the multivesicular body (Youssefian and Cramer, 2000). In 
addition double labelling experiments showed that the a-granule protein, von
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Willebrand factor, and the dense granule protein granulophysin could be found in the 
same MVB. It was demonstrated that dense granule components are segregated from 
other secretion granules within multivesicular bodies. This suggests that the 
multivesicular bodies are a sorting compartment for a-granule and dense granule 
formation.
The multivesicular body in megakaryocytes doesn’t however contain 
significant amounts of lysosomal enzymes despite the fact that lysosomes are formed 
from multivesicular bodies in the endocytic pathway (Heijnen et al., 1998). The 
lysosomes present in megakaryocytes appear to be formed very early in the 
maturation of megakaryocytes even before the formation of alpha granules 
(Stenberg, 1986). Platelet lysosomes are more heterogenous in composition 
compared to both alpha and dense granules containing the ubiquitous lysosomal 
proteins LAMP-1, LAMP-2 and CD63. Endocytic trafficking to the platelet 
lysosome also appears to be independent of the coat protein clathrin (Behnke, 1992). 
A number of disorders have been characterised which have defects in platelet 
granules, some of these inherited granules disorders are termed storage pool 
deficiency due to a defect in the contents of dense and/or a  granules (Lages, 1986).
For the activity of platelets to take place they must transfer the chemical 
substances confined within the storage organelles to the exterior plasma without the 
simultaneous loss of cytoplasmic constituents. After platelets are stimulated they 
loose their discoid shape and become irregularly spherical. The organelles inside the 
platelets become concentrated in the cell centre inside constricted rings of the 
circumferential microtubules. Internal contraction within the cell breaks the 
microtubule ring and drives the secreted contents out of the platelet. Release appears 
to be a highly ordered process with the nature of the organelles involved and the 
amount of products released related to the specificity and strength of the stimuli. 
Products present in lysosomal organelles are not extruded unless platelets are 
maximally stimulated (White, 1985).
1.5 Melanosomes as model system to study lysosome-like organelles
The melanosome has provided a model system for the study of both the 
biogenesis and protein targeting to secretory lysosomes. The melanosome has several 
advantages over other systems: a number of its resident proteins have been
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characterised, melanoma cell lines and primary melanocyte cells from patients and 
mice are easily available and finally a large amount morphological data is available 
on the melanosome.
1.5.1 Premelanosome biogenesis
The synthesis of melanins, the pigments synthesized by mammals 
occur within specific membrane enclosed structures termed melanosomes. Melanin is 
synthesized from tyrosine within melanosomes then polymerised to form fully 
pigmented melanins. Melanosomes contain specific resident proteins that are 
expressed only in the melanocytic lineage. Most that have so far been identified are 
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Table 1.3 Melanosomal resident proteins, functions and associated human disorders 
and mouse mutations (Adapted from Marks and Seabra, 2001).
1.5.2 Protein targeting to mature pigment granules
In stage II premelanosomes melanin synthesis begins suggesting that there 
must be mechanisms that control the delivery of melanosomal membrane proteins 
and melanogenic enzymes. Electron microscopy studies on melanosome 
development revealed that there is enrichment of the melanosomal proteins Pmell7 
and tyrosinase-related protein-1, TRP-1 during melanosome development. This is
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suggestive of multiple sorting processes, which are responsible for the delivery of 
resident proteins. Classic morphological studies show that melanosomes progress 
through a series of development stages and these can be defined into four distinct 
forms (Seiji et al 1963). The early stages lack pigment but contain internal 
membraneous vesicles that very closely resemble the late endosomal multivesicular 
body. The intralumenal fibres from the MVB form into regular parallel arrays in the 
stage II premelanosome that starts to take on a characteristic striated appearance. 
These arrays serve as the site for the actual pigment deposition resulting in a 
darkening and thickening termed stage III. Eventually the pigment concentration is 
such that that the intralumenal space is completely masked by the accumulated 
pigment and this is termed a stage IV premelanosome (Marks and Seabra, 2001).
A direct link between premelanosomes and early endocytic compartments 
was proposed due to the presence of Pmell7 in both early endosomes and a structure 
termed a coated endosome as well as in developed melanosomes (Raposo et al., 
2001). This coated endosome has flat clathrin-containing lattices with a well- 
organised electron dense region between the coat and membrane that possibly 
facilitates sorting through unknown adaptor proteins. The presence o f Pmell7 in this 
coated endosome suggests that the coated endosome may be a critical sorting 
compartment for segregation from endosomes. The coated endosome probably 
corresponds to a stage I premelanosome. All melanosomal proteins may not be 
transported through endosomal compartments based on findings showing TRP1 isn’t 
in endocytic compartments but accumulates at the TGN and in AP-1 coated vesicles 
like LAMP1 (Raposo et al., 2001).
This hypothesis is confirmed by additional data on the requirement of 
dileucine motifs in the trafficking of melanosomal proteins. Using plasmon 
resonance techniques it was shown that AP-3 binds to the cytoplasmic tail of 
tyrosinase, which contains an EEXXXLL motif sequence (X is any amino acid) and 
does not bind to the other adaptor complexes AP-1 or AP-2 (Honing et al., 1998). 
Additional work on the expression of mutant chimeras of the cytosolic tail of 
tyrosinase linked to the transmembrane domain of the lysosomal protein LAMP1 
established that the tyrosinase tail was necessary and sufficient to mediate sorting. 
Correct sorting of the chimeras was mediated by the interplay o f a dileucine signal 
and a tyrosine motif o f the type YXX$ (where $  is a hydrophobic amino acid) 
(Simmen et al., 1999). The properties of the dileucine motif in tyrosinase was shown
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to be different to those present in other proteins such as CD37by overexpression 
studies in non-pigmented cells. Overexpression of tyrosinase resulted in a four-fold 
enlargement of late endosomes and lysosomes and endosomal sorting mediated by 
dileucine and tyrosine motifs was disrupted. This was not the case upon 
overexpression of CD37 suggestive of a second independent sorting pathway to the 
late endosome (Calvo et al., 1999). Additional analysis of a novel protein, Quail 
Neuroretina clone 71 gene (QNR-71) encoding a type I transmembrane glycoprotein 
with homology to melanosomal proteins, has also established a role for the AP-3 
complex in melanosomal protein trafficking. This targeting was mediated by AP-3 
and the dileucine motif was both necessary and sufficient for targeting (Le Borgne et 
al., 2001).
Confirmation of the role of the AP-3 complex in the trafficking of the 
melanosomal protein tyrosinase comes from mouse coat colour mutants, which have 
no functional AP-3 complex. In melanocytes from these mice tyrosinase is 
mislocalized from its usual melanosomal location (Huizing et al., 2001a). Another 
melanosomal protein, TRP1, was localised correctly in these mutant cells again 
suggestive of an independent sorting step after the AP-3 dependent one. Recent data 
has shown that the small GTPase Rab7 is required for the correct trafficking of the 
TRP1 protein. Immunofluorescence analysis showed a colocalisation between the 
two proteins and antisense oligonucleotides to Rab7 blocked the trafficking of TRP1 
(Gomez et al., 2001). It also recently emerged that phosphoinositide 3-kinase may 
play a role in melanosome protein trafficking and more specifically in TRP1 
trafficking. Treatment of MeWo melanoma cells with wortmannin, a potent inhibitor 
of PI3-kinase caused the redistribution of TRP1 to a novel compartment with both 
endosomal and lysosomal characteristics (Chen et al., 2001). The compartment was 
positive for LAMP1 and partially positive for both CD63 and CI-M6PR and the 
movement of the compartment was shown to be microtubule dependent. A PDZ 
domain protein, GIPC (Ga-interacting protein) might also have a role in the TRP1 
sorting step (Liu et al., 2001).
Finally, glycosphingolipids may also have a role in protein trafficking to the 
melanosome. Glycosphingolipids are ubiquitously expressed and little is know about 
their cellular function. They contain two hydrophobic tails with a carbohydrate 
moiety attached to ceramide (lipid anchor). Using a glycosphingolipid deficient 
mouse melanoma line, studies showed that the cells didn’t contain melanin due to
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tyrosinase accumulating in the Golgi rather than being targeted to melanosomes 
(Sprong et al., 2001). Trafficking of both TRP1 and lysosomal enzymes however 
were unaffected. In conclusion this study suggested that glycosphingolipids are 
required for direct transport of specific proteins from the Golgi to melanosomes. 

















Figure 1.2 Possible protein trafficking pathways to melanosomes within melanocytes
1.6 Melanosome transport
In order to accomplish their photoprotective function within skin 
melanosomes must be transferred to the periphery of melanocytes where then can 
then be transferred to keratinocytes. The exact mechanism of transport of stage IV 
melanosomes to the cell periphery is not entirely understood. There is evidence that 
melanosomes are transported via microtubule networks in a bi-directional manner 
enabling them to be transported both to and away form the periphery o f the cell. 
Once they reach the periphery they are released from microtubules and bind to actin 
networks for short-range movements (Wu et al., 1998).
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The mechanism of melanosome transport and peripheral retention has been 
elucidated with the aid of a subset of mouse coat colour mutants that show defective 
melanosome transport. The subset of mouse coat colour mutants, ashen (ash), dilute 
(d) and leaden (In) have normal levels of melanin synthesis but melanosome 
transport in impaired resulting in the clumping of melanosomes around the 
perinuclear area of the cell (Silvers, 1979). All three mutations have identical 
phenotypes and triple homozygotes show no phenotypic difference from single 
mutants. This suggests that the proteins must function in overlapping pathways. The 
cell autonomous, semi-dominant, dilute suppressor (dsu) can suppress all three of 
these mutants (Moore et al., 1988a; Moore et al., 1988b). The dilute suppressor was 
first recognised by its ability to suppress the coat colour phenotype of dilute mice. In 
subsequent experiments it was shown to be able to partially suppress the coat colour 
phenotype of both ashen and leaden mice. The level of suppression could be 
correlated with the extent of restoration of normal melanosome distribution. The 
dilute suppressor gene has yet to be identified and the mouse mutant has no 
phenotype of its own and can only be observed in combination with dilute, ashen or 
leaden (Moore et al., 1994). Table 1.4 outlines these mouse mutants defective in 










(Wilson et al., 2000)
Dilute 15q21
Myo5a 
(Pastural et al., 1997)
Leaden 2q37
Mlph 
(Matesic et al., 2001)
Table 1.4 Mouse coat colour mutants defective in melanosome transport. Table 




The recessive dilute mouse coat colour mutant is characterised by a dilute 
coat colour as its name suggests as well neurological defects. The predicted amino 
acid sequence data indicated that the dilute gene encoded a type of actin motor 
protein, an unconventional myosin heavy chain, termed myosin Va (Mercer et al., 
1991). Myosin Va is a dimeric molecular motor that progresses along actin filaments 
using ATP hydrolysis. Myosins are composed of three domains, an ATPase motor 
head domain, a neck domain and a tail domain that is important for subcellular 
localisation (Reck-Peterson et al., 2000). The dilute transcripts were show to be 
abundant in certain tissue types, particularly neurons. Dilute lethal mice are true null 
mutants for myosin Va and have both pigment and neurological defects (Pastural et 
al., 1997). Dilute viral is an additional myosin Va mouse mutant that has a proviral 
insertion in the myosin Va gene giving rise to pigment defects but no neurological 
problems (Seperack et al., 1995).
Griscelli syndrome is a rare autosomally recessive human disorder 
characterised by partial albinism, immune deficiencies and hemophagocytic 
lymphohistiocytosis (Griscelli et al., 1978). The albinism is caused by an uneven 
accumulation of large pigment granules within melanocytes instead of the usual 
homogenous distribution of small granules. Keratinocytes were also shown to be 
devoid of any melanosomes (Griscelli et al., 1978; Mancini et al., 1998). Molecular 
characterisation of the disorder showed that the syndrome was caused by two 
possible mutations of genes both on human chromosome 15q21, one of which was 
myosin Va the other Rab27a (Pastural et al., 1997).
Analysis of both wildtype and dilute melanocytes demonstrated that in 
mutant cells the melanosomes had normal morphology but were concentrated around 
the perinuclear area of the cell confirming the requirement o f myosin Va in 
melanosome transport (Provance et al., 1996). It was concluded at this stage that 
myosin Va was required for melanosome distribution and not cell shape with regard 
to the formation of cellular dendrites (Wei et al., 1997). Immunofluorescence and 
electron microscopy first demonstrated the colocalisation of myosin Va with 
melanosomes. Both F-actin and myosin Va were concentrated in cellular dendrites of 
melanosomes (Wu et al., 1997). Time-lapse video microscopy revealed melanosomes 
undergo a rapid microtubule-dependent movement to the cell periphery in both 
wildtype and dilute melanocytes (Wu et al., 1998). This melanosome movement was
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completely ablated by the addition of the microtubule interfering drug, nocodazole. 
The microtubule-based transport of melanosomes didn’t, however, result in a net 
accumulation of melanosomes at the periphery. The peripheral accumulations of 
melanosomes were only present in wildtype melanosomes and not dilute 
melanosomes, which lacked myosin Va. This suggested that a myosin Va dependent 
interaction with melanosomes was responsible for this accumulation. Consistent with 
this the overexpression of the melanosome interacting tail domain of myosin Va 
caused a dilute like phenotype. Further evidence about domains in myosin Va, which 
are required for localisation, came from a study by Tsakraklides and co-workers 
(Tsakraklides et al., 1999). Expression o f GFP fusions of various domains of myosin 
Va demonstrated that both the N terminal and neck domains and the N terminal 
domain alone co-distributed in actin rich filopodia. GFP fusions using the C terminal 
tail domain of myosin Va demonstrated that it was this domain that targets the motor 
molecule to the centrosome. This therefore suggests that proper spatial and temporal 
delivery of this protein may have great cellular importance (Lionne et al., 2001).
Later studies established the differential distribution of this actin motor 
protein (Lionne et al., 2001). Endogenous myosin Va preferentially localized around 
the microtubule organising centre (MTOC) of confluent cells but in cells with highly 
dynamic membranes, such as NRK cells, it was also enriched in the leading ruffling 
edges. Using both actin and microtubule interfering drugs the localisation in ruffling 
edges was dependent on the actin network whereas the MTOC localisation was 
dependent on the microtubule network. These results suggested that vesicles use a 
kinesin based microtubule motor for long range cell movements followed by a switch 
in microtubule poor but actin rich areas o f the cell, to myosin Va an actin motor for 
short range movements. The exact mechanism of the role of the myosin Va protein in 
the peripheral retention of melanosomes came with the observation that the actin 
motor protein binds to a receptor-protein complex containing both Rab27a and 
melanophilin.
1.6.2 Rab27a
The Rab GTPases are the largest branch of the p21 Ras superfamily with 
approximately 60 members in humans and serve as vital regulators of membrane 
transport. Rabs are firmly attached to membranes by way of two C-20 geranylgeranyl 
groups that are added post-translationally. Each Rab protein has a steady state
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distribution associated primarily with a single type of membrane within a cell. 
Recruitment of one or more effectors to drive downstream events is associated with 
each Rab protein (Zerial and McBride, 2001). Rabs were originally thought to 
primarily function in docking and fusion of transport vesicles to target organelles. 
Recent studies suggest that Rab proteins also function in organelle and vesicle 
movement (Marks and Seabra, 2001). The complete cDNAs of the two isoforms of 
Rab27 were first isolated in 1997 from both human melanoma cells and melanocytes 
(Chen et al., 1997). Sequence comparisons of the two isoforms with other Rab 
proteins identified them as melanocyte and platelet specific subfamily of Rab 
proteins. Rab27a was the human homologue of the rat ram p25 protein, which had 
been previously cloned from a megakaryocyte library (Nagata et al., 1990). Both 
isoforms had different patterns of expression with the Rab27a isoform expressed in a 
large variety of tissues and the Rab27b isoform primarily expressed in the testis 
(Chen et al., 1997). Positional cloning and BAC rescue showed that the ashen gene 
encodes Rab27a (Wilson et al., 2000).
It was recently proposed that Griscelli syndrome could be caused by 
mutations in Rab27a as well as myosin Va (Menasche et al., 2000). Using 
immunofluorescence and electron microscopy of normal melanocytes, Rab27a was 
shown to colocalise with melanosomes (Bahadoran et al., 2001). The same studies 
performed on cells from a Griscelli patient demonstrated an abnormal melanosome 
distribution and complete lack of Rab27a protein expression. Rescue experiments 
using transient transfections were able to restore melanosome transport confirming 
the crucial role of Rab27a in this process (Bahadoran et al., 2001). Expression of a 
GFP-tagged form of Rab27a showed again the protein was localised to melanosomes 
and in non-pigmented cells it colocalised with the melanosome resident proteins 
TRP-1 and Pmell7 (Hume et al., 2001). Expression of dominant interfering Rab27a 
mutants ablated normal pigment granule transport resulting in a perinuclear 
clustering phenotype similar to that observed in both ashen and dilute. 
Immunoprecipitation studies confirmed that Rab27a coimmunoprecipitated with 
myosin Va suggesting these proteins could directly interact. It was proposed that 
Rab27a recruited myosin Va to melanosomes, as very little of the actin motor protein 
was found on melanosomes in the absence of Rab27a (Hume et al., 2001).
The role of the Rab27b isoform in melanosome transport process is less well 
studied. No patients have yet been identified that have a mutation in the Rab27b
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isoform. However the Rab27b protein has been shown to be present in melanocytes 
and expression of a GFP tagged form of the protein demonstrated that it colocalises 
with both TRP1 and myosin Va (Chen et al., 2002). Expression of dominant negative 
mutants of this isoform resulted again in an ablation of melanosome transport with 
perinuclear clustering but also affected the number and length of dendrites in the 
melanocyte cells.
Analysis of other cells types has revealed additional roles for Rab27a in 
addition to that shown for melanosome movement. Analysis of ashen platelets 
demonstrated that they had reduced amounts of the platelet dense granule contents 
but near normal levels of the organelles themselves (Novak et al., 2002). Only dense 
granules were affected, as both a  granules and lysosomes were present in normal 
numbers and content. Analysis of pancreatic and pituitary tissue showed that Rab27a 
localised on the membrane of insulin dense core granules (Yi et al., 2002). Yeast two 
hybrid analysis revealed that the GTP bound form of Rab27a interacts with 
granuphilin in pancreatic beta cells. Both proteins showed significant and specific 
expression in pancreatic islets and pituitary tissue and colocalise on the membrane of 
insulin dense core granules as revealed by electron microscopy (Yi et al., 2002). 
Recent evidence confirmed that the (3 isoform of the Rab27 protein is involved in 
pituitary hormone secretion (Zhao et al., 2002). This evidence supports the idea that 
the Rab27 subfamily o f small GTPases regulates the exocytosis of dense core 
granules containing peptide hormones in endocrine cells.
Detailed analysis of cytotoxic T lymphocytes (CTLs) has revealed more 
information about the role of Rab27a with regard to secretory lysosome biogenesis 
and function. CTLs are important in the destruction of tumorigenic and virally 
infected cells. They identify target cells and secrete soluble proteins to promote cell 
lysis. CTLs were studied due to the apparent immune deficiencies displayed by 
patients with Griscelli syndrome who had a known mutation in the Rab27a gene. The 
lytic function of CTLs from ashen mice was reduced by more than 90% (Haddad et 
al., 2001). Western blot analysis showed that the cells had normal levels of perforin 
and granzyme A and B protein and the perforin positive granules were present. 
Therefore it was concluded that Rab27a is not required for the biogenesis of effector 
granules in CTLs. The rapid granule secretion from these cells was, however, 
severely defective. Using immunofluorescence and electron microscopy it was 
demonstrated that lytic granules could correctly polarize in the ashen cells but no
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docking of the granules with the membrane was observed (Stinchcombe et al., 2001). 
This result confirmed that Rab27a was required for the exocytosis of the lytic 
granules. This defect could therefore be due to a defect in the docking/fusion event or 
in a short-range myosin-dependent step prior to docking and fusion. This defect is 
however not due to a problem in recruitment of myosin Va as dilute mice show 
normal CTL function (Haddad et al., 2001).
1.6.3 Melanophilin
The leaden mouse mutant arose spontaneously on an inbred C57BR mouse 
strain. The leaden gene was positionally cloned and shown to encode melanophilin 
(Mlph), a previously undescribed protein (Matesic et al., 2001). Northern blot 
analysis showed that Mlph was highly expressed in adult tissues particularly in 
epithelial enriched tissues such as the lung, kidney, skin, small intestine, stomach and 
in melan-a cells. Mlph has homology to two Rab effector proteins, rabphilin 3 A and 
granuphilin. Rabphilin 3 A interacts in vitro with an actin bundling protein only when 
bound to Rab 3A and is thought to regulate vesicle interactions with the cytoskeleton 
regulating neurotransmitter release (Kato et al., 1996). The 590 amino acid Mlph 
protein contain two Zn2+ binding CX2CXi3,mCX2C motifs and a short aromatic rich 
amino acid in the N-terminus, which has homology to a Rab effector domain 
(Matesic et al., 2001). This N terminal Zn2+binding Rab effector domain is termed 
the sip homology domain, SHD. The critical C terminal myosin Va binding domain 
was shown to be composed of an a-helix based coiled coil domain (Nagashima et al., 
2002). Figure 1.3 outlines the structure of the melanophilin protein.
345-381 429-468 590
z n 2+ Coil 1 Coil 2
Figure 1.3 Diagrammatic representation of the melanophilin protein including 
location of known domains (Adapted from Nagashima et al., 2002).
Introducing the full length Mlph into leaden melanocytes rescues the 
melanosome distribution in 85% of transfected cells confirming that the Mlph protein 
is indeed the product of the leaden gene. Immunofluorescence analysis demonstrated
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that Mlph exclusively colocalises with end stage melanosomes (Wu et al., 2002). 
Analysis of CTLs from leaden mice showed normal lytic granules, which were 
correctly polarised to the immunological synapse and killed target cells (Hume et al., 
2002). Therefore neither myosin Va nor Mlph are required for normal CTL function 
whereas Rab27a is crucial. This suggests that Rab27a interacts with different classes 
of effector proteins in different cell types and doesn’t exclusively interact with Mlph.
1.6.4 Melanophilin, Rab27a and Myosin Va complex
Deletion and site directed mutagenesis established that Mlph was the 
‘missing link’ between myosin Va and Rab27a. The N terminal sip homology 
domain, SHD, of Mlph specifically binds to Rab27 a/b isoforms and the C terminal 
half of the protein directly binds the globular tail o f myosin Va therefore forming a 
tripartite complex. The SHD domain alone could efficiently co-immunoprecipitate 
both Rab27 a/b isoforms (Fukuda et al., 2002). Mlph specifically binds to a GTP7S 
loaded form of Rab27a so this interaction appears to be dependent on the nucleotide 
state of the Rab protein (Nagashima et al., 2002) The cloning and characterisation of 
the human Mlph homologue confirmed these murine observations. It was 
demonstrated that Rab27a, Mlph and myosin Va could form a ternary complex in 
human HMV-II melanocyte cells (Nagashima et al., 2002).
Two studies jointly established the temporal sequence of events leading to 
the formation of this complex. Analysis of leaden melanocytes showed that myosin 
Va has a more diffuse cytosolic distribution and is not melanosome localised 
(Provance et al., 2002). However the Rab27a protein is still localised to 
melanosomes in leaden melanocytes. Electron microscopy of these cells confirmed 
myosin Va is mainly localised to the cytoplasmic filaments and the cytosol consistent 
with a cytoskeletal localisation rather than on perimeter membranes (Hume et al., 
2002). It was also noted that reduced levels of myosin Va were observed in both 
leaden and ashen melanocytes suggesting the proteins stability was influenced by the 
other two proteins (Hume et al., 2002). In conclusion the leaden gene product, 
melanophilin, is not required for targeting Rab27a to melanosomes but mediates its 
association with the actin motor protein myosin Va thus regulating the peripheral 
retention of melanosomes.
The binding of myosin Va to Mlph is absolutely dependent on exon F, an 
alternatively spliced exon in the tail of myosin Va (Wu et al., 2002). Only beads
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coated with myosin Va protein containing exon F can bind to Rab27. These 
alternative spliced exons D and F of 27 and 25 amino acids are absent from the 
brain-spliced iso forms of myosin Va (Seperack et al., 1995). This data suggests that 
alternate codon usage could be a way of specifying cargo. Figure 1.4 outlines the 
composition of this tripartite complex.
Figure 1.4 Composition of the tripartite complex between Rab27a, melanophilin and 
myosin Va (Adapted from Fukuda et al., 2002).
1.6.5 Microtubule based melanosome movement
As described, evidence from dilute mice confirmed that at steady state 
reverse transport along microtubules is prevented and that melanosomes are evenly 
distributed at the cell periphery ready for keratinocyte transfer (Wu et al., 1998; 
Provance et al., 1996; Wei et al., 1997). However some animals, such as fish and 
frogs utilize this reversible melanosome movement for rapid skin colour changes. 
Evidence suggests that general cellular organelle transport is controlled and mediated 
by two classes of microtubule associated motor proteins, kinesins and cytoplasmic 
dyneins which are both known to connect organelles to microtubules (Hiokawa et al., 
1998). Recent work in human melanocytes has identified some of the important 
mechanistic controls of microtubule based melanosome movement. Human 





GTP (  Rab27
melanosome
22
demonstrated a colocalisation between kinesin and melanosomes (Hara et al., 2000). 
Antisense oligonucleotide techniques, which reduced kinesin protein levels by 
around 80% in the melanocytes, inhibited the bi-directional melanosome movement 
promoting retrograde transport. Similar studies in human melanocytes showed that 
dynein is also present in human melanocytes. Antisense experiments produced strong 
anterograde transport of melanosomes towards cellular dendrites (Byers et al., 2000). 
Therefore it can be concluded that both kinesin and dynein microtubule motor 
proteins are important in the bi-directional transport o f melanosomes along 
microtubule networks. Figure 1.5 outlines the components and pathways of 
melanosome movement.
Melanocyte Keratinocyte
Actin filaments □  □  Myosin Va
— Microtubules CO Microtubule motors
Melanosome
Figure 1.5 Components and cytoskeletal networks required for the correct transport 
and localisation of melanosomes to the cell periphery for keratinocyte transfer 
(Adapted from Marks and Seabra, 2001).
1.6.6 Melanosome transfer
Melanosomes must be transferred from melanocytes to epidermal 
keratinocytes where they are found in autophagic vacuoles in a perinuclear 
distribution (Corcuff et al., 2001). This process involves complete organelle transfer
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between two different cell types, which is a unique and poorly understood process. 
Early studies suggested possible mechanisms of transfer including phagocytosis of 
melanocyte dendrites by keratinocytes (Seiberg et al., 2000; Seiberg et al., 2001; 
Sharlow et al., 2000; Minwalla et al., 2001) or exocytosis of the organelle into the 
extracellular space with subsequent uptake by keratinocytes (Yamamoto and 
Bhawan, 1994). Time lapse and electron microscopy made it clear that filopodia on 
melanocytes serve as conduits for melanosome transfer (Scott et al., 2002). The 
protein effectors, PAK1 and N-WASP of cdc42, which is known to mediate filopodia 
formation, is present in melanosome-enriched fractions. Expression of activated 
cdc42 accentuates both filopodia formation and melanosome transfer.
1.7 Mouse coat colour mutants
There is a considerable number of mouse mutants that have defects in 
secretory lysosome function and are termed mouse coat colour mutants due to their 
coat pigmentation defects. All of the mutants are autosomally recessive and are 
characterised by their pigmentation dilution. The mouse mutants are either 
coisogenic or cogenic on an inbred strain so they only differ from their parents in the 
mutant gene. The pigmentation defects are in most cases oculocutaneous affecting 
both the skin and eyes. Fourteen of the mouse mutants exhibit a triad of phenotypes 
resembling the human autosomally recessive disorder Hermansky-Pudlak syndrome 
(HPS). Each gene causes a related yet distinct phenotype. The general phenotype 
shown by all of these mice includes pigmentation dilution, prolonged bleeding times 
and lysosomal dysfunction. Table 1.5 outlines the mouse HPS associated mutants 
and their chromosomal locations.
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Cappuccino (cno) 5 -
Cappuccino 
(Ciciotte et al 2003)
Cocoa (coa) 3 8ql3-q22
HPS3 
(Anikster et al., 2001)
Gunmetal (gm) 14 14qll.2-ql3
RGGTA 
(Detter et al., 2000)
Light ear (le) 5 4pl6
HPS4 
(Suzuki et al., 2002)
Mocha (mh) 10 19pl3.3
AP-38 
(Kantheti et al., 1998)
Muted (mu) 13 6p21-23/5pl5
Muted 
(Zhang et al., 2002a)
Pale ear (ep) 19 10q24.1-q25.1
HPS1 
(Ohetal., 1996)
Pallid (pa) 2 15qll-ter
Pallidin 
(Huang et al., 1999)
Pearl (pe) 13 5qll-ql4
AP-3P1 
(Feng et al., 1999)
Reduced pigment (rp) 7 19ql3 ?
Ruby eye (ru) 19 10q24.1-q25.1
HPS6 
(Zhang et al., 2003)
Ruby eye-2 (ru-2) 7 1 lpl5/15qll
HPS5 
(Zhang et al., 2003)
Sandy (sdy) 13 6p21-23/5pl5
DTNBP1 
(Li et al., 2003)
Subtle gray (sut) 3 3q24-q28 ?
Table 1.5 Mouse coat colour mutants associated with human Hermansky-Pudlak 
syndrome. The known mouse and human chromosome location of the genes is shown 
and the associated protein where known (Adapted from Swank et al., 1998).
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Organelle abnormalities in the mouse coat colour mutants take several forms. 
The primary abnormality in these mice is pigmentation with the mutants showing a 
wide range of pigment dilution. The mutants have defects in pigmentation due to 
changes in the number and/or quality of melanosomes. They are usually fewer in 
number and abnormally large in size. Variations within this phenotype include ruby 
eye, which has reduced numbers of melanosomes and which are spherical rather than 
oval in shape (LaVail et al, 1978), mocha has fewer and smaller melanosomes in hair 
(Lane and Doel, 1974), light ear and pale ear have fewer and larger melanin 
granules in the choriod of the eye (LaVail and Sidman, 1974 and Gardner et al.,
1997) and pallidin which has the greatest degree of pigment dilution. The pallidin 
mutant shows an absence of melanosomes from some tissues and an imbalance of 
stage I and II premelanosomes (Boissy and Nordlund, 1997).
All the mutants exhibit prolonged bleeding times to some degree (see table 
1.6). It has been shown in these mice that platelets are present in normal numbers but 
that they are functionally impaired, with what is known as storage pool deficiency 
(SPD). The platelets dense granules are present but they contain little or no contents, 
which should include, ATP, ADP, calcium, adenine nucleotides, serotonin and other 
amines. ADP is known to be important in recruitment of other platelets to injury sites 
by the opening of calcium channels and increasing the levels of cAMP within the 
platelet (Weiss and Lages, 1997) Elevated levels of intracellular cAMP activate 
phospholipase that cleaves arachidonic acid from membrane phospholipids. 
Arachidonic acid is immediately converted by cyclooxygenase into 
endoperioxidases, which are transformed into thromboxane A2 (TXA2). TxA2 is a 
powerful vasoconstrictor and one of the most potent platelet aggregating agents 
known (Gerrard et al., 1978). Serotonin is crucial in blood vessel contraction. It has 
been shown that the bleeding problems in the pallid, pearl, light ear, pale ear, ruby 
eye, ruby eye-2 and gunmetal can be corrected by bone marrow transplants (Novak et 
al 1985,1995; McGarry et al 1986).
The final common abnormality in these mice is the lysosomal defects that are 
present in most of the mutants. The lysosomes are normal in morphology and contain 
normal enzymatic contents but in the mutant mice they show hypo or hyper secretion 
of these enzymes from several different cell types. This can be demonstrated by 
looking at the lysosomal enzyme secretion into urine from kidney proximal tubule 
cells upon testosterone treatment (see tablel.6) (Novak and Swank, 1979; Meisler,
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1978; Swank et al., 1991). Massive amounts of lysosomal enzymes are secreted from 
kidney proximal tubule cells into urine by male mice. Gross and co-workers 
demonstrated that male mice synthesise and secrete large quantities of kidney neutral 
glycosphingolipids that are likely lysosomal in origin (Gross et al., 1992). This 
enzyme secretion can be replicated in female mice by treatment with controlled 
amounts of testosterone. The amount of lysosomal enzyme secretion upon 
testosterone treatment is drastically reduced in a number of the HPS mouse mutants. 
The most severe examples of this phenotype are shown in the pale ear, light ear, 
mocha and pallid mice. In tissues and cells that aren’t actively undergoing secretion 























C57BL/6J (wt) 2.1 - 1 23.0 21
Cocoa (coa) >15 - 1 26.0 25
Gunmetal (gm) >15 - 1 22.0 26
Light ear (le) >15 + 2-3 1.1 48
Mocha (mh) >15 + 2-3 2.1 7.5
Muted (mu) >15 + 2-3 5.8 11
Pale ear (ep) >15 + 2-3 1.2 46
Pallid (pa) >15 + 2-3 3.5 9.6
Pearl (pe) >15 + 2-3 7.4 11
Reduced pigment (rp) >15 + 1.5 - -
Ruby eye (ru) >15 + 1.5-2 5.0 18
Ruby eye-2 (ru-2) >15 + 1.5-2 4.4 17
Sandy (sdy) >15 + 1.5-2 11 6.2
Subtle gray (sut) 7.5 - 1 20.0 -
Table 1.6 outlines the HPS associated mouse coat colour mutants and their 
phenotypic characterisation. Included is the bleeding time demonstrating platelet 
abnormalities, and lysosomal dysfunction (Adapted from Swank et al., 1998).
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1.7.2 Additional phenotypes exhibited by mouse coat colour mutants
In addition to the triad of phenotypes all the mouse coat colour mutants have, 
several of the mutants also exhibit other additional minor phenotypes in a variety of 
other tissues. The pearl mutant has a reduction in sensitivity to dim light (Balkema et 
al., 1983). The mouse has a decrease in basal infoldings at the retinal pigment 
epithelial as well as abnormalities in melanosomes within this tissue. This has been 
suggested as a model for human congenital stationary night blindness. The pallid 
mutants displays increases in intraalveolar pores and subsequent lesions within the 
lungs (Keil et al., 1996). These show similarities with fibrotic lesions of human HPS 
patients but not the bands of collagen scar tissue typical of fibrotic lung disease. The 
mocha mouse is relatively nervous with constant hyperactivity and jerking 
movements (Lane and Doel, 1974). One allele of this mutant is associated with an 
abnormal brain rhythm involving a modulation of the synchronous synaptic 
activation of the neocortical neurons (Noebels and Sidman, 1989). Finally a number 
of the mutants, pallid, mocha and muted have inner ear abnormalities (Swank et al 
1991). These defects result from an absence or abnormality in the otoliths of the 
inner ear as well as reduced inner ear pigmentation. This causes head tilting 
behaviour and balance defects in the mutant mice. Melanin in the inner ear is thought 
likely to be a pool for binding of metals e.g. manganese, where it may function in the 
biosynthesis of mucopolysaccharides (Rolfsen and Erway, 1984).
1.8 Proteins identified from mouse coat colour mutants
1.8.1 Muted
The muted gene encodes a novel ubiquitously expressed transcript for a 185 
amino acid protein (Zhang et al., 2002a). This protein has no homology to other 
known proteins and contains no obvious motifs. The subcellular localization of the 
protein was determined by the transient transfection of melan-a cells with an epitope 
tagged form of muted. The protein is present in vesicles distributed throughout the 
cell body and dendrites but no colocalisation is observed with melanosomes. The 
same result was seen in transfected COS-7 cells that don’t contain secretory 
lysosomes. No patients with Hermansky-Pudlak syndrome have yet to be shown to 
carry a mutation in the muted gene.
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1.8.2 Pallidin
Pallidin, the protein product o f the pallid gene, was first characterised in 1999 
(Huang et al., 1999). Pallidin is a ubiquitously expressed highly charged polypeptide 
of 172 amino acids with a predicted molecular weight of 19.7kDa and with no 
homology to other known proteins. Pallidin protein is both cytosolic and membrane 
associated as shown by fractionation analysis (Moriyama and Bonifacino, 2002). 
Yeast two-hybrid analysis showed pallidin directly interacts with syntaxin 13, a t- 
SNARE that mediates vesicle docking and fusion (Huang et al., 1999). This 
interaction was confirmed by coimmunoprecipitation and immunofluorescence 
analysis that demonstrated the expected overlap of the two proteins. Secondary 
structure predictions revealed that pallidin has a very high alpha helical content and 
both the central and C terminal portions of the protein have a significant propensity 
to form coiled-coil structures (Falcon-Perez and Dell*Angelica, 2002). This protein 
region was also the most conserved between species, with coiled coil structures 
known to mediate protein-protein interactions.
A number of studies on the t-SNARE syntaxin 13 have shown diverse 
functions. The localisation by electron microscopy o f this protein to tubular 
extensions of early endosomes, recycling endosomes and vacuolar endosomes 
containing clathrin suggested a role in receptor recycling from endosomes to the 
plasma membrane (Prekeris et al., 1998). Another study demonstrated the 
requirement of syntaxin 13 for homotypic endosome fusion (McBride et al., 1999). 
Finally the cytoplasmic domain was found to interact with EEA-1 which functions in 
tethering before early endosome fusion. There is much speculation about how this 
function could relate to melanosome biogenesis especially in the light o f recent data 
on the pallid mouse coat colour mutant. The current model for early melanosome 
biogenesis has focused on the existence of an early endosome compartment 
containing large clathrin lattices on its cytoplasmic side and termed the coated 
endosome (Raposo et al., 2001). Syntaxin 13 may therefore be crucial in driving 
early endosome fusions to generate the coated endosome or by mediating the 
removal of recycling receptors. Work on tyrosinase and related proteins showed that 
they appear to traffic from the TGN to premelanosomes and seem to bypass the 
coated endosome (Marks and Seabra, 2001). In this context syntaxin 13 may function 
as a premelanosomal t-SNARE. Steady state levels of syntaxin 13 appeared to be
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reduced in cell extracts from the pallid mouse, suggesting that pallidin may have an 
important role in maintaining the stability of syntaxin 13 (Huang et al., 1999).
After the identification of syntaxin 13 as a binding partner for pallidin further 
cosedimentation and coimmunoprecipitation studies established that pallidin is part 
of a hetero-oligomeric complex of which one component was muted (Moriyama and 
Bonifacino, 2002). At the same time this study was undertaken an additional group 
confirmed the presence of this complex and termed it BLOC-1 (Biogenesis o f 
lysosome related organelles complex 1) (Falcon-Perez et al., 2002). Sedimentation 
velocity analysis demonstrated that soluble pallidin is part o f a 200kDa complex and 
coimmunoprecipitation again showed an interaction between pallidin and muted. 
However, yeast two hybrid analysis demonstrated the interaction between the two 
proteins was not direct. This yeast two-hybrid analysis did show that pallidin was 
capable of self-association, with the coiled-coil domain both necessary and sufficient 
for this self-association. Immunofluorescence analysis of higher-level expression of 
pallidin resulted in actin localisation around the cell nucleus giving a possible 
functional site of action for BLOC-1.
1.8.3 Mocha and Pearl
Adaptor protein complex 3 (AP-3) is a member of the adaptor protein 
complex family of which there are four identified complexes, AP-1, AP-2, AP-3 and 
AP-4. As previously described they have a dual purpose and are important in both 
forming vesicles and recruiting cargo to the newly formed vesicles (Hirst and 
Robinson, 1998). The AP-3 complex is a heterotetramer consisting of 160-kDa 5, 
120-kDa |S, 47-kDa fi and 22-kDa a subunits. The complex in mice and humans 
consists of neuronal and non-neuronal isoforms. The non- neuronal form is 
composed of /33A and /z3A and the ubiquitous 5, o3A  or <j3B subunits 
(DelF Angelica et al., 1997b; Simpson et al., 1997). In neuronal cells the complex is 
made up of 03B, p3B and the ubiquitous subunits (Newman et al., 1995; Pevsner et 
al., 1994; Simpson et al., 1996). It became evident from Drosphilia genetics that the 
AP-3 protein complex was important in pigment production. The garnet (Ooi et al., 
1997; Simpson et al., 1997) and ruby (Kretzschmar et al., 2000) reduced eye pigment 
mutants in Drosphilia were shown to be mutations in the 8 and /53A subunits of the 
AP-3 complex respectively.
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The mocha mouse coat colour mutant is a null allele of the 8 subunit of the 
AP-3 complex (Kantheti et al., 1998). Shortly after the pearl mouse was identified as 
having a mutation in the 03 A  subunit of the AP-3 complex with a complete absence 
of any detectable mRNA in a variety of tissues (Feng et al., 1999). 03 A  protein was 
undetectable in all the cells and tissues from pearl mice. Interestingly it was noted 
that the expression of other AP-3 subunits in pearl cells was reduced and that the 
usual punctate distribution of AP-3 in these cells is a more diffuse cytosolic pattern 
upon immunofluorescence analysis (Zhen et al., 1999). Analysis of the assembly and 
function of the remaining subunits of the AP-3 complex in both mocha and pearl 
cells showed that the 03 and fi3 subunits can still co-assemble into a heterodimer in 
mocha and 8 and o3 could likewise co-assemble in pearl cells (Peden et al., 2002). 
The o3 subunit remained monomeric in mocha and the p3 subunit was destroyed in 
pearl.
Generation of a null allele of 03 A  gave a more severe phenotype than 
that observed in pearl but with an absence of any neurological defects (Yang et al., 
2000). Immunofluorescence analysis of both embryonic fibroblasts and adult 
melanocytes from pearl mice showed the lysosomal proteins LAMP I and II, and the 
melanosomal protein tyrosinase mislocalized from their usual subcellular locations. 
LAMP I and II appeared to cluster at the cell surface whereas tyrosinase resides 
within non-endosomal vesicular structures. There are two models for the possible 
functional mode of action of the AP-3 complex in LAMP protein sorting. The first 
model suggests AP-3 recruits LAMP’S into the direct trafficking pathway from the 
TGN to endosome then finally the lysosome. The other model suggests AP-3 
functions in an early/recycling endosome compartment in which LAMP’S become 
segregated from other integral membrane proteins which cycle back to the plasma 
membrane. Both of these models could explain the plasma membrane accumulation 
of LAMP proteins in the absence of functional AP-3 (Starcevic et al., 2002). 
Mutation analysis of the 03 A subunit in rescue experiments on pearl cells confirmed 
that it is the hinge and/or ear domains of the subunit, which were functionally the 
most important (Peden et al., 2002). These results confirmed that a mutation in 03 A 
affected the trafficking of both lysosomal and melanosomal proteins and the hinge 
and/or ear domains were functionally the most important. A potential regulator of the 
function of AP-3 is phosphorylation. In in vivo studies both the 03 A  and neuronal
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/33B subunits are heavily phosphorylated on serine residues (Newman et al., 1995; 
Dell*Angelica et al., 1997b).
It remains controversial as to whether AP-3 dependent protein targeting 
requires the coat protein clathrin from both immunofluorescence and 
immunoelectron microscopy (Peden et al., 2002; Simpson et al., 1996; Simpson et 
al., 1997; Dell’Angelica et al., 1998). If this process does not require clathrin an 
additional scaffolding protein may be required with studies in yeast providing 
information on this possibility. The Vps41p protein in yeast shows no real homology 
to clathrin yet is required in AP-3 dependent trafficking. It binds directly to the 6 
subunit of AP-3 (Rehling et al., 1999; Darsow et al., 2001).
Consistent with the mocha mouse not showing any immunological defects, 
analysis of macrophages and B cells in these mice showed that they have no 
abnormalities in the trafficking of MAC invariant chain complexes from the TGN to 
endosomal compartments for peptide loading (Sevilla et al., 2001). This suggests that 
this particular trafficking pathway has an AP-3 independent mechanism.
1.8.4 Gunmetal
Analysis of proteins involved in vesicular transport was performed by 
immunoblot analysis o f platelet extracts from mouse coat colour mutants (Richards- 
Smith et al., 1999). Most platelets contained normal levels of these proteins except 
for the gunmetal mouse, which showed decreased amounts of SNAP-23 protein. 
SNAP-23 is a membrane-associated protein, which is an important link in membrane 
fusion events (Guo et al, 1998). Final clarification of the genetic mutation causing 
the gunmetal phenotype came with the finding that gunmetal results from a G-» A 
substitution mutation within the subunit of the 60kDa enzyme Rab geranylgeranyl 
transferase (Rabggta) (Detter et al., 2000). The Rabggta enzyme adds two 
geranylgeranyl 20 carbon isoprenoid residues to each of two C terminal cysteine 
residues found in double cysteine motifs such as CXC, CCXX and CC within Rab 
proteins (Desnoyers and Seabra, 1998). During geranylgeranylation a thioether bond 
is formed between the cysteine sulphur atom and the geranylgeranyl group. When 
Rab proteins are double geranylgeranylated their hydrophobic character increases 
dramatically aiding their insertion into target membranes, which is crucial for their 
correct functioning.
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Immunoblot analysis of gunmetal platelet extracts demonstrated a 70% 
reduction in the amount of Rabggta with a corresponding 70% reduction in Rabggta 
function (Detter et al., 2000). Studies have been performed to look at the prenylation 
defects of various Rab proteins in platelets, melanocytes and other tissues in 
gunmetal mice (Zhang et al., 2002b). The degree of prenylation in platelet extracts 
was analysed by protein mobility on SDS-denaturing gels, Triton X I14 partitioning 
and differential centrifugation. These studies revealed that the Rab proteins 27a, 11a, 
4 and lb  were most severely affected in gunmetal platelets in terms of non- 
prenylation and subsequently not membrane associated. This wasn’t the case in 
various other tissues where the Rab proteins were correctly membrane associated. 
This tissue specific difference may be due to the amount of Rab proteins within a 
particular cell type that need to be prenylated. Immunofluorescence analysis o f both 
melan-a and gunmetal melanocytes demonstrated that Rab27a has a punctate 
distribution in melan-a cells but this was disrupted in the gunmetal cells which 
showed a much more diffuse cytosolic distribution due to the non-prenylation of the 
protein. In the CTLs of gunmetal mice there is a partial loss of killing and lytic 
granules don’t appear to be polarized properly (Stinchcombe et al., 2001). This 
appears to be independent of the Rab27a protein as previously described suggesting 
that other Rab proteins might promote microtubule-dependent polarization of lytic 
granules. The gunmetal mouse illustrates the importance and correct localisation of 
Rab proteins for the function of secretory lysosomes. It has been speculated that the 
mutant tissue specific effects seen in the gunmetal mouse are probably due to the 
increased levels of Rab proteins in platelets and melanocytes because of the higher 










Figure 1.6 Diagrammatic representation of the hypothesis for the mode of action of 
the Rabggta enzyme and the phenotypic effects observed in the gunmetal mouse.
1.8.5 Pale ear
The pale ear (ep) mouse mutant arose spontaneously in a C3HeB/FeJ inbred 
strain (Lane and Green, 1967) with homozygous adult mice exhibiting pale ears and 
tails. The ep mutant mouse was suggested to be the homologue for Hermansky- 
Pudlak syndrome, as the mutant most closely resembled the triad of phenotypes 
shown by human Hermansky-Pudlak syndrome patients. This spontaneous mouse 
mutation is caused by the insertion of an IAP element in the 3’ coding region 
(Gardner et al 1997), the net result being the loss of the C terminal 46 amino acids of 
the mouse ep protein.
Only the pale ear and ruby-eye mutants map to mouse chromosome 19, which 
is homologous to human chromosome 10q2 containing the HPS gene (Wildenberg et 
al, 1995 and Fukai et al, 1995). The mouse pale ear gene was identified as the 






demonstrated an increase in size of the mRNA transcript in ep mice due to the 
presence of the insertion element in the 3’ end of the gene. There were however no 
quantitative differences in the levels of mRNA between the wt and ep mutant mice 
tissues (Gardner et al, 1997). Northern blot analysis revealed mRNA expression in 
heart, brain, spleen, lung, liver, kidney and testis with an absence from skeletal 
muscle. The mouse and human genes are highly conserved at both the nucleotide 
(83% identity) and amino acid levels (81% identity). In addition both the mouse and 
human HPS genes contain a rare AT-AC intron. In the human HPS gene this rare 
intron is intron 16 and the homologous intron 15 of the mouse HPS gene is likewise 
an AT-AC intron (Feng et al., 1997). This form of intron is characterised by a 
dinucleotide AT occurring at the 5* end and an AC at the 3* end (Hall and Padgett,
1994).
Analysis of both the melanosomes and platelet dense granules in ep/ep 
homozygous mice has been conducted by electron microscopy (Gardner et al, 1997). 
The choriodal melanosomes within the eye tissue are abnormally large and retinal 
epithelial melanosomes are aberrantly shaped and incompletely melanized. Platelet 
numbers in ep/ep mice are normal but these contained very few dense granules. The 
aggregation of these platelets is abnormal and the ATP release from them is greatly 
decreased. Homozygous mutants also show much-diminished life spans with none 
surviving a two-year experimental period (McGarry et al., 1999). This was mainly 
due to the severity of lung abnormalities observed in these mutants.
1.9 Hermansky-Pudlak syndrome in humans
1.9.1 Phenotype of Hermansky-Pudlak syndrome patients
The Hermansky-Pudlak syndrome was first described in 1959 (Hermansky 
and Pudlak, 1959) as a disorder of tyrosinase-positive oculocutaneous albinism, 
bleeding tendency and ceroid-lipofuscin lysosomal storage disease. The condition is 
life threatening with the occurrence of progressive pulmonary fibrosis, 
granulomatous colitis, renal failure and cardiomyopathy. The condition is usually 
fatal between the ages of 30-50 years due to restrictive lung disease, haemorrhage or 
colitis. All of the triad of phenotypes are associated with functional defects in 
secretory lysosomes in platelets, melanocytes and reticuloendothelial tissue. HPS is
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usually a rare disorder but in northwest Puerto Rico it occurs at a frequency of 1 in 
1800 due to a founder effect making it the most common single gene disorder 
(Witkop et al., 1990).
1.9.2 Chediak-Higashi syndrome in humans
There is an additional autosomally recessive single gene disorder that is 
similar to HPS and is termed Chediak Higashi syndrome (CHS). Patients show 
similar pigmentation, and bleeding problems but with an additional immunological 
dysfunction. CHS is a lethal disorder characterised by severe immunological defects, 
partial albinism, recurrent bacterial infections and the presence of giant intracellular 
organelles including lysosomes, melanosomes, platelet dense granules and cytolytic 
granules (McVey Ward et al., 2000). Patients exhibit abnormally large melanosomes 
that cluster in the perinuclear area of the cell (Windhorst et al., 1968) and abnormal 
platelet dense granules (Rendu et al., 1983). The CHS disease is homologous to the 
mouse coat colour mutant beige. The gene responsible for CHS was positionally 
cloned to mouse chromosome 13 (Barbosa et al., 1996). The gene was highly 
conserved in all species and encoded a very large protein of predicted 429kDa 
molecular weight and termed LYST for lysosomal trafficking regulator. Protein 
sequence analysis revealed the presence of N terminal HEAT repeats, thought to 
mediate membrane associations and often associated with vesicle transport. In 
addition a C terminal BEACH found in this protein and a number o f distantly related 
proteins, which are factors associated with the spingomyelinase activation. The 
function of this domain is unknown but it is usually followed by a number of WD-40 
domains, thought to mediate protein-protein interactions (Nagle et al., 1996). The 
protein exhibits a primarily cytosolic subcellular distribution (Perou et al., 1997).
The exact function of the LYST protein still remains to be elucidated, however work 
on CTLs suggests the reduced CTL killing ability in CHS is due to an inability to 
secrete lytic granules indicating a possible role in fusion or fission (Stinchcombe et 
al., 2000).
1.9.3 Platelet storage pool deficiency in HPS
Most patients with Hermansky-Pudlak syndrome have mild hemorrhagic 
problems but these can vary between patients. Some patients have considerably 
increased bleeding times that can cause difficulties, for example during simple tooth
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extractions. Irreversible secondary aggregation of HPS platelets after stimulation is 
lacking but can be rescued by overstimulation with epinephrine. Using thin section 
transmission electron microscopy of platelets from HPS patients, a marked reduction 
or absence of dense granules was reported (Witkop et al 1987). The absence of dense 
granules in HPS patients was also shown on unstained whole mounts of platelets. 
This type of storage pool deficiency (SPD) with an absence of dense granules is 
termed 5 SPD. The deficiency of the dense granule contents including serotonin, 
calcium, ATP, ADP and pyrophosphate accounts for the bleeding disorder observed 
in these patients. Clearly the basic defect in these patients is a specific abnormality in 
organelle development that prevents formation of intact granule structures.
A number of biochemical studies on dense granule membrane proteins have 
yielded further information about the nature of 8 SPD in HPS patients. The first 
specific dense granule membrane protein was identified by the production of 
monoclonal antibodies raised against purified dense granules (Gerrard et al., 1991). 
One of the monoclonal antibodies produced identified a 40kDa protein by 
immunoblot analysis specifically on dense granule preparations. The antibody gave 
punctate staining on permeabilised platelets. The protein contained a carbohydrate 
component and formed multimeric complexes much like snaptophysin so was termed 
granulophysin. Immunoblot analysis on HPS platelets showed much reduced levels 
of this protein. This was later confirmed by quantitative ELISA analysis; again 
showing reduced levels of granulophysin in HPS platelets (Shalev et al., 1992). Later 
studies using amino terminal sequencing showed granulophysin was homologous to 
CD63. Antibodies to CD63 detected fewer granules in platelets from HPS patients 
compared to normal platelets using immunofluorescence analysis (Nishibori et al., 
1993).
Additional work on the lysosomal granule membrane protein LAMP-2 
showed its presence in platelet dense granule membranes (Israels et al., 1996). 
Detailed flow cytometry of thrombin-stimulated platelets showed normal platelets 
have a biphasic surface expression of LAMP-2 consistent with early expression from 
dense granules followed by minimal later lysosomal granule release. However when 
these studies were repeated with HPS platelets only late lysosomal associated 
LAMP-2 expression is observed. These studies confirm that dense granules are 
completely absent from the platelets of HPS patients and aren’t simply just the 
granule structures themselves lacking the correct contents.
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1.9.4 Albinism in HPS
As described previously the skin pigment melanin is formed in specialized 
secretory lysosomes termed melanosomes within melanocyte cells in the skin 
epithelium. Patients with HPS exhibit hypopigmentation of the skin, hair and eyes. 
Patients with HPS exhibit a high degree o f photosensitivity due to hypopigmentation 
of the choroids within the retina of the eye. The hypopigmentation in general is 
heterogeneous ranging from severe dilution to near normal. This pigmentation defect 
is termed oculocutaneous albinism (OCA) and the enzyme tyrosinase responsible for 
melanin production is present within melanocytes (Swank et al., 1998).
Studies on melanocytes cultured from the mouse mutant pale ear which is 
homologous to HPS in humans, demonstrated that melanocytes from these mutant 
mice contained very few abnormally large melanosomes (Gardner et al., 1997). It has 
however been controversial as to whether these abnormally large melanosomes are 
present in humans. A study of a Puerto Rican patient showed that no large 
melanosomes were present (Boissy and Nordlund, 1997). However a recent study 
using electron microscopy of skin biopsy samples from a Japanese patient with HPS 
demonstrated the presence of these large melanosomes as well as stage I, II 
unmelanized premelanosomes (Horikawa et al., 2000). When these melanocytes are 
cultured the cells show no change in morphology but giant melanosomes are present 
in approximately 5-10% of the cells.
Analysis of the trafficking of known melanogenic enzymes in melanocytes 
from HPS patients yielded a useful insight into the defects in these particular cells. 
Pure cultures of melanocytes from four HPS patients show that tyrosine hydroxylase 
activity in lysates is normal therefore the levels of this enzyme were normal (Boissy 
et al., 1998). However the activity in intact cells is dramatically reduced (by up to 
50%). In addition DOPA histochemistry has proven to be a useful technique to detect 
the location of melanin producing enzymes in specific cells. These copper containing 
enzymes catalyse the conversion of tyrosine to DOPA (di hydroxy phenyl alanine) 
which then undergoes a further oxidation to DOPA quinone. This DOPA quinone 
undergoes a series of spontaneous reactions to form dark melanin pigment that can 
easily be visualised. This histochemical reaction is unusual as it uses the natural 
substrate (DOPA) and the natural product (melanin) rather than artificial analogues. 
DOPA histochemistry showed an extensive amount of DOPA product specifically in 
cistema and vesicles of the TGN and in melanosomes. The same study on HPS
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melanocytes demonstrated that numerous melanosomes had no DOPA product, but a 
number o f abnormal large structures and numerous 50nm vesicles scattered 
throughout the cytoplasm were DOPA positive. Immunofluorescence analysis on the 
localisation o f the proteins TRP-1 and granulophysin in HPS cells showed a less 
dense granular staining pattern and numerous large structures, which aren’t present 
in control cells. This data is confirmed by antisense studies again in SK-MEL-188 
pigmented melanoma cells (Sarangarajan et al., 2001). Cells were transfected with 
HPS1 in either the sense or antisense orientation to see the effects. Antisense cells 
have a decrease in melanin at passage 6 after transfection with tyrosinase activity in 
intact cells much reduced. Immunofluorescence and electron microscopy analyses 
demonstrated no difference in location of tyrosinase or TRP-1 in untransfected or 
sense transfected cells, however in antisense cells these proteins localized to distinct 
large granule structures throughout the cytoplasm. The interpretation from these 
studies is that the pigmentation defects in HPS patients result from the incorrect 
localisation of the melanogenic proteins tyrosinase, TRP-1 and TRP-2 in 
melanocytes lacking HPS1 protein.
1.9.5 Ceroid-Lipofuscin lysosomal storage disease in HPS
Patients with Hermansky-Pudlak display a dysfunction of lysosomes in 
particular tissues known as ceroid-lipofuscin storage disease. This defect was 
initially identified in bone marrow macrophages when the syndrome was first 
characterised (Hermansky and Pudlak, 1959). These macrophages contain large 
clumps and masses within large vacuoles. Further analysis was performed by White 
and co workers, (White et al., 1972), on bone marrow macrophages from both 
juvenile and adult HPS patients to define this material present within the 
macrophages. Light microscopy of wet droplets of concentrated macrophages 
demonstrated no abnormalities in the juvenile HPS macrophages but the adult 
macrophages contained clumps of gold tinted particles and masses of large vacuoles 
within the cells. They noted that this conversion was a progressive transformation 
resulting in an end stage cell whose damaged cytoplasm is replaced by huge lipid 
containing vacuoles surrounded by particulate debris. Fusion of small sacs leads to 
the formation of larger vacuoles and the association of sacs containing degenerating 
material. This results in the formation of huge irregular inclusions. The main role of 
bone marrow macrophages is the absorption and degradation of erythrocytes, so it is
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assumed they are the main source of the ceroid material. Histochemical studies 
suggested the material is a complex lipopigment containing carbohydrate, protein 
and fat and being very similar or identical to lipofuscin or ceroid. A number of 
studies on patients have demonstrated the presence of ceroid in a variety of tissues 
particularly of the reticuloendothelial system for example renal tubular epithelial 
cells, spleen macrophages, and throughout the gastrointestinal tract (Schinella et al., 
1985).
Detailed pathological studies of a Japanese patient with HPS outlined the 
distribution of cells containing ceroid-like pigment, summarised in table 1.7.
Organ Degree of accumulation Organ Degree of accumulation
Bone marrow + + + Pancreas +
Spleen + + + Oesophagus +
Liver + + + Stomach +
Lymph node + + Small bowel +
Lung + Large bowel + + +
Kidney + + + Testis +
Heart + Prostate +
Adrenal + Urinary bladder +
(+ + + Severe, + + Moderate, + Slight)
Table 1.7 Ceroid accumulations in various organs and tissues of a Japanese patient 
with Hermansky-Pudlak syndrome (Taken from Takahashi and Yokoyama, 1984).
Bronchial lavage studies of a patient with HPS also demonstrated ceroid 
within alveolar macrophages within the lung (White et al., 1984). This accumulation 
of ceroid within the reticuloendothelial system usually leads to the onset of fibrosis 
in HPS patients resulting in granulomatous colitis of the gut (Schinella et al., 1980) 
or pulmonary fibrosis within the lungs (Hermansky and Pudlak, 1959). When 
macrophages become activated they undergo an increase in oxygen consumption and 
secretion of superoxide anions and hydroperoxide. It has been postulated that this 
production of oxygen species in these ceroid filled lung macrophages and gut tissue 
may cause the tissue damage and fibrosis observed in the HPS patients (White et al., 
1984).
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1.10 Genetics of HPS
The HPS gene was first localized by linkage disequilibrium mapping to a 
0.6cM interval of the human chromosomal segment 10q23.1-q23.3 (Fukai et al.,
1995). This method is well suited to the precise localization of genes for rare 
autosomally recessive disorders by the advantage of identity by descent. At the same 
time another group analysed pooled DNA samples from Puerto Rican patients and 
screened the genome for candidate loci (Wildenberg et al., 1995). They found 
evidence for significant linkage for a marker also on chromosomal segment lOq. This 
identified chromosomal region didn’t include any known genes as potential 
candidates requiring the use of positional cloning to identify the gene. A YAC and 
BAC map was generated and the candidate gene segment was identified within the 
BAC/PAC contig by cDNA selection, genomic sequencing and exon trapping (Oh et 
al., 1996). The selection of cDNA from a human melanoma cDNA library using 
elements of the contig yielded only a single cDNA corresponding with a novel gene.
Subsequently the genomic structure of the HPS1 gene was fully 
characterised, with the gene containing 20 exons spanning approximately 30.5kb 
(Bailin et al., 1997). Four alternative splice products of HPS 1 were identified with 
exon 9 or a portion of exon 20 either included or excluded from the HPS1 mRNA. A 
total of 15 non-pathological DNA sequence polymorphisms have been identified 
many of which were silent and thought to result in no effect. Recently a variant 
HPS1 cDNA containing the same 5’ sequence and a unique 3’ sequence of 319bp 
was analysed (Wildenberg et al., 1998). This suggested two alternative transcripts are 
produced from a single gene and the presence of two polyadenylated transcripts in a 
variety of cells and tissues demonstrated by RT-PCR and Northern blot analysis. 
More recently a psuedogene was discovered by sequence database search that shows 
a high degree of similarity to HPS-1 cDNA (Huizing et al., 2000). The pseudogene 
contained several intact exons and 95% sequence homology to HPS1 cDNA.
A number of mutations present in the HPS1 gene of patients with 
Hermansky-Pudlak syndrome from various regions of the world have been 
characterised. From the original cloning paper three different frameshift mutations 
were identified all resulting in C terminal truncations of the HPS1 polypeptide (Oh et 
al., 1996). The first is the Puerto Rican mutation that is 16bp duplication in exon 15 
giving a frameshift distal to Pro496 with the resultant nonsense polypeptide
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terminating at codon 586. 22 Puerto Rican patients were identified as being 
homozygous for this frameshift. The homogeneity of this mutation in Puerto Rico 
suggests it arose in the early population or during colonization. The second mutation 
characterised was the Japanese frameshift which was a single base duplication within 
codon Ala441 again resulting in a frameshift and termination of a nonsense 
polypeptide at codon 451. Finally a Swiss frameshift mutation was characterised 
with an additional cytosine in a run of eight at codon Pro324 again resulting in a 
nonsense polypeptide terminating at codon 451. Subsequently analysis of a further 
22 non-Puerto Rican HPS patients identified three new mutations, two further 
frameshifts and a nonsense mutation at Thr332, Ser396 and Glul33 (Shotelersuk et 
al., 1998). A total of 12 different mutations of HPS 1 have been identified. Analysis 
of 44 Puerto Rican and 24 non-Puerto Rican HPS patients showed the presence of a 
frameshift hotspot between codons 321-322 (Oh et al., 1998). All of the patients 
show varying degrees in severity of their HPS symptoms according to the particular 
mutation that they posses.
Northern blot analysis of mRNA from a variety of tissues and cell types 
detected a major 3.0kb mRNA and a minor 3.9kb mRNA in all tissues and cells 
studied (Oh et al., 1996). But these levels varied in abundance with HeLa cells 
containing the lowest levels. Expression studies in HPS1 have been reported for the 
Puerto Rican 16-bp duplication, in which no HPS1 mRNA was detected (Hazelwood 
et al., 1997). The three mutations identified by Shotelersuk and colleagues have been 
shown to produce none or very reduced levels of mRNA by Northern blot analysis 
(Shotelersuk et al., 1998). The mutation at Thr332 resulted in a much-reduced 
amount of HPS 1 mRNA, and the Ser396 mutation resulted in the complete absence 
of HPS 1 mRNA. Typical non-Puerto Rican HPS1 patients have been shown by 
Northern blot analysis to produce significant amount of HPS 1 mRNA.
1.10.1 HPS1
The major mRNA transcript of the HPS1 gene codes for a 700 amino acid 
polypeptide of 79.3kDa expected molecular weight (Bailin et al., 1997). The minor 
isoform, the result of alternative splicing of exon 9 encoding amino acids 290-313, 
codes for a 75.9 kDa polypeptide. The protein contains no homologies to any other 
known proteins and no significant identifiable motifs of interest. When the protein 
sequence was first analysed it was thought to contain two potential transmembrane
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regions (79-95 and 369-396) and two apparent N-glycosylation sites (528 and 560) 
(Oh et al., 1996) but these were both dismissed in later studies (Oh et al., 2000). 
There is a Pro-Leu-Leu motif present at the extreme C terminus of the human HPS1 
polypeptide that is thought to be an important trafficking sequence for melanosomal 
proteins such as Pmel 17 and tyrosinase (Kwon et al., 1991).
Preliminary molecular characterisation studies on the HPS1 protein have been 
performed. Northern and Western blot analysis demonstrated that HPS1 is present in 
all cell lines and tissues tested and protein levels aren’t higher in melanoma or 
megakaryocyte cell lines (Dell’Angelica et al., 2000b). Fractionation and 
immunoprecipitation studies concluded that approximately 80% of HPS 1 protein is 
cytosolic and 20% peripheral membrane associated. Immunofluorescence analysis of 
M l fibroblasts transiently expressing His tagged HPS1 protein revealed a diffuse 
cytosolic distribution consistent with the fractionation studies. Colocalisation studies 
confirmed that overexpression of HPSlp has no effect on the punctate distribution of 
AP-3. An immunoprecipitation and recapture procedure failed to show that HSPlp 
directly interacted with ct3 subunit of the AP-3 complex. Both of these studies 
illustrated that HPSlp doesn’t appear to play a role in the AP-3 dependent trafficking 
pathway. Cytofluorometric analysis of B-lymphoblastoid cells from HPS patients 
with a HPS1 mutation showed that there is no increase in expression of the 
lysosomal protein CD63 at the cell surface. This demonstrated that these patients 
have no defects in the trafficking of lysosomal proteins.
Further fractionation analysis yielded information about potential HPS1 
containing protein complexes. Cytoplasmic fractionation by gel filtration followed 
by immunoblotting of human lymphoblastoid cells revealed that the HPS1 protein is 
part o f a 200kDa complex (Oh et al., 2000). The same experiment was repeated using 
FME melanoma cells. The fractionation result yielded using these cells was very 
different to that from the human lymphoblastoid cells. The HPS1 protein is part of a 
complex greater than 500kDa in the melanoma cells (Oh et al., 2000). The HPS1 
protein is partially membrane associated as shown by phase separation using triton 
X-l 14 with the HPS1 protein exclusively partitioning into the soluble phase. Tris- 
HCL disruption of the large granule fraction from these FME melanoma cells 
abolished the HPS1 protein membrane interaction. Further immunofluorescence 
analysis of melanoma and melanocyte cells revealed that a large fraction of HPS 1 is 
concentrated in the perinuclear area in a somewhat granule pattern that appears to
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correspond with early stage melanosomes. There was virtually no colocalisation with 
the lysosomal marker LAMP-1 or the trans Golgi network marker TGN46. This 
localisation result was also confirmed by electron microscopy.
It can therefore be concluded that the HPS1 protein is part of a ubiquitous 
cytosolic complex, and in specialized cells such as melanocytes it becomes 
transiently and specifically associated with membranous components of early 
organellogenesis (Oh et al., 2000). The actual function of the HPS1 protein and the 
other protein components of these high molecular weight complexes remain to be 
elucidated.
1.10.2 HPS2
Due to the finding that the pearl and mocha mouse coat colour mutants had 
mutations in subunits of the adaptor complex AP-3, studies were performed to 
investigate if  patients diagnosed with HPS syndrome may also have similar 
mutations and not simply just in the HPS1 gene. A panel of fibroblasts from different 
HPS patients were analysed by immunofluorescence and Western blotting using 
antibodies to various subunits of the AP-3 complex (Dell* Angelica et al., 1999). Two 
siblings suffering from HPS were found to have greatly reduced levels of some of the 
AP-3 subunits but the other adaptor complexes AP-1 and AP-2 were unaffected.
Both the patients are compound heterozygotes for mutations in the 03A subunit of 
the AP-3 complex. It was therefore concluded that the HPS2 gene encoded the /33A 
subunit o f the AP-3 complex. One of the mutant alleles was a 21 amino acid internal 
deletion and the other was an L580R non-conservative substitution. Both of these 
mutations were in the trunk domain of the subunit protein that is presumed to be 
important in the assembly with other AP-3 subunits. Studies on the patient’s 
fibroblasts demonstrated that they have increased surface expression of the 
lysosomal proteins CD63, LAMP-1 and LAMP-2 and increased internalisation of 
antibodies to these proteins upon incubation with the cells. Non-lysosomal proteins 
were all unaffected in this study.
To study the potential additive effects of mutations in both the HPS1 and the 
P3A subunits, mice doubly homozygous for both HPS1 and HPS2 were bred (Feng 
et al., 2002). Cooperation was evident from this cross as the mice exhibited increased 
hypopigmentation, lysosomal and platelet dense granules defects. Serotonin levels in 
platelet dense granules were depressed to only 1% of normal levels giving an
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indication of the severity of this double mutation. The defects were however still all 
confined to the secretory lysosomes. This study showed that the pearl and pale ear 
genes must be functionally interactive in related but independent pathways and 
confirms the molecular studies on HPS1 protein (Dell’Angelica et al., 2000b).
Further analysis of melanocytes from HPS2 patients showed the melanosomal 
protein tyrosinase is mislocalized from a granular pattern to being predominantly 
confined to a perinuclear area within structures resembling multi vesicular bodies 
and/or late endosomes (Huizing et al., 2001a). An additional melanosomal protein 
TRP-1 shows a normal granular distribution. Transfection of the HPS2 melanocytes 
with the /33A subunit of AP-3 subunit restored the tyrosinase protein to its correct 
localisation, confirming that the trafficking of tyrosinase was dependent on the AP-3 
adaptor protein complex. Previous data has established a direct interaction between 
the fi3 A subunit of AP-3 subunit and tyrosinase via a dileucine signalling motif in 
the melanosomal protein (Dell*Angelica et al., 1997a). TRP-1 also contains a 
dileucine signalling motif but it contains different amino acids around this signal 
compared to tyrosinase, which may suggest it is transported to premelanosomes in a 
non-AP-3 dependent manner.
1.10.3 HPS3
Homozygosity mapping on pooled DNA from six families with Hermansky 
Pudalk syndrome from central Puerto Rico localised a new HPS susceptibility gene 
to human chromosome 3q24 (Anikster et al., 2001). This gene product is termed 
HPS3 and has a putative product o f 113.7 kDa. High levels of HPS3 mRNA are 
present in kidney, liver, and placenta. Again this protein contains no predicted 
transmembrane regions, glycosylation sites or homology to other known proteins. 
Analysis of eight non-Puerto Rican HPS patients who did not show the 16bp 
duplication characteristic of HPS 1 disease, and had normal levels of AP-3 subunits 
demonstrated that they have mutations in the HPS3 gene. A common mutation of 
1303 + 1 G—>A causing a splice site mutation removing exon 5 was identified in five 
Ashkenazi Jews (Huizing et al., 2001b). Northern blot analysis of fibroblast mRNA 
confirmed the absence of HPS3 transcripts in these patients. All the patients with 
HPS3 mutations are mildly hypopigmented but all have a history of excessive 
bleeding
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The mouse coat colour mutant in the homologous mouse chromosome 
location to human HPS3 is subtle gray. However subtle gray mice were shown by 
Northern blot studies to contain normal levels of HPS3 mRNA (Huizing et al., 
2001c). The subtle gray mouse does contain the normal number of platelet dense 
granules therefore has been ruled out as being the murine homologue of HPS3. The 
only other mouse mutant mapping to murine chromosome 3 is cocoa. The cocoa 
gene consists of 17 exons that encode a novel 1002 amino acid polypeptide that has 
no homology to any other known proteins with the mRNA expressed in a wide 
variety of cell types (Suzuki et al., 2001). Sequence analysis revealed that the mouse 
cocoa gene is homologous to human HPS3. Immunofluorescence analysis of the 
overexpression of cocoa demonstrated a mainly cytoplasmic distribution in cultured 
melanocytes. This study concluded that the cocoa protein perhaps functioned in a 
non-AP-3 trafficking pathway.
1.10.4 HPS4
The final form of the Hermansky-Pudlak syndrome, HPS4, has only recently 
been identified in 2002. The pale ear mouse mutant is very similar to the light ear 
mutant suggesting that le could be a potential human HPS locus. As previously 
described double homozygous light ear and pale ear mice have a phenotype identical 
to the single homozygous mutants suggesting that these two proteins may function in 
the same pathway. The human le homologue, HPS4 was identified and shown to be 
present on human chromosome 22ql 1.2-12.2 (Suzuki et al., 2002). The mouse HPS4 
protein is a polypeptide of 671 amino acids with a predicted molecular weight of 
72.7kDa. Like the HPS1 protein the HPS4 has no homology to other known proteins 
or any recognisable motifs. The human HPS4 sequence was obtained by RT-PCR 
and is a polypeptide of 708 amino acids with a predicted molecular weight of 
76.9kDa. High levels of HPS4 mRNA detected by Northern blot analysis, was shown 
in the heart, brain, liver, and testis, with much lower levels in skeletal muscle.
Twenty non-Puerto Rican HPS patients were screened for the presence of 
mutations in the HPS4 gene. Seven patients were identified with mutations including 
nonsense, frameshift and inframe insertion mutations only in the HPS4 gene (Suzuki 
et al., 2002). Immunofluorescence analysis of melanoma cells transiently transfected 
with HPS4 and double labelled with HPS1 showed that HPS4 had a similar vesicular 
distribution pattern as HPS1 and there was only some colocalisation between the two
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proteins in certain vesicles. Immunoblot analysis of pale ear and light ear lysates 
showed both samples have an absence of HPS 1 protein, this was suggestive of HPS4 
playing a role in the biosynthesis, stability or processing of HPS1.
All of the proteins associated with Hermansky-Pudlak syndrome are 
ubiquitously expressed yet the main manifestations of the disease occur only in a few 
specific cell types. The exact functional roles of the HPS1, HPS3 and HPS4 proteins 
still remain to be determined.
1.10.5 BLOC complexes
Three recent research studies have characterised the protein complexes in 
which the HPS1 and HPS4 proteins are resident (Chiang et al., 2003; Nazarian et al., 
2003 and Martina et al., 2003). Co-immunoprecipitation experiments demonstrated 
that both epitope-tagged and endogenous HPS1 and HPS4 proteins assemble with 
each other in vivo. This complex was termed BLOC-3 (for biogenesis of lysosome- 
related organelles complex) and was predominantly cytosolic with a small amount 
being peripherally associated with membranes (Martina et al., 2003). Mutant 
fibroblasts deficient in either HPS1 or HPS4 displayed abnormal localization of 
lysosomes and late endosomes, which were less concentrated at the juxtanuclear 
region. Nocodazole treatment of mutant and wildtype fibroblasts demonstrated that 
the distribution of lysosomal protein LAMP-1 positive structures became widely 
peripheral. Within 90mins after treatment the wildtype fibroblasts had recovered the 
steady state LAMP-1 distribution almost completely. However mutant cells were 
much less efficient at recovering from the nocodazole treatment. These results are 
consistent with a role for BLOC-3 in regulating the localization of lysosomes and 
late endosomes to the perinuclear area of the cell (Nazarian et al., 2003).
Fractionation analysis of melanoma cell homogenate demonstrated the full 
repertoire of complexes in which the HPS1 and HPS4 proteins are resident. The 
~500kDa BLOC-3 complex containing both HPS1 and HPS4 is membrane 
associated. Within BLOC-3 HPS1 and HPS4 are components of a discrete ~200kDa 
module termed BLOC-4. In the cytosol HPS1, but not HPS4 is part o f another 
complex, termed BLOC-5 (Chiang et al., 2003). These complexes and components 
are summarised in figure 1.7
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Melanoma cell homogenate

















HPS 1; no HPS4
Figure 1.7 Fractionation scheme of BLOC-3, BLOC-4 and BLOC-5 complexes in 
melanoma cells (taken from Chiang et al., 2003).
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1.11 Aims
The main aims of this study are to confirm the subcellular localisation of the 
HPS1 protein in mammalian fibroblast and melanoma cell lines. To establish the 
subcellular distribution pattern of the HPS1 protein in a human mature 
megakaryocyte cell line. Examine if the HPS1 protein colocalises with lysosome- 
related organelles in specialized cell types such as megakaryocytes and melanocyte 
cells. Investigate the membrane-association of the HPS1 protein in mammalian cells 
to determine if it is peripherally associated with membranes as deduced in previous 
published research. Attempt to characterise the functional role of the HPS1 protein in 
mammalian cells with particular reference to the biogenesis and function of 
lysosome-related organelles. Produce a highly sensitive monoclonal antibody to the 
human HPS1 protein using bacterially expressed human protein as the antigen in this 
procedure. Utilise any resultant monoclonal antibody to the HPS1 protein to aid 
biochemical studies of the protein. Use immunoprecipitation reactions to determine 
proteins that interact directly with the HPS1 protein in mammalian cells. This study 
particularly focused on confirming that the adaptor protein complex-3, which is 
important in lysosomal and lysosomal-related organelle protein trafficking, does not 
directly interact with the HPS1. In addition to identify if the HPS1 protein in any 
way directly binds to the melanophilin, Rab27a, myosin Va tripartite complex which 
is critical in the peripheral retention of the lysosome-related organelle, the 
melanosome, in melanocyte cells. Finally examination of the possible role of the 
HPS1 protein in the actual transport of lysosome-related organelles towards the 
periphery of the cell, which is an important process but the molecular components 





Unless otherwise stated all general laboratory chemicals and solvents were from 
Sigma-Aldrich company Ltd. (Poole, Dorset, UK), Fisons scientific UK Ltd. 
(Loughborough, UK) or BDH Laboratory supplies (Merck Ltd., Poole, Dorset, UK).
2.1.2 Tissue culture chemicals
Unless otherwise stated all tissue culture chemicals and reagents were from 
Sigma-Aldrich company Ltd. (Poole, Dorset, UK).
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2.1.3 HPS1 antibodies
Antibody Antigen Source Species Dilution 
IF IB
HPUD 1:1 HPS1 peptide seq: 
DQEFEESLRLRLKFGQSEN




HPUD 1:2 HPS1 peptide seq: 
DQEFEESLRLRLKFGQSEN




HPUD 2:1 HPS1 peptide seq: 
MDGFSMLEKKLKEGPEP




HPUD 2:2 HPS1 peptide seq: 
MDGFSMLEKKLKEGPEP




HPUD 4:1 HPS1 peptide seq: 
AGQLARRLWEASRI




HPUD 4:2 HPS1 peptide seq: 
AGQLARRLWEASRI




Clone 9 E.Coli expressed HPS1 
protein
University of Bath, 
UK
Mouse Neat Neat
Clone 16 E.Coli expressed HPS1 
protein
University of Bath, 
UK
Mouse Neat Neat
Clone B2 E.Coli expressed HPS1 
protein
University of Bath, 
UK
Mouse Neat Neat
Table 2:1 Details of antibodies generated against the human HPS1 protein used in this 
study.
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2.1.4 Additional primary antibodies








Dr M. Robinson, Dept 
Clinical Biochemistry, 
University of Cambridge, 
UK
Rabbit polyclonal 1/250 1/500
Penta His 
tag










BD Transduction, Oxford, 
UK




BD Transduction, Oxford, 
UK
Mouse monoclonal 1/500
TGN46 Serotec, Oxford, UK Sheep polyclonal 1/250 -
EEA-1 
clone 14
BD Transduction, Oxford, 
UK




Dr J.P. Luzio, Dept 
Clinical Biochemistry, 
University of Cambridge, 
UK
Rabbit polyclonal 1/1200
CD63 Biodesign International, 
Kennebunk, US




Sigma, Poole Dorset, UK Mouse monoclonal 1/500 1/500
Actin Sigma, Poole Dorset, UK Rabbit polyclonal 1/150 1/500
2.1.5 Secondary antibodies for Immunofluorescence analysis
(All Jackson ImunoResearch Laboratories. Inc, West Grove, PA, USA)
Antibody Species Conjugate Dilution for IF
anti-Rabbit IgG (H+L) Donkey FITC 1/100
anti-Rabbit IgG (H+L) Donkey Texas Red 1/100
anti-Mouse IgG (H+L) Donkey FITC 1/100
anti-Mouse IgG (H+L) Donkey Rhodamine 1/100
anti-Rat IgG (H+L) Donkey FITC 1/200
anti-Rat IgG (H+L) Donkey TRITC 1/100
anti-Goat (H+L) Donkey Texas Red 1/100
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2.1.6 Secondary antibodies for Western blot analysis




















2.2 Cell culture and transfection
2.2.1 Culture of COS-7, Mel 164, CHRF, Melan-a and MeWo cells lines
COS-7 (ECACC, Wiltshire, UK) and Mel 164 (kindly provided by and Dr P. 
Savage, Verlinde Hospital, Cardiff, UK) cell lines were maintained in DMEM media 
supplemented with 10% foetal calf serum, penicillin 100 U/ml, streptomycin lOOpg/ml 
and glutamine 290pg/ml. CHRF cells were maintained in RPMI-1640 media 
supplemented with 10% foetal calf serum, penicillin lOOU/ml, streptomycin lOOpg/ml 
and glutamine 290pg/ml. Melan-a cells (kindly provided by Dr D. Bennett, St George’s 
Hospital Medical School, London, UK) were maintained in RPMI-1640 media 
supplemented with 5% foetal calf serum, penicillin lOOU/ml, streptomycin lOOpg/ml 
and glutamine 290pg/ml and in addition to this 200nM Phorboll2-myristate 13-acetate 
and where indicated lOOpM Phenylthiocarbamide. MeWo cells (ECACC, Salisbury, 
UK) were maintained in EMEM media supplemented with 10% foetal calf serum,
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penicillin lOOU/ml, streptomycin lOOpg/ml and glutamine 290pg/ml and in addition 1% 
non essential amino acids.
All cells were subcultured every 4-5days by removing the media, washing the 
cells in sterile 37°C PBS and adding 1ml of 37°C trypsin/EDTA solution (0.5% trypsin 
in 0.53mM EDTA in Puck’s saline A). Once the cells had detached after ~5mins they 
were resuspended in an appropriate amount of media and diluted into fresh media in a 
ratio of 1:5 to 1:10 depending on the cell line. They were placed into a new tissue 
culture flask and incubated at 37°C in a 5% CO2 incubator (LEEC, Nottingham, UK). 
Cell confluence was estimated using a TMS light microscope (Nikon, Japan).
2.2.2 Preparation of Frozen stocks
All cells were grown up in 75cm3 tissue culture flasks to a confluency of > 60%. 
The cells were removed from the flask using trypsin/EDTA solution and centrifuged at 
l,500rpm for 5mins in a benchtop centrifuge (MSE, UK). The cell pellet was then 
resuspended in 1ml of ice-cold cell freezing media () and transferred to a 2ml cryogenic 
vial (Coming Science products, USA) on ice. The cells were cooled to -80°C for 1-2 
days prior to storage in liquid nitrogen.
2.2.3 Reviving cells from liquid nitrogen storage
The vial of frozen cells were removed from liquid nitrogen and rapidly thawed 
in a 37°C water bath before addition of 10ml of culturing media. The cells were spun in 
a benchtop centrifuge at l,500rpm for 5mins. The media was removed and the cells 
resuspended in 6ml of culturing media and transferred to a 25cm tissue culture flask. 
The cells were grown to >80% confluence before being subcultured.
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2.2.4 Transfection of mammalian cells
For immunofluorescence analysis sterile 22mm2 No 1 glass coverslips (SLS, 
Nottingham, UK) were placed into the wells of a sterile six well tissue culture plate. The 
cells were subcultured and resuspended in a suitable volume of culture medium, and 
0.5ml of suspension was placed onto each coverslip. The cells were resuspended to 
obtain approximately 50% confluency on the coverslip. The cells were incubated at 
37°C for lhr to allow the cells to adhere to the coverslips. 2mls of media warmed to 
37°C was added to each well and the cells incubated at 37°C overnight.
lOOpl of serum free DMEM media was placed into a 1.5ml eppendorf tube, 3pi 
of Genejuice™ (Novagen, Nottingham, UK) or Fugene™ (Roche, East Sussex, UK) 
reagent was added, gently mixed and incubated at RT for 5mins. lpg  of DNA was 
added, gently mixed and incubated at RT for 15mins. The transfection mixture was then 
added dropwise to the 2ml of media on each coverslip and incubated at 37°C overnight. 
For whole cell lysate protein preparations the cells were seeded to 50% confluency in 
150mm2 tissue culture dishes (Triple red, Oxfordshire, UK) and 25mls of media added. 
15pi of Fugene™ or Genejuice™ reagent was added to 500pl of serum free DMEM 
media and 5pg of DNA added.
2.2.5 Generation of stable cell line expressing HPS1
Transfections were carried out as follows: two 75cm3 tissue culture flasks of 
COS-7 cells were grown to 60% confluency. The cells were washed once in 5ml of PBS 
and 1ml of trypsin/EDTA solution added and incubated at 37°C for 5mins. 8ml of 
DMEM media was added and the suspension centrifuged at l,500rpm for 5mins in a 
benchtop centrifuge. The cell pellet was washed in 5ml of ice cold PBS and again 
centrifuged at l,500rpm for 5mins. The cell pellet was resuspended in 0.8ml of ice-cold
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HEBS buffer (20mM Hepes, 137mM NaCl, 5mM KC1, 0.7mM Na2H P04, 272mM 
sucrose pH 7.0). 20pg of pHM6 HPS1 DNA was added to the cells and the suspension 
placed into a 0.4cm Gene Pulser™ cuvette (Bio-rad Laboratories, Hemel 
Hempstead,UK) on ice. The cells were electroporated at 0.22KV 960/xF in the Gene 
Pulser™ (Bio-rad Laboratories, Hemel Hempstead, UK), and left to stand at RT for 
lOmins. The cell suspension was added to 25ml of DMEM media and placed into a 
150mm2 tissue culture plate. The cells were incubated at 37°C for 24hr before fresh 
DMEM plus 0.5 mg/ml G418 (Gibco BRL, Paisley, UK) was added.
The cells were incubated in selective media for three weeks until discrete 
colonies were observed. The colonies were removed from the plate by adding IOjlxI of 
trypsin/EDTA solution to each colony and gently scrapping the cells off the plate with 
the end of a pipette tip. The cells were transferred into lOOpl of selective media in a 96 
well plate and grown up into larger tissue cultureware as the cells became
2.3 General Molecular Biology
2.3.1 PCR
PCR reactions were performed using 38pl of MQ H20 , 5pi of lOx Thermo Pol 
™ Polymerase buffer (NEB, Hitchen, UK), lpl of 50x dNTP’s (Roche, East Sussex, 
UK), 2.5pl of 20pM forward primer, 2.5pl of 20pM reverse primer (Gibco BRL, 
Paisley, UK) 50ng template DNA and 1U of VentR ™ Polymerase (NEB, Hitchen, UK) 
in 0.5ml eppendorf tubes. The PCR was carried out using the PTC-100™ cycler (MJ 
research, Essex, UK) for 25 cycles of 94°C lmin, 55°C lmin, 72°C 2mins. The PCR 
product was run out on a 0.5% agarose (ICN Biomedicals, Ohio, USA) gel in TAE 
running buffer (40mM Tris, ImM EDTA (pH8.0), 0.11% (v/v) glacial acetic) and gel
56
purified using the QiaQuick gel extraction kit (Qiagen, West Sussex, UK) into lOpl of 
MQ H20 .
2.3.2 Restriction digests
Restriction digests for diagnostic purposes were performed in lOpl reactions 
using lp l of lOx restriction enzyme buffer (Promega, Southampton, UK), 0.5pl of DNA 
solution, lp l of 1 mg/ml BSA (Promega, Southampton, UK), 6.5pi of MQ H20 . The 
reactions were incubated at 37°C for lhr, before running out the reaction on a 0.5 % 
agarose gel (ICN Biomedicals, Ohio, USA) in TAE running buffer and purifying the 
DNA fragment using the QiaQuick gel extraction kit (Qiagen, West Sussex, UK) into 
lOpl of MQ H20 .
2.3.3 Ligation and transformation
Ligation reactions were set up in 0.5ml eppendorf tubes using 50ng of digested 
vector DNA (made up to 1/d with MQ H20), and 200ng of digested PCR product DNA 
(made up to 6/d with MQ H20), lp l of lOx T4 DNA ligase buffer (Roche, East Sussex, 
UK), lp l of MQ H20  and lp l of V2o diluted T4 DNA ligase (Roche, East Sussex, UK). 
The reaction was incubated at 16°C overnight on the PTC-100™ cycler (MJ research, 
Essex, UK). 2pi of the ligation reaction was added to 40pl of thawed XL-1 Blue 
competent E.Coli (Gibco BRL, Paisley, UK). The cells were placed into a sterile 0.2cm 
Gene Pulser cuvette (Bio-rad Laboratories, Hemel Hempstead, UK) and electroporated 
at 2.3 KV and 960pF in a Gene Pulsar (Bio-rad Laboratories, Hemel Hempstead, UK), 
lml of 37°C 2YT media (16g/L bacto-tryptone, lOg/L bacto-yeast extract, 5g/L NaCl 
pH 7.0) was added to the cells and the suspension transferred to a 15ml conical tube.
The cells were incubated at 37°C, shaking for lhr before plating onto selective 2YT
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agar (15g/L agar) plates. Plasmid DNA from resultant colonies was prepared by the 
standard alkaline lysis method (Sambrook et al, 1989). Diagnostic restriction digests 
were performed to check for the incorporation and proper orientation of the insert. An 
appropriate clone was selected for large-scale plasmid DNA purification using the 
Qiagen Plasmid maxi kit (Qiagen, West Sussex, UK).
2.3.4 Generation of pHM6 and pMH HPS1 constructs
The pHM6 and pMH mammalian expression vectors (Roche, East Sussex, UK) 
containing the full length open reading frame of HPS 1 were obtained (kindly provided 
by Dr Teahan, GlaxoSmithkline, Stevenage, UK). Modifications were needed at the N 
and C termini o f the vector to enable the HA and His tags to be utilized. 
Oligonucleotide primers (Gibco BRL, Paisley, UK) were designed to the full length 
HPS1 sequence with Hind III and Eco R1 restriction sites for cloning into the multiple 
cloning site of pHM6 and pMH. The primer sequences were;
pHM6 forward 5' CCCAAGCTTCATGAAGTGCGTCTTGGTGGCCACT 3' 
pHM6 reverse 5' CGGAATTCCTAGAGCAGGGGGATACGGGAGGCCTC 3' 
pMH forward 5' CCCAAGCTTGCCAAGATGAAGTGCGTCTTGGT 3’ 
pMH reverse 5' CGGAATTCCCGAGCAGGGGGATACGGGAGGCCTC 3' 
(Restriction sites are underlined)
2.3.5 Generation of the ApMEP4 HPS1 construct
To generate the inducible ApMEP4 mammalian expression construct (kindly 
provided by Dr G. Banting, University of Bristol, UK) containing the full length open 
reading frame of HPS 1, oligonucleotide primers (Gibco BR1, Paisley, UK) were
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designed to the pHM6 construct containing the full length HPS1. The forward primer, 
containing a Kpn I restriction site was designed to the HA tag coding region of the 
pHM6 construct: 5’ AAGCTGGTACCCATGTACCCATAC 3'. A reverse primer was 
designed to the His tag coding region of the pHM6 construct containing an Xho I site: 5' 
CCGCTCGAGTAGGGCCCTTAATGATG 3'. The full length HPS1 sequence with 
HA and His tags was cloned into the Kpn I and Xho I sites in the multiple cloning site 
of ApMEP4.
2.3.6 Generation of truncated HPS1 constructs
Two expression constructs encoding C- terminal truncations of the HPS1 gene 
were generated. The constructs contained the HPS1 coding sequence from lbp to 
161 lbp and lbp to 2169bp encoding the first 495 and 654 amino acids respectively. 
Oligonucleotide primers (Gibco BRL, Paisley, UK) were designed to the appropriate 
place in the pMH construct containing the full length open reading frame of HPS 1, with 
Hind III and Kpn I restriction sites incorporated into the primers for cloning into the 
multiple cloning site of the pMH vector. The primer sequences are:
pMH forward 5' CCCAAGCTTGCCAAGATGAAGTGCGTCTTGGT 3'
1-495 reverse 5' GGGGTACCCTAGCCTCCCCTGCTGGGGG 3’
1-654 reverse 5' GGGGTACCCTAGCTGTAGCGCAGGAG 3’
2.3.7 Maltose binding protein expression construct
The pMAL vector (NEB, Hitchen, UK) containing the full length open reading 
frame of HPS 1 was kindly provided by Dr C. Teahan, GlaxoSmithkline, Stevenage,
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UK. The open reading frame of HPS 1 had been inserted into the Eco R1 and Hind III 
restriction sites of pMAL.
2.3.8 Generation of pET 28a HPS1 construct
To generate the pET 28a bacterial expression construct containing the full-length 
open reading frame of HPS 1 with an N terminal His tag, oligonucleotide primers (Gibco 
BRL, Paisley, UK) were designed to the pMH construct containing the full-length 
sequence of HPS 1. The primers were designed with Eco RI and Hind III restriction sites 
for cloning into the multiple cloning site of the pET 28a vector (Novagen, Nottingham, 
UK):
Forward primer 5’ CCGGAATTCATGAAGTGCGTCTTG 3'
Reverse primer 5’ CCCAAGCTTCTAGAGCAGGGGGATA 3’
2.4 Immunofluorescence analysis of HPS1 distribution
2.4.1 Immunofluorescence analysis
The media was removed from the coverslips and three quick washes with PBS, 
Dulbecco A (0.2g/L KC1, 0.2g/L NaH2P 0 4, 8g/L NaCl, 1.15g/L Na2H P04, pH 7.3 
Oxoid, Unipath LtD., Basingstoke, Hampshire, UK) were performed. The cells were 
fixed in 2mls of 2% (w/v) paraformaldehyde in PBS for 20mins at RT or in -20°C 
methanol at -20°C for 5mins. The cells were washed three times for 5mins in PBS. 
Paraformaldehyde fixed cells were then permeabilized in 2mls of -20°C methanol at -  
20°C for 5mins or with 0.1% (v/v) Triton x-100 in PBS at RT for 5mins. The cells were 
washed in 2mls of PBS then blocked in 2mls of 0.2% (w/v) bovine serum albumin
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(BSA) in PBS or 10% (v/v) foetal calf serum in PBS. 70pl of primary antibody diluted 
in 0.2% (w/v) BSA in PBS or 5% (v/v) foetal calf serum in PBS, was placed onto a 
piece of parafilm™ (American National Can, Chicago, USA). The coverslips were 
inverted onto the antibody and incubated at RT for lhr. The cells were returned to the 
dish and washed twice for 5mins in 0.2% (w/v) BSA in PBS or 5% (v/v) foetal calf 
serum in PBS and twice for 5mins in PBS. 70pl of diluted secondary antibody was 
placed onto a piece of parafilm™ and the coverslips were inverted onto it. The 
coverslips were incubated in the dark at RT for 20mins. The coverslips were again 
returned to the dish and washed twice for 5mins with 0.2% (w/v) BSA in PBS or 5% 
(v/v) foetal calf serum in PBS and twice for 5mins in PBS. The coverslips were 
mounted on standard glass microscope slides (SLS, Nottingham, UK) onto a 25pl drop 
of mowiol (Calbiochem, Nottingham, UK). The cells were viewed on a Zeiss LSM510 
laser scanning confocal microscope (Zeiss, Germany).
2.5 Microtubule disruption
2.5.1 Microtubule disruption of HPS1 transfected cells
COS-7, Mel 164 and MeWo cells were seeded and transiently transfected 
as described in 2.2.4. After the overnight incubation the DMEM media was removed 
from the coverslips and was replaced with 2mls of DMEM media containing the 
following microtubule disrupting drugs, 10/ig/ml Nocodazole, 1/iM Vincristine and 
IfiM Paclitaxel. The cells were then incubated for a further 4hrs at 37°C in the CO2 
incubator before immunofluorescence or immunoprecipiatation analysis.
2.6 Protein Biochemistry techniques
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2.6.1 Fractionation of stable HPS1 expressing cells
Each 150mm2 tissue culture dish of cells was washed with PBS before the cells 
were removed using 2mls of 37°C Trypsin/EDTA solution for 5mins. 8ml of DMEM 
media was added and the suspension centrifuged at 1,500 rpm for 5mins. The cell pellet 
was washed in 5ml of ice cold PBS, again centrifuged at l,500rpm for 5mins and 
resuspended in 2ml of ice cold PBS containing Complete™ protease inhibitor cocktail 
(Roche, East Sussex, UK). The sample was sonicated on ice for three lOsec bursts. 
Following 15 strokes in a 5ml automatic homogenizer, the homogenate was centrifuged 
at 100,000rpm in a TLA-100.3 fixed angle rotor in an ultracentrifuge (Beckman 
Coulter, California, USA) at 4°C for 30mins. This yielded supernatant and membrane 
pellet fractions. The membrane fraction was resuspended in 250pl o f ice-cold PBS plus 
protease inhibitor cocktail (Roche, East Sussex, UK). The fractions were then assayed 
for protein content using a protein microassay (Bio-rad Laboratories, Hemel 
Hempstead, UK).
2.6.2 Bio-Rad Protein Assay
A protein microassay (Bio-rad Laboratories, Hemel Hempstead, UK) was used 
to quantitate the total protein content of samples. The sample was made up to 800pl 
with MQ H2O and 200pl of dye reagent concentrate added. The sample was mixed and 
incubated at RT for 5mins before the absorption at 595nm was measured on a 
spectrophotometer (Philips, UK). A calibration curve was constructed using 0-25pg of 
BSA.
2.6.3 SDS Polyacrylamide gel electrophoresis (SDS-PAGE)
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Electrophoresis was carried out using the discontinuous system of Laemmli 
(Laemmli, 1970). Protein samples were mixed 1:1 with Laemmli sample buffer, 4% 
(w/v) SDS, 230mM Tris, 2mM EDTA, 20% (v/v) glycerol and 8/xg/ul bromophenol 
blue, pH6.8 (Bio-rad Laboratories, Hemel Hempstead, UK) and 5% (v/v) 2- 
mercaptoethanol, before heating to 95°C on a heat block for 5mins. Discontinuous 
polyacrylamide gels (lower resolving gel and upper stacking gel) were performed using 
the mini Protean II electrophoresis cell (Bio-rad Laboratories, Hemel Hempstead, UK). 
Gels were prepared with the following solutions: acrylamide/bis acrylamide 30% (29:1), 
resolving gel buffer (1.5M Tris, 10% (w/v) SDS pH 8.8), stacking gel buffer (1M Tris, 
10% (w/v) SDS, pH6.8), 10% (w/v) ammonium persulfate and N,N,N3,N3 
tetramethylethylenediamine. For the mini Protean II cell the resolving gel was made to 
0.375M Tris and 0.1% (w/v) SDS with 8-10% acrylamide concentrations, whilst the 
stacking gel was 0.126M Tris and 0.1% (w/v) SDS with 5% acrylamide.
Upper and lower buffer chambers were filled with running buffer (25mM Tris, 
0.1% (w/v) SDS, 192 mM glycine pH 8.3). Gels were run at 120V and 180V until the 
dye front reached the bottom of the gel. Protein bands were detected by staining for lhr 
in Coomassie stain solution (Bio-rad Laboratories, Hemel Hempstead, UK) and 
destaining in fixative (30% (v/v) methanol, 10% (v/v) glacial acetic acid). Protein bands 
were also detected by silver staining using the silver stain plus kit (Bio-rad 
Laboratories, Hemel Hempstead, UK). For preservation all gels were dried down 
between cellulose sheets in a gel drying frame (Sigma, Poole, UK).
2.6.4.Electrotransfer of protein from SDS-PAGE gels to nitrocellulose
Four sheets of 10cm x 8cm 3mm filter paper (Whatmann, Kent, UK) a single 
10cm x 8cm piece of Immobilon™-NC transfer membrane 0.45/mi (Millipore,
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Gloucester, UK) and two blotting pads were pre-soaked in transfer buffer (25mM tris, 
192mM glycine, 20% (v/v) methanol pH 8.3). The gel was placed onto two sheets of 
pre-soaked filter paper on the blotting pad. The transfer membrane was placed over the 
gel and all the air bubbles removed. The remaining filter paper and pad were placed on 
top and the sandwich loaded in the mini Protean II transfer apparatus (Bio-rad 
Laboratories, Hemel Hempstead, UK). The current was run at 350mA for lhr. After 
electrotransfer, the transfer membrane was rinsed in PBS before staining with 0.1% 
(w/v) Ponceau S in 5% glacial acetic acid.
2.6.5 Western Blotting
The nitrocellulose membrane was blocked in PBS-T (30mM NaCl, 2.68mM 
KC1, lOmM Na2HP04,1.76mM KH2P04, pH 7.2, 0.2% (v/v) Tween 20) with 5% (w/v) 
marvel dried skimmed milk powder for lhr with rocking at RT. The nitrocellulose was 
washed briefly in PBS and incubated with primary antibody diluted in 0.2% (w/v) BSA 
in PBS overnight, with rocking at 4°C. After four 15min washes in PBS 2% (w/v) 
marvel the nitrocellulose membrane was incubated with horseradish peroxidase 
conjugated secondary antibody for 2hr at RT. After four 15min washes in PBS 2%
(w/v) marvel the membrane was incubated for lmin with ECL detection reagent 
(Amersham, Little Chalfont, Buckinghamshire, UK). The nitrocellulose was wrapped in 
saran wrap (Dow Chemical Corp, USA) and exposed using the Epi chemi II darkroom 
and LAB WORKS software (UVP lab products, Cambridge, UK).
2.7 Expression and purification of a HPS1 His tag fusion protein
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2.7.1 Transformation of Bacterial expression cells
BL21 DE3 competent E. Coli cells (Novagen, Nottingham,UK) were 
transformed with the pET28a HPS1 or pMAL HPS1 vector DNA. The cells were 
thawed and 20pl aliquoted into a 1.5ml eppendorf tube, lpg of plasmid DNA was added 
to the cells and the sample then incubated on ice for 5mins. The cells were heated to 
42°C for 30secs in a heat block before a further 2min incubation on ice. 80pl of pre 
warmed (37°C) 2YT media was added to the cells which were then incubated at 37°C 
with shaking for lhr. lOpl of cells was then mixed with 90pl of 2YT media and spread 
on a 2YT agar plate containing 25pg/ml ampicillin (Sigma, Poole, Dorset, UK) and 
incubated overnight at 37°C.
2.7.2 Culture and lysis of pMAL HPS1 bacterial cells
An aliquot of 5ml of 2YT broth containing 25pg/ml ampicillin was inoculated 
with a colony from the transformation plate and incubated at 37°C, with shaking 
overnight. 500ul of the overnight culture was then used to inoculate 100ml of rich 
media (lOg/L bacto-tryptone, 5g/L yeast extract, 5g/L NaCl, 2g/L glucose) plus 
100/ig/ml ampicillin. The culture was grown at 37°C, with shaking until the optical 
density at 600nm reached ~0.5. Isopropyl /3- D- thiogalactopyranoside (IPTG) was 
added to the remaining culture to a final concentration of 0.3mM and a further 3hrs 
incubation at 37°C. The sample was centrifuged at 4,000g in a TA 16-250 rotor, in an 
Allegra 25R centrifuge (Beckman Coulter, California, USA). The cells were 
resuspended in 5ml of ice-cold column buffer (20mM Tris.Cl pH 7.4 ,200mM NaCl, 
ImM EDTA) before being stored at -20C overnight. The sample was then thawed and 
sonicated in 15sec pulses over three minutes. The sample was then centrifuged in the 
TA 14-50 at 9,000g for 20mins at 4°C to yield soluble supernatant and insoluble pellet
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fractions. Samples were taken throughout the induction and extraction procedure 
combined with laemelli sample buffer (Bio-rad Laboratories, Hemel Hempstead, UK) 
and boiled at 95°C for 5mins on a heat block. Samples were then analysed by SDS- 
PAGE analysis and immunoblotting.
2.7.3 Culture and lysis of pET 28 HPS1 bacterial cells
An aliquot of 5ml of 2YT broth containing 25pg/ml ampicillin was inoculated 
with a colony from the transformation plate and incubated at 37°C, with shaking 
overnight. From this culture lOOpl was added to 100ml of 2YT, 25pg/ml ampicillin 
broth which was shaken at 37°C until the optical density at 600nm on a 
spectrophotometer was ~0.5. Fusion protein production was induced by addition IPTG 
(Sigma, Poole, Dorset, UK) to a final concentration of 0.4mM and further incubation at 
37°C for 3hrs. The cells were pelleted by centrifugation in a TA 16-250 rotor, in an 
Allegra 25R centrifuge (Beckman Coulter, California, USA) at 5,000g for lOmin at 
4°C. The pellet was resuspended in 5ml of ice cold 50mM NaPC>4, 300mM NaCl, pH 
7.0 plus Complete™ EDTA free protease inhibitors (Roche, East Sussex, UK) and 
stored overnight at -20°C. The cells were then thawed and sonicated six times for 
20secs on ice and then the resultant sample centrifuged at 12,000g for 20mins at 4°C in 
a TA 14-50 rotor in the Allegra 25R centrifuge. Samples were taken throughout the 
induction and extraction procedure combined with Laemmli sample buffer (Bio-rad 
Laboratories, Hemel Hempstead, UK) and boiled at 95°C for 5mins on a heat block. 
Samples were then analysed by SDS-PAGE analysis.
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2.7.4 Isolation of inclusion bodies from pET 28a HPS1 expression
The resultant cell pellet from the pET 28 HPS1 induction was resuspended in 
5ml of ice cold lOOmM NaCl, ImM EDTA, 0.1% (w/v) deoxycholic acid, 50mM Tris 
pH 8.0. The suspension was incubated on ice with occasional mixing for lOmins. MgCk 
was added to a final concentration of 8mM and deoxyribonuclease I (Sigma, Poole, 
Dorset, UK) to lOpg/ml. The sample was incubated at 4°C with occasional mixing for 
8hrs. The sample was then centrifuged at 10,000g for lOmins in a TA 14-50 rotor and 
the supernatant discarded. The pellet was washed once by resuspending in lOOmM 
NaCl, ImM EDTA, 50mM Tris, 1% (v/v) NP-40 pH 8.0 and centrifuged at 10,000g for 
lOmins. The final pellet was resuspended in 4ml of PBS. Small samples (<10/d) of the 
final inclusion body prep were combined with Laemmli sample buffer (Bio-rad 
Laboratories, Hemel Hempstead, UK) for SDS-PAGE analysis.
2.7.5 Purification of HPS1 His tagged fusion protein
The inclusion body preparation was combined with 4ml of Laemmli sample 
buffer (Bio-rad Laboratories, Hemel Hempstead, UK) and boiled at 95 °C for 5mins on a 
heat block. Discontinuous polyacrylamide gels (lower resolving gel and upper stacking 
gel) were set up on the Protean II xi slab cell (Bio-rad Laboratories, Hemel Hempstead, 
UK). Gels were prepared as outlined in section 2.6.2. For the Protean II xi slab cell the 
resolving gel was made to 0.375M Tris and 0.1% (w/v) SDS with 8% acrylamide 
concentration, whilst the stacking gel was 0.126M Tris and 0.1% (w/v) SDS with 5% 
acrylamide.
Upper and lower chambers were filled with running buffer (25mM, 0.1% (w/v) 
SDS, 192mM glycine pH 8.3). 3ml of inclusion body sample was loaded onto the gel 
and run overnight at 15mA until the dye front reached the bottom of the gel. A band of
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gel at the appropriate molecular weight containing the His tagged HPS1 fusion protein 
was excised using a razor blade. The gel slice was loaded into size 2 dialysis tubing 
with a molecular weight cut off of 12-14 kDa (Medicell International Ltd, London, UK) 
along with 10 times the gel volume of 500mM Tris, 1% (w/v) SDS, pH 8.3. The tubing 
was placed into a horizontal electrophoresis tank in 25mM Tris, 200mM glycine, 0.1% 
(w/v) SDS pH 8.3, buffer and the protein eluted from the gel at 100V for 3hrs.
The gel slice was removed form the tubing that was then resealed and the 
sample was dialysed against PBS for 48hrs at RT. The sample was concentrated down 
by placing the tubing in polyethylene glycol 20,000MW for approximately 
30mins.Finally the sample was concentrated down further to ~500pl using a 
50,000MW, 0.5ml spin concentrator (Chemicon, Southampton, UK) following the 
protocol provided.
2.8 Monoclonal antibody production
2.8.1 Immunization of mice
Two Balb/c mice (Charles River Inc., UK) were immunized with 5pg of HPS1 
protein extract with ImmunoEasy™ (Qiagen, West Sussex, UK) adjuvant 
subcutaneously following the protocol provided. An identical booster injection was 
given four weeks later and at four further weekly intervals.
2.8.2 Macrophage feeder layer
Balb/c mice (Charles river Laboratories Inc., UK) were sacrificed by cervical 
dislocation and the fur and skin sterilised by immersion in 70% (v/v) ethanol. The skin 
was dissected back to expose the peritoneum. 5ml of sterile PBS was injected into the
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peritoneal cavity. The abdomen was massaged to suspend the peritoneal macrophages 
into the PBS, which was then withdrawn by a pipette through a hole cut in the 
peritoneum. The macrophage suspension was irradiated for approximately 8mins (2,000 
rads) using a caesium source. The cells were pelleted by centrifugation for 5mins at 
l,500rpm in an MSE benchtop centrifuge. The supernatant was discarded and the cells 
resuspended in 500pl of cloning media (RPMI-1640, 5% (v/v) hybridoma foetal bovine 
serum, 2mM glutamine, 1% (v/v) tylosin, 5% (v/v) hybridoma cloning factor (Origen, 
IGEN International Inc., USA) and 1% (v/v) OPI supplement). A cell count was 
performed using a haemocytometer and the macrophages diluted into a suitable volume. 
The macrophages were seeded the day before the fusion at 20,000 cells per cm3 
(50pl/well) over five 96 well tissue culture flat bottom dishes in cloning media 
containing 100/zM hypoxanthine, OAfiM aminopterin and 16/iM thymidine (HAT 
supplement, Sigma, Poole, Dorset, UK).
2.8.3 Fusion procedure
X-63 myeloma cells (ECACC, Wiltshire, UK) were grown up in 25cm3 tissue 
culture flasks in maintenance media, (RPMI-1640,10% (v/v) hybridoma foetal bovine 
serum, 2mM glutamine, 1% (v/v) tylosin, 5% (v/v) hybridoma cloning factor (Origen, 
IGEN International Inc, USA), 1% (v/v) OPI supplement) in addition, 132/zM 8- 
azaguinine up to 2 weeks before the fusion.
The immunized mice were sacrificed by cervical dislocation and the spleen was 
extracted. The spleen was then washed out using 10ml of sterile PBS using a large 
needle and syringe into a sterile petri dish. The cell suspension was transferred to a 
15ml centrifuge tube and the lumps triturated using a sterile 1ml pastette. The 
suspension was transferred to a sterile 50ml centrifuge tube and 20million log phase X-
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63 cells were added. The suspension was centrifuged at l,500rpm for lOmins at RT in a 
benchtop MSE centrifuge and the supernatant discarded. 1ml of 37°C PEG/PBS (4.5g 
PEG 4000, 5.5ml PBS) was added dropwise whilst swirling the mixture over a lmin 
period. A further 1ml of 37°C PBS was added dropwise over lmin and finally further 
PBS up to 20ml. The suspension was centrifuged at l,500rpm for lOmins at RT and the 
supernatant discarded. The cell pellet was resuspended in 20ml of RPMI-1640 media 
before being transferred to two 25cm3 tissue culture flasks. The fusion was incubated 
overnight at 37°C in a CO2 incubator.
The cells were removed from the flask by gentle pipetting with a sterile 1ml 
pastette and pooled together. The suspension was again centrifuge at l,500rpm for 
5mins at RT and the supernatant discarded. The cell pellet was resuspended in 50ml 
cloning media plus HAT supplement (Sigma, Poole, Dorset, UK) and dispensed at 
lOOpl/well over the five macrophage conditioned 96 well plates. These plates were 
incubated for 5 days at 37°C in a CO2 incubator. The cells were fed with 160pl of fresh 
cloning media plus HAT supplement every three days until hybridoma clones became 
visible. The hybridoma clones were then grown up into 24 well and finally six well 
tissue culture plates for ELISA analysis.
2.8.4 Freezing down of clones
The hybridoma cells were removed from the six well tissue culture plate by 
gentle pipetting with a sterile 1ml pastette, placed into a sterile 15ml centrifuge tube and 
spun at l,500rpm for 5mins at RT. The supernatant was discarded and the cell pellet 
resuspended in 500pl of cloning media. The cells were placed on ice for 15mins before 
lm l of ice-cold hybridoma freezing media (50% (v/v) hybridoma foetal bovine serum 
(Sigma, Poole, Dorset, UK), 20% (v/v) hybridoma DMSO (Sigma, Poole, Dorset, UK)
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and 30% (v/v) cloning media) was added. The cells were placed into 2ml cryogenic 
vials (Coming Science Products, USA) and cooled down over the vapour phase of 
liquid nitrogen before being placed into long-term liquid nitrogen storage.
2.8.S ELISA analysis
HPS1 protein extract was diluted to 5pg/ml in coating buffer (15mM Na2CC>3, 
34mM NaHCC>3, pH 9.6) and dispensed at lOOpl/well into maxisorp immuno™modules 
(Nunc, UK) and incubated at 4°C overnight. The plates were then washed with PBS 
0.1% (v/v) Tween (PBS-T) three times, before each well was blocked with 350pl of 
PBS-T 1% caesein for 2 hrs at RT. The plates were then washed twice with PBS-T. 
Supernatant or diluted serum was added to a final volume of 100pl/well and incubated 
at RT for 2hrs. The plate was then washed twice with PBS-T and twice more with PBS. 
Secondary antibody was diluted Viooo into PBS-T, lOOpl added per well and incubated 
at RT for 2hrs. Plates were washed twice more in PBS-T and finally twice in PBS. 
lOOpl of fresh substrate (2mg/ml tetramethylbenzidine in ImM sodium acetate, 33mM 
citric acid, 0.025% (v/v) hydrogen peroxide, pH6.0) was added to each well and 
incubated at RT for lOmins. The reaction was stopped by the addition of 50pl/well of 
1.84M, sulphuric acid. The optical density at 450nm was read on a 96 well plate reader 
(Tecan systems, USA) with the reference filter set at 700nm.
2.9 Immunoprecipitations
2.9.1 Immunoprecipitation of HPS1
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Each 150mm tissue culture dish of cells was washed once with 10ml of PBS 
before incubation in 2mls RIPA buffer (50mM Tris, 150mM NaCl, 1% (v/v) NP40, 
0.5% (w/v) DOC, 0.1% (w/v) SDS pH 7.5) plus Complete™ mini EDTA free protease 
inhibitor cocktail (Roche, East Sussex, UK) for lOmins on ice. The lysate was passed 
through a 21-gauge needle (Terumo, Belgium) several times before centrifugation at 
l,500rpm for 5mins in a benchtop centrifuge. The lysate was pre-cleared using lOOpl of 
uncoupled Protein A sepharose beads (Sigma, Poole, Dorset, UK) for lhr rotating at 
4°C. 2pl of antibody was bound to 50pl of washed protein A sepharose beads for 6hrs at 
4°C on a rotator.
The beads were then washed three times with RIPA buffer and during the final 
wash transferred to fresh 1.5ml eppendorf tubes. The beads were then incubated with 
500pl of lysate at 4°C overnight on a rotator. The beads were washed three times with 
lml of RIPA buffer at RT for lOmins on a rotator before being transferred to fresh 
1.5ml eppendorf tubes. The beads were finally incubated with 40pl of 1:1 diluted 
Laemmli sample buffer (Bio-rad Laboratories, Hemel Hempstead, UK) at 95 °C for 
5mins or at RT for lOmins. All immunoprecipitants were analysed by SDS-PAGE 
analysis or Western blotting as outline in sections 2.6.3, 2.6.4 and 2.6.5.
2.9.2 Biosynthetic radiolabelling
MeWo cells either transfected as described in 2.2.4, or non-transfected were 
grown on 50mm tissue culture dishes to approximately 80% confluency. The dishes 
were washed twice with 37°C PBS, then the cells incubated in 5ml of methionine and 
cysteine free DMEM media containing 5% (v/v) foetal calf serum, for lhr at 37°C in a 
gassed incubator. After washing twice with 37°C PBS, 1.2ml of methionine and 
cysteine free media containing 100/xCi Trans35S-Label (ICN Biomedicals Ltd, Thame,
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UK) was added and the cells incubated at 37°C for 30mins. They were then transferred 
to ice and washed three times with PBS and the cells lysed in 0.5ml of ice-cold protein 
extraction buffer (plus Complete™ mini EDTA free protease inhibitor cocktail (Roche, 
East Sussex, UK), for lOmins. The labelled sample was used for immunprecipitation as 
outlined in section 2.9.1. All immunoprecipitants were analysed by electrophophoresis 
carried out using the discontinuous system of Laemmli as outlined in section 2.6.3. 
Protein gels were stained with Coomassie blue, dried down as described, section 2.6.3, 
and analysed using a FLA-5000 phosphorimager (Fuji, Japan).
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Chapter 3.0
Characterisation of polyclonal antibodies and generation of 
monoclonal antibodies to HPSlp
3.1 Introduction
At the commencement of this research project no commercial antibodies or other 
reagents were available against the human form of the HPS1 protein. With the intention 
of defining the subcellular localisation and function of the HPS1 protein there was a 
need to generate these specific reagents. As part of the collaboration with Dr C. Teahan, 
GlaxoSmithkline, six polyclonal antibodies generated against the human HPS1 protein 
were provided for use during this study. Three separate peptides corresponding to the 
following regions of the human HPS1 protein were generated: 1) HPUD1, corresponds 
to an N terminal region of the HPS1 protein from amino acids 19-35 containing the 
following amino acid sequence DQEFEESLRLRLKFGQSEN; 2) HPUD2, is present 
towards the centre of the protein sequence and contains amino acids 399-415 
corresponding to the following sequence MDGFSMLEKKLKEGPEP; 3) HPUD4, was 
taken from the C terminal portion of the HPS1 protein sequence and contains amino 
acids 684-697 corresponding to the following sequence AGQLARRLWEASRI. These 
are summarised in the materials and methods section. Each peptide was used to 
immunize two separate rabbits. All of the rabbits had test bleeds taken from them during 
the immunization procedure, which were analysed by ELISA analysis against the 
peptides used. All six rabbits produced good immune responses against the HPS1 
peptides used. After the immunization procedure was completed the HPS1 antibodies 
were affinity purified from the rabbit serum. The six polyclonal antibodies designated, 
HPUD1:1, HPUD1:2, HPUD2:1, HPUD2:2, HPUD4:1 and HPUD4:2 were provided as 
both neat serum and affinity purified stocks.
The only characterisation of the polyclonal antibodies performed at 
GlaxoSmithkline consisted of the ELISA analysis performed during the production 
procedure. Therefore full characterisation of these polyclonal antibodies was required 
using both immunoblotting and immunofluorescence analysis. In addition to the 
polyclonal antibodies a mammalian expression construct containing the full-length 
human HPS1 cDNA was provided. This construct was used in the characterisation of
74
the polyclonal antibodies and subsequently in characterisation of a monoclonal antibody 
generated in this study as described below.
3.2 Generation of an N-terminally HA-tagged HPSlp construct
To substantiate results obtained in immunofluorescence and immunoblotting 
experiments with the polyclonal antisera raised against HPSlp, an epitope-tagged 
HPSlp expression construct was used. Primers were designed to the HPS1 coding 
sequence to enable the insertion of HPS1 cDNA into the pHM6 vector with a stop 
codon at the C terminus. The HPS1 full-length cDNA was generated from these primers 
in a PCR reaction. The PCR reaction generated the required single HPS1 cDNA for 
subcloning into the pHM6 expression vector. To generate the construct the PCR product 
and vector were digested using the restriction enzymes Hind III and Eco RI. Potential 
clones were screened for the presence of the pHM6 HPS 1 construct. Plasmid DNA was 
extracted from the clones and a diagnostic restriction digest performed on this DNA. 
Positive clones containing the construct of interest would yield two fragments in this 
digest, one the 2.0kb HPS1 coding sequence and the other the 5.4kb pHM6 vector. 
Figure 3.1 is an image of the resultant products from this diagnostic digest. Both pHM6 
HPS 1 and existing pMH HPS 1 constructs were sequenced prior to use to check they 
contained the expected full length HPS 1 coding sequence (data not shown).
Figure 3.1 Image of the agarose gel of the products of the restriction digests on 14 
bacterial clones containing the potential pHM6 HPS1 construct. A large amount of 
DNA was present in the digest but all o f the clones except two (lanes 5 and 6) yielded 




3.3 Immunofluorescence analysis of transiently transfected HA-tagged 
HPSlp
Both of the HA tagged HPSlp constructs were used to transiently express the 
HPS1 protein in COS-7 African green monkey kidney epithelial cells. The cells were 
processed for immunofluorescence analysis using either the HPS1 polyclonal or HA 
monoclonal antibodies as described in Materials and Methods.
Confocal micrographs shown in Figure 3.2 depict the distribution of HPS 1 in 
COS-7 cells over expressing the C terminal HA tagged forms of HPS 1 detected using 
the HPUD 2:1 polyclonal antiserum to the HPS1 protein. Both constructs gave exactly 
the same distribution of HPS 1 protein, except that the N terminal tagged construct gave 
a lower transfection efficiency. All of the polyclonal antisera to the HPS1 protein gave 
exactly the same pattern of protein expression. The HPUD 2:1 antiserum gave a slightly 
increased level of fluorescence and was selected for imaging purposes. In Figure 3.2, 
the HPS1 protein is present mainly in a large number of small punctate structures 
distributed throughout the cytosol. However, when high levels of transiently expressed 
HPS1 protein were present, the protein appeared to aggregate together into larger 
clumps (Figure 3.3). This aggregated protein appeared to be mainly in the perinuclear 
area of the cell. A rat monoclonal HA antibody was used for immunofluorescence 
analysis in these transiently over expressing cells but gave large amounts of background 
staining. However, the polyclonal antiserum proved useful for immunofluorescence 
analysis experiments on over expressing cells and was therefore used in further 
localisation experiments described below and in studies in Chapter 4.0 and 5.0.
In order to ensure that the pattern observed in the confocal sections shown in 
Figure 3.2 was typical of that found throughout the cell, serial sections were taken from 
representative COS-7 cell over expressing the C-terminal HA tagged from of HPS 1 
protein and processed for immunofluorescence analysis using the HPUD 2:1 polyclonal 
antibody to the HPS1 protein. The series of images in Figure 3.4 shows a similar 
distribution in all sections.
3.4 Generation of a stably expressing HPSlp cell line
Although HPS1 protein could be detected by immunofluorescence analysis in 
transiently transfected cell cultures using the HPUD antisera, detection by 
immunoblotting with either the HA or HPUD antibodies proved unsuccessful. One
76
Figure 3.3 COS-7 cells transiently overexpressing FIPS1 protein.
CO S-7 cells were transiently transfected with the C terminal HA epitope tagged HPS1 construct. 
C ells were processed for immunofluorescence analysis after parafromaldchyde fixation and 
triton xlOO permeabilisation using the HPUD 2:1 polyclonal antibody to the HPS1 protein 
follow ed by a Texas Red conjugated anti-rabbit IgG secondary antibody.
Figure 3.3 COS-7 cells transiently overexpressing high levels o f  HPS 1 protein.
COS-7 cells were transiently transfected with the C terminal HA epitope tagged HPS1 construct. 
Cells were processed for immunofluorescence analysis after fixation in paraformaldehyde and 
triton xlOO permeabilisation using the HPUD 2:1 polyclonal antibody to the HPS I protein 
followed by a Texas red conjugated anti-rabbit IgG secondary antibody.
Figure 3.4 Z stack scries o f  a CO S-7 cell stained for the transient ovcrexpression o f  HPS 1 protein. 
COS-7 cells were transiently transfected with the C terminal HA tagged form o f  HPS 1 and procssed 
for immunofluorescence analysis after paraformaldehyde fixation and triton xlOO permeabilisation 
using the HPUD 2 :1 polyclonal antibody to the HPS1 protein and a Texas Red conjugated 
anti-Rabbit IgG secondary antibody.
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possibility for the lack of signal might be the limited number of cells expressing HPSlp 
or the relatively low protein expression per cell. In addition to characterising the HPUD 
antisera, a long-term goal of the study was to isolate interacting proteins; therefore 
detection of the HPSlp by immunob lotting was essential. Consequently, a cell clone 
stably expressing HPSlp was generated. In order to allow for the regulation of 
expression levels, a construct containing HA tagged HPS 1 in delta pMEP was 
generated, by amplifying the coding sequence using PCR (Figure 3.5) and inserting it 
into the Kpnl and Xhol sites of the ApMEP vector. Figure 3.5 shows the PCR product 
generated using primers designed to the HPS 1 coding sequence and HA tag in the 
pHM6 HPS 1 construct.
3.0 k b -----
2.0 k b -----
1.5 kb —
1.0 k b -----
0.5 k b -----
Figure 3.5 PCR products to generate HPS1 insert for subcloning into the ApMEP4 
vector. Lanes (a) and (b) contain the PCR products run out onto an agarose gel. A single 
intense band at around 2.0kb can be seen on the gel, which is the expected size for the 
full-length coding region of HPS 1 gene.
The PCR product and ApMEP4 DNA were used in a restriction digest with Kpn 
I and Xho I. The pieces of DNA were ligated together and used to transform competent 
E.Coli cells. Plasmid DNA was extracted and used to check for the presence of the 
correct construct (data not shown). The ApMEP4-HPS 1 construct was used to transfect 
COS-7 cells as described in Materials and Methods. Cells were treated 48 hours after 
transfection with 200/xg/ml hygromycin B. After two weeks of treatment discrete clones 
were visible. Thirty of these clones were transferred and expanded. The remaining cells 
in the large dish were all removed and also used in the induction studies as a mixed 
population of potential positive clones. All 30 clones as well as some of the mixed 




for 48 hours. They were processed for immunofluorescence analysis using the HPUD 
2:1 polyclonal anti-HPSl antiserum. However, none of the clones nor any of the mixed 
population showed even low level HPS1 protein expression and simply showed slight 
nuclear staining suggestive of antibody cross reactivity. Several further attempts were 
made however none proved successful.
Consequently further experiments were conducted using the pHM6-HPSl 
construct. COS-7 cells were transfected with this construct and selection using the 
antibiotic G418 was started 24 hours later. After two weeks in selection media the 
number of colonies remaining in the dish prevented the isolation of individual clones. 
Consequently the cells were trypsinised, the majority retained for further analysis by 
immunofluorescence and immunoblotting and the rest seeded for isolation of clonal cell 
lines. The expression levels in this mixed population of stable cells were determined 
using a different rat high specificity monoclonal antibody to the HA epitope tag. A high 
number of cells but not all, in this population were expressing the HA tagged HPS1 
protein so colonies were grown up and the cloning procedure carried out as described in 
Materials and Methods.
In addition to the immunofluorescence analysis on this non-clonal population of 
potential stable cells, whole cell lysates were used for immunoblot analysis. Whole cell 
lysates were prepared from COS-7 cells transiently transfected with the pHM6 HPS1 
and from the non-clonal population of cells obtained during the attempted production of 
the stable cell line constitutively expressing the HPS1 protein. Figure 3.6 shows the 
result from this immunoblot analysis on the stable non-clonal population of cells.
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Figure 3.6 Immunoblot analysis of untransfected, transiently transfected and stable non- 
clonal cell population o f COS-7 cells. Lanes (a) and (b) are whole cell lysates from 
COS-7 cells, lanes (c) and (d) are COS-7 cells transiently transfected with the pMH 
HPS1 construct and finally lanes (e) and (f) are a non-clonal population of COS-7 cells 
stably expressing pHM6 HPS1. Lanes (a), (c) and (e) were probed with the polyclonal 
HPS1, HPUD1:1 antibody diluted 1/2000, lanes (b), (d) and (f) were probed with the 
HA monoclonal antibody diluted 1/500. The expressed HA tagged HPS1 protein can be 
observed in both lanes (e) and (f) from the non-clonal population o f stable cells
Both the epitope and HPS 1 antibodies detected an intense band of protein at the 
expected molecular weight of 79kDa in the non-clonal population o f stable cells. The 
HPS1 polyclonal antibody detected another band at around 70kDa. This immunoblot 
result confirmed the immunofluorescence analysis, which suggested a number o f cells 
in the non-clonal population were expressing the N terminal HA epitope tagged form of 
the HPS 1 construct.
This immunoblot analysis was repeated a number of times to confirm the result 
and to get an accurate determination of the molecular weight of the apparent band in the 
stable non-clonal population. The actual molecular weight of this band of protein was 
determined to be 79.43kDa, exactly the expected 79kDa for the human HPS1 protein. 
Figure 3.7 shows repeat immunoblot analysis of this non-clonal population of cells this 
time using all six polyclonal antibodies to the HPS 1 protein in addition to the epitope 
antibody.
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Figure 3.7 Immunoblot analysis of COS-7 non-clonal cell population stably expressing 
the pHM6 HPS1 construct. All whole cell lysates samples on the blot were from the 
mixed population of cells. Lane (a) was probed with HPUD1:1, (b) with HPUD1:2, (c) 
HPUD 2:1, (d) with HPUD 2:2, (e) HPUD 4:1, (f) HPUD 4:2 all diluted 1/2000, and 
both (g) and (h) with the HA epitope antibody diluted 1/500. The HPS1 polyclonal 
antibodies all detected the stably expressed HPS1 protein (*) except HPUD 4:1 and 4.2. 
A major band of approximately 80kDa was detected using the anti-HA antibody (*) in 
addition to a band at approximately 50 and 45kDa.
After a period of two weeks sufficient discrete colonies had grown up in 
the tissue culture dish for the individual colonies to pick and grown on further. A total 
of 48 colonies were picked and each transferred into one well of a 24 well plate and the 
selection continued. To analyse if any of the clones were stably expressing the HPS1 
protein the cells were all analysed by immunofluorescence analysis and processed using 
the high specificity HA epitope antibody. Immunofluorescence analysis was done on 
each and five o f the clones were selected for further analysis. Figure 3.8 shows a 
representative micrograph of three of these clones as well as a cell from the non-clonal 
population of cells produced during the cloning procedure.
The HPS 1 protein in the stable cell lines showed a predominantly punctate 
distribution pattern reminiscent of that observed in the cells transiently transfected with 
either the same N terminal HA tagged HPS 1 construct or the C terminal tagged 
construct. The staining pattern o f the HPS 1 protein was in part, punctate, cytosolic and 
in some cases aggregated. The actual levels of protein within each cell were mostly
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Figure 3.8 COS-7 cells stably overexprcssing I IPS 1 protein.
COS-7 cells stably expressing an N terminal IIA epitope tagged form o f  HPS 1 protein were 
processed for immunofluorescence analysis after methanol fixation and permeabilisation with a 
monoclonal anti-HA primary antibody and FITC conjugated secondary antibody. One cell from 
the mixed population o f  stable cells (a) and individual clones, clone 15 (b), clone 22 (c) and 
clone 36 (d)..
much less than had been observed in the transiently transfected cells, which is expected 
for a stably expressing cell line. This result suggested that the localisation of the HPS1 
protein in the transiently transfected cells was similar to that observed in cells stably 
over expressing the protein.
Close observation of the immunofluorescence pattern of the expressed HPS1 
protein in the population of cells within each clone was carried out. Within each clone 
the population of cells had a variable rate of HPS 1 protein expression. A number of 
cells within the population appeared to show no HPS1 protein expression at all, and the 
cells that were expressing showed variable rates of expression but these were usually 
less than those observed in the transient transfection experiments. Consequently dilution 
cloning of these five clones selected was carried out. The cells were plated out at one 
cell per well of a 96 well plate and grown up in selective media for a further two weeks 
until additional clones of cells were observed. These clones showed exactly the same 
intra-clonal variation in HPS1 protein expression. Immunoblot analysis was performed 
on whole cell lysates prepared form each of the five clones to confirm the expression of 
the HPS1 protein and to assess the levels of HPS 1 expression (Figure 3.9).
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Figure 3.9 Immunoblot analysis of clones of COS-7 cells stably expressing HPSlp. 
Upper panel shows immunoblot analysis of whole cell lysates from clone 15 (a), clone 
22 (b), clone 35 (c), clone 36 (d), clone 47 (e) and COS-7 cells (f) probed with 
monoclonal anti-HA epitope antibody diluted 1/500. A band at 79kDa could be 
observed in all of the lanes for the clones, which was absent from the negative control 
COS-7 sample. Lower panel shows immunoblot analysis of all of the same samples in 
this blot probed with the 0 tubulin antibody, diluted 1/1000, as a positive control for the 
immunoblot.
Figure 3.9 shows that all of the samples were expressing the HA tagged HPS1 
protein as had been observed by immunofluorescence analysis. The clones did shown 
some variation of levels of HPS 1 protein expression when compared using the 0 tubulin 
blot as a control for equal loading. The immunoblot suggested clone 36 contained the 
most HPS 1 protein. This result correlated well with observations from the 
immunofluorescence analysis which indicated that of all of the clones, clone 36 
contained the greatest number of cells in the population that were expressing the HA 
tagged HPS1 protein.
The immunoblot analysis was repeated on whole cell lysate from clone 22, 
which contained the highest level of total protein, using all of the polyclonal antiserum 
against the HPS 1 protein to confirm the protein expression. The immunoblot for this 
analysis is shown in Figure 3.10.
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Figure 3.10 Immunoblot analysis of potential HPS1 stably expressing COS-7 
clones using polyclonal HPS1 antisera. Lane (a) COS-7 lysate probed with HPUD 1:1, 
lane (b) lysate from Clone 22 probed with 1/500 diluted monoclonal HA epitope 
antibody. Lysate from clone 22 probed with 1/2000 diluted polyclonal antibodies, (c) 
HPUD 1:1, (d) HPUD 1:2, (e) HPUD 2:1, (f) HPUD 2:2, (g) HPUD 4:1 and (h) HPUD 
4:2.
The over expressed HPS 1 protein was visible in the clone 22 whole cell lysate 
using all of the polyclonal anti-HPSl antisera except HPUD 4:2. A number of 
additional bands were observed when immunoblotting with all these antisera. Figure 
3.10 demonstrated that the stably expressing HPS1 protein could be observed in whole 
cell lysate by immunoblotting with antisera against the HPS 1 protein.
3.5 Immunoblotting and immunofluorescence analysis of lysates from 
human cell lines probed with HPUD antibodies
The HPS 1 protein is ubiquitously expressed in human tissues and cell lines with 
variable levels of protein expressed (Dell’Angelica et al., 2000b). Since the results from 
the expression studies indicated that the antisera could detect over expressed protein by 
immunoblotting, analysis was performed on whole cell lysates from a variety of human 
cell lines to determine if any o f the antibodies could detect endogenous levels o f HPS 1 
protein. The lysates were prepared from HeLa cervical carcinoma, HEK 293T, 
embryonic kidney epithelia, HEP G2, Hepatocyte epithelia, HT29, colon 









epithelia and CHRP mature megakaryocytes. The lysates were immunoblotted using the 
HPUD 1:1 polyclonal anti-HPSl antisera and the results shown in Figure 3.11.
HeLa HEK HEP G2 HT29 AM LB Panc-1 CHRP




Fig 3.11 Western blot analysis using HPUD 1:1, polyclonal HPS1 antibody and 
monoclonal anti-/3 tubulin antibody. Whole cell lysates were prepared from the 
following human cell lines, (a) HeLa, cervical epithelial, (b) HEK 293 T, embryonic 
kidney epithelia, (c) HEP G2, Hepatocyte epithelial, (d) HT29, colon adenocarcinoma 
epithelial, (e) AMLB, acute myelogenous leukaemia, (f) Panc-1, pancreatic epithelial 
and (g) CHRF, megakaryocyte. The bottom section of the blot below 55kDa was 
incubated with 1/1000 diluted monoclonal (3 tubulin control antibody and the upper 
section with 1/2000 diluted polyclonal HPUD 1:1 antibody.
As seen in Figure 3.11 the HPUD 1:1 antibody detected two bands in most of 
the cell lines and three discrete bands in the HT29, HEK and Panc-1 cell lines. A lower 
major band corresponded to approximately 70kDa, and a slightly larger band in the 
Panc-1 sample. None of these bands corresponded to the expected molecular weight of 
79kDa for the major isoform of the HPS1 protein. This experiment was repeated with 
all six o f the different polyclonal antibodies (data not shown). The results were 
consistent with the same bands appearing each time. One explanation for the number of 
bands is non-specific cross reactivity with proteins other than HPS1 in these samples. 
However, the higher 90-lOOkDa molecular weight band was very strong in the Panc-1 
sample, more so than the HT29 sample.
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A band at approximately 79kDa was observed in additional samples of Panc-1
lysates as seen in Figure 3.12 indicating that the levels of expression of intact
endogenous HPSlp in Panc-1 may be on the borderline o f detection with the HPUD
antisera whereas it is below levels of detection in the other cell lines.




Fig 3.12 Repeat Western blot analysis, using 1/2000 diluted HPUD 1:1, polyclonal 
HPS1 antibody and 1/1000 diluted monoclonal anti-/? tubulin antibody. Whole cell 
lysates were prepared from the following human cell lines, (a) CHRF, megakaryocyte 
(b) HeLa, cervical epithelial, (c) HEK 293 T, embryonic kidney epithelial, (d) HEP G2, 
Hepatocyte epithelial, (e) HT29, colon adenocarcinoma epithelial, (f) Panc-1, 
pancreatic epithelial and (g) & (h) COS-7 African green monkey kidney epithelial cells.
Immunofluorescence analysis using all six polyclonal HPS1 antibodies was 
performed using the Panc-1 pancreatic epithelial cells due to the interesting result from 
the Western blot analysis. Initially Panc-1 cells were fixed in methanol and processed 
for immunofluorescence analysis using only the HPUD1:1 antibody and viewed on the 
confocal microscope. Since no specific signal was detected in the untransfected COS-7 
cells (in the transiently transfected cultures) in previous immunofluorescence analysis 
the background level o f staining was compared with that o f the Panc-1 cells. Both cell 
lines just gave non-specific background staining which looked slightly filamentous in 
nature or in the COS-7 cells, which also gave a strong nuclear non-specific staining 
pattern. A number o f additional experimental conditions were modified to try to reduce 
the background non-specific staining without success.
3.6 Production and characterisation of a monoclonal antibody to 
HPSlp
In order to generate a monoclonal antibody a suitable antigen was required 




HPS1 protein. To produce this antigen recombinant human HPS1 protein would be 
expressed in a bacterial protein expression system. This recombinant protein would be 
purified and then used to elicit the immune response required.
3.6.1 Expression of recombinant HPS1 protein using MBP system
As the final part of the collaboration with GlaxoSmithkline a bacterial protein 
expression construct was provided. This construct was the pMAL bacterial expression 
vector, which contained the full coding sequence for HPS1. A diagnostic restriction 
digest was performed on the construct to confirm the presence of the HPS1 sequence 
and finally the construct was sequenced before protein expression. The construct was 
transformed into BL21 (DE3) E.Coli, which were then grown up to a larger scale and 
recombinant protein expression induced by the addition of IPTG. The protein 
expression was continued over several hours when a crude extract and soluble 
supernatant was then generated. Small aliquots of samples were removed throughout the 
induction experiment for SDS-PAGE analysis. Results for this protein expression are 
shown in Figure 3.13.
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Figure 3.13 Bacterial protein expression using pMAL HPS1 construct. Bacterial protein 
expression experiment showing (a) uninduced BL21 (DE3) cells, (b) lhr induced, (c) 
2hr induced, (d) 3hr induced, (e) final crude extract and (f) final insoluble material.
Figure 3.13 suggested no protein expression at the expected molecular weight of 
130kDa was observed in any sample. Immunoblot analysis was performed on all of the 
samples to see if low-level protein expression was present that could not be detected 
using coomassie blue analysis of the SDS-PAGE gel. Figure 3.14 shows the results of
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Figure 3.14 Immunoblot analysis of bacterial protein expression using a 1/2000 diluted 
polyclonal antibody to HPS1. All samples were identical to those in Figure 3.13. Only 
one band was observed at 60kDa in all samples including the uninduced negative 
control sample.
Repeated attempts at expression suggest that some HPS1 protein expression had 
occurred, however this was very low and insufficient for further use. It was suspected 
that the recombinant protein might have degraded during the induction procedure. To 
eliminate this as much as possible the induction temperature was reduced to 30°C to try 
to reduce protein degradation and enhance protein folding. The experiment was repeated 
otherwise as previously described and the results are shown in Figure 3.15.
HPS1
protein
Figure 3.15 Bacterial protein expression using the pMAL protein expression system 
using lower temperature induction. Bacterial protein expression showing (a) uninduced 
cells, (b) lhr induction, (c) 2hr induction, (d) crude extract and (e) insoluble matter.
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Observation of Figure 3.15 shows that upon this change in induction 
temperature, HPS1 protein expression appears to have occurred with a band of protein 
at ~130kDa in the induced samples and absent from the uninduced control sample.
Upon extraction virtually all of this expressed protein partitioned into the insoluble 
matter fraction rather than the soluble crude extract. This insolubility o f the protein 
could possibly make extraction and purification of the recombinant protein difficult.
The actual levels of expressed protein obtained during this induction experiment were 
also not as high as expected. An alternative system was employed to try to overcome all 
these difficulties.
3.6.2 Expression of recombinant His-tagged HPS1 protein
The pET system is a widely used bacterial protein expression system resulting in 
the expression of the recombinant protein of interest containing a His tag at either the N 
or C termini. In this study the pET 28a vector was utilised which would result in the 
generation of HPS1 recombinant protein with an N terminal His tag. The vector was 
obtained and primers designed to the HPS 1 coding sequence, to enable the generation of 
the HPS1 coding sequence suitable to ligate into the pET 28a vector. The primers were 
designed and used in a PCR reaction. The products of this PCR reaction were analysed 
by electrophoresis and are shown on an agarose gel in Figure 3.16.
Figure 3.16 PCR products of reaction to generate HPS1 coding sequence to clone into 
the pET28a vector. The total PCR reaction was run over two lanes of the agarose gel 
above. A single product at the expected size of 2.0kb was observed.
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The PCR DNA was extracted from the agarose gel and used in a restriction 
digest using both Hind III and Eco RI. At the same time the pET 28a vector was also 
digested using both Hind III and Eco RI and the two pieces of DNA ligated together. 
Small-scale DNA preparations were performed on a number of colonies and this DNA 
used in diagnostic restriction digests using Hind III and Eco RI. The products of these 
digests were analysed by electrophoresis and the resultant agarose gel is shown in 
Figure 3.17. The majority o f the clones gave two DNA fragments at both 5.3kb 
corresponding to the pET 28a vector and 2.0kb the HPS1 insert demonstrating that these 
clones contained the correct construct. Several of the other clones gave fragments at 
~4.5kb and ~2.5kb which represented uncut forms of plasmid DNA, which lacked the 
correct HPS 1 insert.
6.0kb— ■
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Figure 3.17 Diagnostic restriction digests of possible pET 28a HPS1 construct 
containing clones. The products of digests on 14 of these clones are shown, with 9 
clones (numbers 1,3,7, 9,10,11,12,13 and 14) showing the correct fragmentation pattern 
of a 2.0kb HPS1 insert and a 5.3kb vector.
One clone containing the correct insert was used for a large-scale plasmid prep 
and the DNA used in a sequencing reaction to check that the construct was as 
anticipated. Once the construct was sequenced it was used in a small-scale protein 
expression experiment to try to obtain recombinant HPS1 protein using this alternative 
system. The bacterial cells were grown up and protein expression induced using IPTG 
over a four-hour time scale. After induction a crude extraction procedure was performed 
to obtain both soluble and insoluble fractions. Samples were removed throughout the 
experiment for SDS-PAGE analysis. The results from first induction experiment are 








Figure 3.18 Bacterial protein expression using the pET system. Lane (a) uninduced 
cells, (b) lhr induced, (c) 2hr induced, (d) 3hr induced and (e) 4hr induced samples. A 
band at the expected molecular weight of 80kDa was observed on the stained gel.
As shown by the results in Figure 3.18 there did appear to be a significant 
amount of recombinant HPS1 protein expression. The band of protein was absent form 
the negative control uninduced cells. To confirm the identity o f this protein band 
immunoblot analysis was performed using both a polyclonal antibody to the HPS1 
protein and a monoclonal antibody to the His tag. The results from both of these 
immunoblot studies were inconclusive (data not shown). Neither antibody picked up the 
recombinant HPS1 protein at 79kDa, but the His tag antibody used was known to only 
be able to detect purified high levels o f His tag protein. These results suggested that the 
expressed protein might not be the expected HPS1 protein as neither antibody could 
detect this protein from the immunoblot analysis. The whole protein expression 
procedure was repeated including the original transformation of the BL21 (DE3) cells to 
try to repeat the observed data from the previous induction. The induction using IPTG 
was this time minimised to three hours, which is a usual maximal induction time with 
this system. After induction a simple extraction was performed on the E. Coli to yield a 
crude soluble extract and the remaining insoluble material. Samples were taken 
throughout the protein expression and were analysed by SDS-PAGE and coomassie 
blue staining with the results shown in Figure 3.19.
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Figure 3.19 Repeat bacterial HPSlprotein expression using the pET system. Lanes (a) 
and (b) uninduced cells, lanes (c) and (d) 3hr induced cells, (e) and (f) insoluble 
material and finally lanes (g) and (h) crude supernatant. A large amount of recombinant 
HPS 1 protein was produced in this experiment and after extraction was predominantly 
present in the insoluble material.
It was clear from this repeat induction that the system was producing significant 
amounts of the HPS 1 protein by comparison with the uninduced cells and that the 
majority of this expressed protein was insoluble. To try to solubilise the expressed 
protein and enable protein purification using the His tag 6M Guanidine HC1 was 
utilised. The induction procedure was performed as described up to the point of 
extraction. The insoluble pellet was resuspended in 6M guanidine HC1 and used to bind 
to a Talon™ spin resin column following the protocol provided with the column. The 
eluted protein was dialysed in PBS to remove the guanidine to enable the analysis of the 
eluted protein by SDS-PAGE analysis. All samples from the procedure were analysed 









Figure 3.20 Bacterial protein expression and extraction using denaturing agent. Lanes 
(a) and (b) uninduced cells, lanes (c) and (d) 3hr induced sample, lanes (e) and (f) 
soluble extract, lanes (g) and (h) insoluble extract and finally lanes (I) and (j) eluted 
protein after denaturation, binding, elution and dialysis.
Utilisation of guanidine did not appear to have resulted in the desired effect. A 
large amount of HPS 1 protein was expressed during this experiment, shown by the 
intense band at 79kDa in both the induced sample and the insoluble extract. Only a very 
minor amount of HPS 1 protein was present in the eluted sample. This could possibly be 
due to the incomplete solubilisation of the HPS1 protein from the soluble extract. This 
insoluble material would probably have not bound efficiently to the resin in the column, 
giving rise to the low yield observed in the eluted lane on the SDS-PAGE gel.
Instead of attempting more solubilisation experiments an alternative method was 
employed to try to overcome this issue. Performing the induction of the protein for 
longer periods at lower temperatures often increases the yield of soluble expressed 
proteins. The induction was performed at the standard 37°C for three hours as well as at 
the lower temperatures of 25°C and 16°C overnight. After induction simple extractions 
were performed to give soluble and insoluble extracts. Samples were taken during the 
growth and induction procedures and were analysed by SDS-PAGE and coomassie blue 
staining. The results of this experiment are shown in Figures 3.21 and 3.22.
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Figure 3.21 Bacterial protein expression carried out with induction at various 
temperatures. Lane (a) pET uninduced, lane (b) pET induced 3hr, 37°C, lane (c) pET 
HPS 1 uninduced 16°C, lane (d) pET HPS 1 induced overnight 16°C, lane (e) pET 
HPS 1 uninduced 25°C, lane (f) pET HPS1 induced overnight 25°C, lane (g) pET HPS1 
uninduced 37°C and lane (h) pET HPS1 induced 3hr, 37°C.
From Figure 3.21 it could be observed that when compared to the negative 
control empty vector, all of the induced samples appeared to contain the HPS 1 protein 
at 79kDa. There did appear to be a significant amount of protein in all of the samples 
irrespective of the actual induction temperature and time used. The simple protein 
extraction procedure was performed on all of the induced samples to yield insoluble and 
soluble samples. Small aliquots of each sample were removed and analysed by SDS- 










Figure 3.22 Extraction of protein from bacterial cells, after recombinant protein 
expression at various temperatures. Lane (a) 10/xl soluble extract 16°C induction, (b) 
20/zl soluble extract 16°C induction, (c) 10/d insoluble extract 16°C induction, (d) 10/d 
soluble extract 25°C induction, (e) 20/d soluble extract 25°C induction, (f) 10/d 
insoluble extract 25°C induction, (g) 10/d soluble extract 37°C induction, (h) 20/d 
soluble extract 37°C induction and (i) 10/xl insoluble extract 37°C induction.
The results from Figure 3.22 demonstrate that high-level recombinant HPS1 
protein was produced whatever the induction temperature utilised. In all cases the 
protein remained exclusively insoluble.
3.6.3 Purification of recombinant HPS1 protein
Insoluble aggregated protein is an excellent reagent for the immunization of 
mice in the generation of monoclonal antibodies. The utilisation of insoluble material 
does make the purification procedure more complex, as the standard method using a 
nickel column to bind the His tag containing recombinant protein is unsuitable. 
Therefore, an alternative method of purification of the HPS1 protein was utilised instead 
of a resin column to obtain material for the immunization of mice for monoclonal 
antibody production. First all the insoluble HPS 1 protein was extracted by the 
purification of inclusion bodies from the insoluble material after the bacterial protein 
expression. Samples were removed throughout the procedure to enable full analysis of 
the protocol by SDS-PAGE analysis. All of the samples were stained with coomassie 
blue and are shown in 3.23.
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Figure 3.23 Extraction of inclusion bodies from bacterial cells, after recombinant 
protein expression. Lane (a) insoluble pellet after 37°C induction, (b), (c), (d) & (e) 
supernatants removed during inclusion body purification procedure, (f) 2/d final 
inclusion bodies, (g) 5/d inclusion bodies, (h) 10/d inclusion bodies, (i) 15/d inclusion 
bodies and (j) 20/d inclusion bodies. A final total of 5ml of inclusion body preparation 
was obtained and the HPS1 protein can be seen concentrated in this preparation.
As shown in Figure 3.23 the recombinant HPS1 protein was highly concentrated 
in the inclusion body preparation as expected. This inclusion body preparation was used 
to crudely purify the HPS1 protein. This was achieved by separating all of the protein 
components of the inclusion body preparation by SDS-PAGE on a large TRIS SDS gel. 
When the separation was complete a segment of gel was removed corresponding to the 
location of the HPS 1 protein. The protein was removed from the gel slice by the process 
of electroelution into a buffer containing a high SDS content and inside a piece of 
dialysis tubing. Once electroeluted from the gel the HPS 1 protein was dialysed against 
PBS to remove all o f the SDS to enable its injection into mice. A large amount of 
buffer, approximately 200ml, containing the protein was concentrated down to yield a 
sample with a high concentration of the bacterially expressed HPS1 protein. A protein 
estimation was performed on the final sample to give an accurate determination o f the 
protein content. Before the sample was injected into mice the final sample was analysed 
by both SDS-PAGE and immunoblot studies to confirm it was indeed purified HPS1 
protein containing as small amount of contaminating proteins as possible. The results of 










Figure 3.24 SDS-PAGE and immunoblot analysis of purified recombinant HPS1 
protein. A) SDS-PAGE analysis of purified protein with lane (a) and (b) containing 10/xl 
aliquots of protein. Only one obvious band at 80kDa can be observed. B) immunoblot 
analysis of final extract using 1/2000 diluted HPUD 2:2 polyclonal antibody to the 
HPS1 protein. Lane (a) 10/d of sample, (b) 5/d of sample and (c) 2/d of sample.
Both analyses suggested high levels of recombinant HPS1 protein were present 
in this final extract with no obvious contaminating proteins. The protein estimation 
revealed that 10/xg of protein was purified from this first experiment. The purification 
experiment was repeated to obtain larger quantities of protein for the monoclonal 
antibody production. All final samples obtained were analysed as outlined in Figure 
3.24 to confirm its composition before it was used for immunizations.
3.6.4 Immunisation and characterisation of bleeds prior to fusion
The recombinant HPS1 protein obtained from the purification of the bacterially 
expressed protein was used to immunize two Balb/c mice with. 10/xg of protein was 
combined with the adjuvant ImmunoEasy™ and injected subcutaneously into the mice. 
The first injection was performed and the mice given four weekly booster injections, 
four weeks after the initial immunization. Tail bleeds were obtained from the mice after 
the first boost immunization. Serum from these bleeds was used for ELISA analysis 
against ELISA plates coated with the purified HPS1 recombinant protein. The serum 
samples were diluted onto the plates to assess if any o f the mice were producing an 
immune response against the HPS1 protein. In addition to HPS1 coated plates in all 
ELISA studies BSA coated plates were used as negative controls for the experiment but
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the data from these plates is not shown. In all cases the serum gave very low scores on 
ELISA analysis with these BSA coated plates. The results of the ELISA analysis on 
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Figure 3.25 ELISA analysis o f serum from mice after first boost immunization. All 
ELISA analysis was performed against the purified recombinant HPS1 protein. Both 
mouse 1 and mouse 2 showed increased immune responses to the HPS 1 protein in the 
analysis when compared to the normal mouse serum negative control.
Figure 3.25 demonstrates that both the mice appeared to be producing an 
immune response against the recombinant protein after the first boost. At a dilution of 
1/100 the normal mouse serum gave an optical density reading in the ELISA of 0.2 
whereas mouse 1 gave a reading of 1.0 and mouse 2 a reading of 0.8. The titre levels 
were still low and would need to increase to an optical density of around 3.0 before
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hybridoma production could be considered. Tail bleeds were taken form the mice after 
the third boost and used in ELISA analysis exactly as described previously. The results 
for this analysis are presented graphically in Figure 3.26.
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Figure 3.26 ELISA analysis o f both first and second bleeds from mouse 1 and 2. Both 
of the second bleeds from the mice show an increased immune response to the 
recombinant HPS1 protein when compared to either the first bleeds or the negative 
control normal mouse serum.
Both mice appeared to show a strong immune response to the HPS 1 protein after 
the third boost. The boost immunizations were continued on both mice to obtain the 
highest immune response from the mice as possible before hybridoma production. From 
the ELISA data shown in Figure 3.26 both mice were showing titres consistently high 
enough to be used for fusion and hybridoma production. Mouse 2 was selected for 
fusion as it showed a slightly increased immune response to HPS 1 protein when
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compared to mouse 1. During the sacrifice procedure, as much blood as possible was 
removed from the mouse and the serum extracted. This was the final serum sample and 
was used in ELISA analysis to establish the final level of the immune response of 
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Figure 3.27 ELISA analysis of all bleeds form mouse 2 including final bleed. ELISA 
analysis of all serum samples obtained from mouse 2 against recombinant HPS1 
protein. Both the second and final bleeds had a high immune response against the HPS 1 
protein making this mouse suitable for use in a fusion and subsequent hybridoma 
production.
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The results of the final bleed compared to the second bleed suggested that the 
immune response of the mouse to the HPS1 had reached a maximal value and was 
unlikely to increase even after further boost injections. The levels of the immune 
response of the mouse when measured by ELISA analysis were reasonably high and the 
fusion experiment proceeded. The optical density values were slightly lower in this 
experiment due to variations in experimental conditions including accuracy of dilutions 
and pipetting and also the ambient temperature in the laboratory. They were however all 
relative to each other in one single experiment. In addition to this ELISA analysis the 
serum from the mice was used in both immunofluorescence and immunoblot analysis to 
see if antibodies in the serum could detect HPS1 protein over expressed in mammalian 
in vitro systems. Whole cell lysates were prepared form COS-7 cells and COS-7 cells 
transiently over expressing the human HA tagged HPSlp protein. The lysates were then 
used for immunoblotting with serum from the mouse tail bleeds of both mouse 1 and 2 
and in addition a monoclonal antibody to the HA epitope tag. The results of the 
immunoblot analysis are shown in Figure 3.28.
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Figure 3.28 Immunoblot analysis using second bleeds from mice after immunization 
with recombinant HPS 1 protein. All protein samples used in the immunoblot analysis 
are whole cell lysate from either COS-7 cells transiently expressing HPS1 in Part I or in 
Part II whole cell lysate from untransfected COS-7 cells. The samples were probed with 
the following sera and purified antibodies (a) normal mouse serum, 1/500 dilution, (b) 
normal mouse serum, 1/250 dilution, (c) normal mouse serum, 1/100 dilution, (d) 
Mouse 2 serum, 1/500 dilution, (e) Mouse 2 serum, 1/250 dilution, (f) Mouse 2 serum, 
1/100 dilution, (g) Mouse 1 serum 1/500 dilution, (h) Mouse 1 serum, 1/250 dilution, (i) 
Mouse 1 serum, 1/100 dilution and finally (j) HA epitope antibody dilution 1/500.
The immunoblot analysis demonstrated that the negative control normal mouse 
serum picked up a few non-specific bands in both the transfected and untransfected cell 
lysate samples at all dilutions tested. The positive control HA epitope antibody gave no 










single band at 79kDa corresponding to the HPS1 protein in the pMH HPS1 transfected 
COS-7 lysate sample (Part A, lane j). All of the mouse serum samples at various 
dilutions detected no specific bands in the COS-7 untransfected lysate samples. 
However all of the serum samples at all dilutions tested detected a single band at 79kDa 
in the pMH HPS1 transiently transfected lysate samples. Antibodies to the HPS1 protein 
were present in these two sera that were not present in the normal unimmunized mouse 
sera.
Preliminary analysis was also performed using the mouse 2 final serum for 
immunofluorescence analysis. Transiently transfected COS-7 cells were processed for 
immunofluorescence analysis using the sera as the primary antibody. The cells were 
imaged on the confocal microscope and the results shown in Figure 3.29. The serum 
contained antibodies, which could detect transiently expressed HPS1 protein in COS-7 
cells by immunofluorescence analysis. Two transfected control cells incubated with 
only the secondary antibody were included to show that this secondary antibody had no 
cross-reactivity. The staining pattern of the over expressed HPS1 protein was punctate 
and distributed throughout the cytosol of the cells. This was identical to the staining 
pattern observed in identical studies except for the utilisation of the polyclonal HPS1 
antibodies. The mice were producing antibodies to the HPS1 protein after immunization 
with the recombinant HPS1 protein that were useful in detecting over expressed protein 
by both immunofluorescence and immunoblotting.
3.6.5 Fusion and hybridoma production
For the first fusion procedure mouse 2 was selected as it simply showed higher 
levels of reactivity to the HPS1 protein when compared to mouse 1 using ELISA 
analysis. The mouse was sacrificed and its spleen removed, cells dispersed and fused 
with immortalised X-63 myeloma cells using polyethyleneglycol. The cells were 
incubated for 24 hours before they were all plated onto five macrophage coated 96 well 
plates. The cells were incubated until hybridoma clones became visible, which took 
between 2-4 weeks. Once the clones became confluent the supernatant was removed 
from them and used in ELISA analysis against the recombinant HPS1 protein. In the
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Figure 3.29 1 mmunofluorescence analysis using serum from mice immunized with recombinant 
HPS1 protein.
COS-7 cells were transiently transfected with the pMH HPS1 construct and processed for 
immunofluorescence analysis after paraformaldehyde fixation and triton xlOO permeabilisation.
In images (a) and (c) the cells were incubated wth 1/150 diluted Mouse 2 final serum from the tail 
bleed as the primary antibody, in images (b) and (d) the cells were only incubated with the Texas 
red cojugated anti-mouse IgG secondary anitbodv.
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analysis normal mouse serum was used as a negative control and the final serum 
obtained from mouse 2 before the fusion was used as the positive control. All o f the 
ELISA optical density readings from the clones were used to calculate the percentage 
when compared to the positive control. Any clone showing a score of greater than 25% 
of the positive control potentially could be a hybridoma producing antibodies to the 
HPS1 protein. The results of this ELISA analysis are presented graphically in Figure 
3.30.
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Figure 3.30 ELISA analysis of hybridoma clones from mouse 2. All five 96 well plates 
are shown individually in a graphic representation. Each blue column represents one 
clone of cells, which grew at that location on the plate (x and y axis). The height of the 
bar (z axis) is the percentage score upon ELISA analysis when compared to the positive 
control. A number of clones gave ELISA scores greater than 25%, which is a good early 
indicator of potential hybridomas producing the antibody o f interest.
The efficiency of this fusion experiment was calculated by counting the number 
of wells on the 96 well plates in which clones grew up. There were a total of 84 clones 
in this fusion out of a possible 480 wells on the plates. This gives a fusion efficiency of 
17.5%. This is a comparatively low efficiency, but the variation between each fusion is 
dependent on a wide variety o f factors. A large number o f the clones gave a very low 
score upon ELISA analysis, as shown in Figure 3.30 by the very low bars on the graph.
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A number of clones, which gave reasonable scores were expanded and re-screened 
using exactly the same method described. A number of clones died off or became 
contaminated during this procedure so are not included in any subsequent analysis. It is 
usual for clones to initially show a high score on ELISA analysis and in subsequent 
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Figure 3.31 First and second ELISA analysis after cloning. Graph shows the score on 
ELISA analysis as a percentage of the positive control after the first and second cloning. 
Only clone 4F2 gave a second screen ELISA score of greater than 25% of the positive 
control.
The results for the second screening showed that none of the clones from this 
fusion reached a percentage score of greater than 25% of the positive control. None of
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these clones were therefore thought to be expressing antibodies to the recombinant 
HPS 1 protein. Mouse 1 was still available to utilise and even though it had produced a 
lower level immune response after the immunizations with the recombinant protein, the 
levels of response were still high enough to use this mouse in a fusion experiment. The 
fusion was repeated exactly as outlined previously. This was the final serum obtained 
before the fusion and was used for ELISA analysis against the HPS 1 protein along with 
all the serum samples obtained during the immunization procedure. The results of this 
experiment are shown graphically in Figure 3.32.
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Figure 3.32 ELISA analysis of all bleeds form mouse 1 including final bleed. ELISA 
analysis of all serum samples obtained from mouse 1 against recombinant HPS1 
protein. Both the second and final bleeds had a high immune response against the HPS 1 
protein making this mouse suitable for use in a fusion and subsequent hybridoma 
production. The optical densities values were lower than observed previously and it is 
suspected that this is due to degradation of the HPS 1 protein after prolonged storage.
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Mouse 1 was used in a repeat o f the fusion procedure. The fusion efficiency of 
this experiment was fairly low with a calculated efficiency of 22%. This was slightly 
increased on the previous fusion but still lower than the expected average efficiency. 
The ELISA scores as a percentage of the positive control were generally significantly 
lower than those observed in the previous fusion procedure. This may be due to any 
number o f experimental factors including the temperature regulation of the reaction and 
technique used or due to mouse 1 which did have a lower immune response than mouse 
2 to the HPS1 recombinant protein after the immunizations. From this preliminary 
analysis the clone positioned in well D8 on plate one appeared to give the highest score 
using this method. It gave a value of 33% of the positive control final serum. The clone 
was grown up and dilution cloned to give one cell per well over two 96 well plates. The 
cells were allowed to grow up into new clones, which took two weeks. After they 
became confluent all of the resultant clones, a total of 82, were analysed by ELISA 
analysis exactly as described previously. The results of this second screen are shown 
graphically in Figure 3.33.
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Figure 3.33 ELISA analysis of clones obtained after dilution cloning of 1D8. All clones 
tested showed a high score on ELISA analysis of between 45-63% compared to the 
positive control shown in well D11 on the Figure.
After the dilution cloning all the resultant clones showed a much-increased score 
upon ELISA analysis against recombinant HPS 1 protein. This suggests that the clones 
may be producing more antibody than the original clone and is a common phenomena
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often exhibited after dilution cloning. Six of the clones with the highest percentage 
score in this experiment were grown up and dilution cloned again. This is to ensure that 
a single cell was the founder of each clone and that the population of cells was truly 
monoclonal. At all stages of dilution cloning the supernatant from clones was retested 
using ELISA analyses to confirm that they were still producing the antibodies to the 
recombinant HPS1 protein.
A total of six final clones, which gave good high scores on ELISA 
analysis were obtained from the original D8 clone found on plate 1 of the fusion. The 
antibody that the clones were producing was isotyped using a capture ELISA procedure. 
Instead of coating the ELISA plates with HPS1 protein they were coated with anti­
isotype specific antibodies. Supernatant from the growing final clones, 1C6, 1H10, 2D6, 
2F9, 2F10 and 2H7 was analysed this way to define the isotype of the antibody they 
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Figure 3.34 Capture ELISA isotyping of antibody produced by hybridoma. The negative 
control for the experiment was cloning media, and the positive control was the final 
serum obtained from mouse 1 after the immunizations. The additional lanes show the 
resultant hybridoma clones obtained after the fusion and subsequent dilution cloning. A 
total of six isotype classes o f antibody were tested for in this capture ELISA.
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The results from the capture ELISA show that all of the final hybridoma clones 
from this experiment produced antibodies that were of the IgGl class. All of the clones 
gave very low ELISA scores when compared to the positive control for the other 
isotype classes. Additional analysis using alternative experimental procedures was 
required to confirm that this antibody specifically reacted to the HPS1 protein and not 
an additional contaminant within the purified extract.
3.6.6 Characterisation of monoclonal antibodies to HPSlp by immunofluorescence 
microscopy and immunoblotting
Preliminary studies using immunofluorescence analysis was carried out on the 
supernatant from these hybridomas. Both COS-7 cells and COS-7 cells which were 
transiently transfected with the pMH HPS1 construct, were processed for 
immunofluorescence analysis using the supernatant from the growing hybridoma clones 
as the primary antibody. Cells were imaged on the confocal microscope and the results 
of the study are shown in Figure 3.35. All images shown in this figure are from the 
transiently transfected COS-7 cells. A negative control cell incubated without any 
primary antibody showed no background staining indicating that the secondary antibody 
was in no way cross-reacting with any proteins within the cells. A positive control was 
included using the final serum obtained from mouse 1 to stain the transiently transfected 
COS-7 cells. The serum detected the expressed HPS1 protein in these cells shown by 
the punctate pattern of distribution throughout the cell. All six of the hybridoma clones 
gave exactly the same results with each one detecting the transiently expressed HPS1 
protein. The antibody from these hybridomas detected low levels of protein expression 
in these cells, with virtually no background staining. This was most apparent when 
observations of the nuclear region were made. Immunofluorescence analysis using the 
polyclonal antibodies to HPS1 had often yielded non-specific nuclear staining in a large 
majority of the cells imaged. This was completely absent using these monoclonal 
antibodies. This result suggested that the hybridomas were producing a monoclonal 
IgGl isotype antibody against the HPS1 protein, which could detect over expressed 
protein in COS-7 cells.
Additional analysis was performed using this monoclonal antibody and 
immunoblot analysis. Two cell types were selected in which to perform this analysis. 
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Figure 3.35 COS-7 cells transiently transfected with pMH HPS1 construct and processed for 
immunofluorescence analysis alter paraformaldehyde fixation and triton xlOO permeabilisation using 
the undiluted supernatant from the hybridoma clones generated from mouse 1. The negative control 
image shows a transiently transfected cell processed without the supernatant. The positive control 
image was obtained using 1/150 diluted final serum obtained after the immunization procedures on 
mouse 1. The additional images show a representative cell from transfected cells processed using the 
supernatant from the indicated hybridoma clone.
higher levels of endogenous HPS1 protein within them. The immunoblot analysis was 
first performed in transiently transfected COS-7 cells using neat supernatant from the 
hybridomas and the standard HRP system of detection. The images of the resultant 
experiment are shown in Figure 3.36.
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Figure 3.36 Immunoblot analysis of transiently transfected COS-7 cells using 
monoclonal supernatant. Lane (a) positive control, mouse 1 final serum diluted 1/500, 
(b) negative control, media only as primary antibody, (c) hybridoma clone 2H7, (d) 
clone 2F10, (e) clone 2F9, (f) clone 2D6, (g) clone 1H10 and (h) clone 1C6. All 
samples except the negative control detected the 79kDa over expressed HPS1 protein.
The results from this immunoblot analysis demonstrated that all six final 
hybridoma clones produced antibodies, which detected the over expressed HPS1 protein 
in COS-7 cells by immunoblotting. The final serum gave a much higher background 
than the clones due to the presence of an array of other antibodies in the serum 
compared to the single antibody produced by the hybridoma clones. The negative 
control lane was devoid of any bands confirming that the secondary antibody was not in 
anyway cross-reacting with any other proteins. Five of the clones detected exactly the 
same protein bands on the immunoblot with the majority of the staining being the HPS1 
protein with a few non-specific bands of fairly low intensity at approximately 130, 100 
and 60kDa. Clone 1C6 did seem to show a slight variation in this staining pattern. With 
this sample only the HPS1 band at 79kDa was seem but this wasn’t as intense as in all
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of the other samples. The experiment was repeated exactly as outlined except using 
COS-7 whole cell lysates that were untransfected. The data for this study is not shown 
but the all of the monoclonal antibodies appeared to detect no HPS1 protein using this 
system.
In addition to this analysis attempts were made to try to determine if the 
monoclonal antibodies could detect endogenous levels of HPS1 protein in both Mel 164 
melanoma cells and in the COS-7 endothelial cells. The results for this study are shown 
in Figure 3.37.
Figure 3.37 Immunoblot analysis using monoclonal antibodies against untransfected 
and transiently transfected cell lysates. Lane (a) Untransfected COS-7 cells, (b) pMH 
HPS1 transfected COS-7 cells, (c) Untransfected Mel 164 cells and (d) pMH HPS1 
transfected Mel 164 cells. Clone 2D6 supernatant was used in this analysis and detected 
the transiently over expressed HPS1 protein in both cell types.
Immunoblot analysis demonstrated that using this technique the supernatant 
from the hybridomas could only detect the over expressed HPS 1 protein in both cell 
types tested. No endogenous HPS 1 protein was detected in either cell type. A non­
specific band was detected at around 60kDa in all of the samples on the blot. This result 
was similar for all the hybridoma clones tested. After this initial result, experimental 
modifications were made to the immunoblot procedure to try to improve the sensitivity 
of the technique to see if low level endogenous HPS1 protein could be detected using 
the monoclonal antibodies. The immuoblot procedure was only modified at the 
detection stage. In preference to horse radish peroxidase and Eel™ reagent Vectastain™ 





signal on the resultant immunoblot. Essentially the experiment was as outlined in Figure 
3.37 except for this modified detection system. The results o f this experiment are shown 
in Figure 3.38.
Figure 3.38 Immunoblot analysis of whole cell lysates from COS-7 and Mell64 cells 
using monoclonal antibody to HPS1 and Vectastain™ detection system. A) 30/ig of 
protein is loaded per lane. B) 10/xg of protein per lane. Lane (a) Mel 164 cells transiently 
transfected with pMH HPS1, (b) untransfected Mel 164 cells, (c) COS-7 cells transiently 
transfected with pMH HPS 1 and (d) untransfected COS-7 cells. All samples were 
incubated with neat Clone 2D6 supernatant. Arrowheads show the detected HPS1 
protein at 79kDa.
Evidence from this study showed that the monoclonal antibody could detect the 
transiently expressed protein both in the endothelial and melanoma cells. However even 
using this increased sensitivity approach no band of HPS 1 protein was detected in the 
untransfected whole cell lysates. A multitude of minor protein bands were detected in 
all of the samples at a wide range of molecular weights. The increased detection 
efficiency enhanced this background level of staining by the 2D6 monoclonal antibody. 
Therefore using either of the twp techniques stated it appeared that the monoclonal 
antibody produced could not detect endogenous levels of HPS 1 protein. The antibody 




Full characterisation of the polyclonal antibodies to the HPS1 protein which 
were provided as part of a collaboration, revealed that they were useful in detecting over 
expressed HPSlp by both immunoblotting and immunofluorescence, however 
endogenous protein could not be detected in the various human cell lines analysed. The 
HPS1 protein is known to have a ubiquitous expression profile across a number of 
different cell types and tissues (Dell’Angelica et al., 2000b) and would therefore be 
expected to be present. The level of HPSlp expression in these cell lines, therefore, may 
be too low or the antibodies of not sufficient affinity to enable endogenous protein 
detection. However, immunoblot analysis of a variety of cell lines using these anti- 
HPS1 polyclonal antibodies did reveal a significant band at around 90kDa only in the 
Panc-1 cell line, which is a pancreatic cell line. This is a novel finding which may be 
significant in the light of recent research on the small GTPase Rab27a and it’s role in 
pancreatic cells. As well as it’s important role in melanosome peripheral retention, 
Rab27a has been shown to have a role in the exocytosis of dense core granules in 
endocrine tissue (Yi et al., 2002). Overexpression of Rab27a enhances high K+ induced 
insulin secretion with the simplest interpretation being that Rab27a acts to maintain the 
size of the pool of fusion ready vesicles by recruiting vesicles to the docking site. No 
research to date has looked at the possible role of the HPS1 protein in pancreatic 
function due to patients not exhibiting any outward signs of endocrine defects. Griscelli 
patients defective in Rab27a also have no obvious endocrine defects making the results 
on the role of Rab27a in pancreatic tissue unexpected. This significant band on 
immunoblot analysis in this study could represent an additional unknown isoform of 
HPS1 with a potential role in pancreatic cell function.
Monoclonal antibodies are widely used tools in cell biology including 
membrane trafficking studies. The antibodies themselves usually show a greater 
specificity to the required protein than polyclonal antibodies and with the resultant 
hybridoma cell line producing the antibody in a limitless supply. If  only polyclonal 
antibodies are available this can limit dual labelling studies if subcellular marker 
antibodies are also polyclonal and therefore incompatible. It was anticipated that the 
generation of a monoclonal antibody would increase the specificity of HPS 1 protein 
detection in a variety of experimental models in this study and enable more detailed
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immunofluorescence analyses to be carried out. The polyclonal antibodies provided as 
part of a collaboration, were unable to detect endogenous levels of HPS 1 protein by 
either immunoblotting or immunofluorescence analysis as described previously.
The transient overexpression of HPS 1 protein in COS-7 cells resulted in a 
variable distribution pattern of the expressed protein. The protein was sometimes 
punctate, sometimes cytosolic and sometimes aggregated together. Two previous groups 
had utilised different antibodies to the HPS1 protein in their characterisation of this 
protein. Firstly, DelT Angelica and co-workers had generated a polyclonal antibody to 
the human HPS1 protein. This was achieved by immunizing rabbits with a peptide 
corresponding to amino acids 253-267 of the human protein sequence. The resultant 
antibody was affinity purified and fully characterised. The antibody was unable to 
detect endogenous levels of HPS 1 protein in either HeLa cells or M l fibroblasts by 
either immunofluorescence of immunoblot studies. It could however detect endogenous 
levels of protein by an immunoprecipitation recapture procedure using 35S radiolabelled 
supernatants from HeLa and a variety of other cells lines (Dell’Angelica et al., 2000b). 
This study mirrors the results in this research study and suggests this is a characteristic 
of polyclonal anti-HPSl antibodies. This study also demonstrated that the transient 
overexpression of HPS 1 protein resulted in a largely diffuse cytoplasmic pattern 
(Dell’Angelica et al., 2000b). These results are somewhat contradictory to that observed 
in this study which resembled more of the melanoma-like distribution. The transient 
overexpression study referred to above used a construct containing a HIS tag which was 
also present in the pHM6 HPS1 construct used in this study so the localisation 
differences observed were unlikely to be the result of the epitope tag. Upon higher-level 
protein expression in COS-7 cells the HPS1 protein aggregated together particularly 
around the perinuclear area of the cell. This aggregation was not observed at lower 
levels of expression suggesting that this aggregation is not a typical pattern of 
distribution of HPS 1 protein in COS-7 cells.
Secondly, Oh and co-workers used an alternative technique by cloning the 
cDNA for two segments of the HPS1 protein encoding amino acids 1-463 and 462-700 
in the pET 28a (+) bacterial protein expression vector. This construct was introduced 
into BL21 (DE3) pLysS E.Coli and protein expression induced using IPTG. The 
resultant proteins were purified by SDS-PAGE analysis and elution before a 1:1 mixture 
of both proteins was injected into mice and rabbits. The resultant rabbit polyclonal 
antisera were affinity purified and the monoclonal antibodies were used as tissue culture
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supernatant. The polyclonal antibody detected both the major and minor isoforms of 
HPS1 by immunoblot analysis on lymphoblastoid tissue but a number of other non­
specific bands were present on the blot. The monoclonal antibody detected endogenous 
HPSlp in melanoma lysate without any non-specific bands. In addition the monoclonal 
antibody detected endogenous levels of the protein in fibroblasts by 
immunofluorescence analysis (Oh et al., 2000). The endogenous HPS1 protein had a 
mainly cytoplasmic distribution in fibroblasts whereas in melanoma cells it showed a 
perinuclear concentration and globular component suggestive of organelles (Oh et al., 
2000). These two studies elegantly demonstrated the differences in specificity that can 
occur between polyclonal and monoclonal antibodies generated against the same 
protein. In this study a monoclonal antibody to the human HPS1 protein was produced 
in much the same way as described by the work of Oh and co-workers i.e., generating 
recombinat human HPS1 protein using a bacterial expression system. As part o f a 
collaboration with GlaxoSmithkline a construct was provided which was a bacterial 
expression vector pMAL containing the full length coding sequence of the human HPS1 
gene. This vector utilised the maltose binding protein tag, which is cloned onto the 
termini of the protein of interest for subsequent purification purposes. This expression 
system was used in this study and good levels of recombinant protein expression were 
achieved in BL21 E.Coli cells. However, all of the protein produced by the bacteria was 
insoluble making purification by the recommended technique difficult. It was believed 
that the insoluble nature of the expressed protein might have been the result of the 
actual maltose binding protein tag on the protein. The HPS1 protein is 79kDa in size 
and the maltose binding protein an additional 50kDa resulting in a protein of quite 
substantial size. This very large highly expressed protein probably aggregated together 
during its expression resulting in it becoming insoluble and packaged into inclusion 
bodies within the bacteria.
As an alternative to this maltose binding protein system a His tag bacterial 
protein expression system was employed. This system utilises a very short tag of 
histidine residues on the N or C termini of the protein to enable purification using a 
nickel resin for example. It was anticipated that this much shorter protein tag might 
prevent the expressed HPS1 protein from becoming insoluble. Using this system very 
high levels of expression of HPS 1 protein were achieved but it appeared the protein was 
insoluble. Alternative techniques were employed to try to increase the solubility of the 
protein. This included reducing the temperature during the induction period, which is
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known to slow down the rate of transcription and translation aiding the folding of 
proteins as they are manufactured. This however had no effect no the solubility of the 
protein produced using this system. One way to overcome this problem is to alter the 
vector and the E.Coli host cell line used in the induction procedure. Very high levels of 
protein expression as exhibited by the pET28a system in this study often yield insoluble 
proteins and altering the host strain or vector may result in tighter control of expression 
and therefore reduced levels of the expressed protein increasing the possibility of a 
soluble protein being the end result. It was supposed that the nature of the HPS1 protein 
itself might be lending itself to the formation of insoluble protein product. When the 
HPS1 protein was originally cloned, two regions of the protein were speculated to be 
transmembrane regions. These regions contain a number of hydrophobic amino acids, in 
one case 56% hydrophobic amino acids (Oh et al., 1996). It is possible that during the 
bacterial protein expression these hydrophobic runs of amino acids were clustering 
together from different polypeptides resulting in the polypeptides aggregating together. 
It would be difficult to overcome this problem merely by a vector or host strain change.
In addition to the work generating a monoclonal antibody, soluble recombinant 
HPS1 protein could have been utilised in a variety of other studies. This could have 
included pull-down experiments by immobilising the HPS1 protein onto a resin column 
and ‘fishing’ for additional proteins that interacted with HPS1. Attempts were made to 
solublise the protein using both guanidine and urea but analysis of these subsequent 
solubilised samples proved difficult. However it is known that insoluble proteins make 
good antigens if used to immunize mice. For this reason it was decided to utilise the 
insoluble material rather than make any further attempts at forming soluble HPS1 
protein. The technique used throughout was essentially identical to that employed by Oh 
and co-workers (Oh et al., 1996). No mention in their study was made about the 
solubility of the recombinant protein the HPS1 protein produced.
The new adjuvant ImmunoEasy™ was selected as the adjuvant o f choice in this 
study due to it being minimally toxic to the animals used in the immunizations and it 
has been shown to elicit a high immunogenic response in these animals compared to 
other adjuvants. Analysis of serum samples from both mice that were immunized show 
that they both produced a high level immune response to the insoluble recombinant 
HPS1 protein extract. This suggested that the protein itself was immunogenic and the 
adjuvant was producing the desired effect.
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The actual number of clones that resulted from both sets of fusion experiments 
was much lower than expected. Fusion efficiency does vary considerably between 
different studies due to a large number of different factors. It is critically important that 
a stable temperature of 37°C is maintained throughout the two-week outgrowth period. 
This is difficult to attain with multi-user facilities and may be one reason for the 
apparent low efficiency. It can also be affected by the quality of the resultant spleen and 
myeloma cells.
The first round ELISA scores of hybridoma clones from both sets of fusions 
were rather low and values in the region of 50% or higher of the positive control would 
be expected to indicate a high level antibody producing hybridoma had been produced. 
In both fusions the highest ELISA score was in the region of 25-35% of the positive 
control, which was considerably lower than the ideal. If a number of additional mice 
were immunized and consequently more fusions a better fusion and therefore 
hybridoma may have resulted. The low efficiency could also be due to differences in 
reagents such as the batch of PEG buffer used. A number of clones that had high level 
ELISA scores on first round analysis were grown up and re-analysed. As is often the 
case these clones often then prove to be false positives, which show very low ELISA 
scores on any subsequent analysis. Only one clone from the second fusion demonstrated 
ELISA scores consistently on all subsequent screens of greater than 25% of the positive 
control. As this was the only potential hybridoma producing anti-HPSl antibodies, it 
was selected and used for further characterisation and study.
Preliminary characterisation of the resultant antibody produced from this clone 
was crucial to confirm it was indeed producing the required antibody. Firstly the clone 
was dilution cloned three times in total to ensure a homogenous monoclonal population 
of cells was produced. Final ELISA analysis of these clones revealed a much-increased 
ELISA score against the recombinant protein extract. This is often the case when the 
cells are dilution cloned and allowed to grow up fully. The reason that this full 
characterisation was so important was due to the nature of the recombinant protein 
extract used to immunize the mice with. The inclusion body extract was purified by 
separating out all of the protein components from within it by SDS-PAGE analysis. A 
band of gel corresponding to a molecular weight of between 70-80kDa was removed 
from the gel and all of the protein components form that piece of gel removed by 
electroelution. From further analysis it did appear that this purified extract contained 
mainly the expressed HPS1 protein but there was one or two minor contaminating
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proteins within it. Therefore it remained a possibility that because this purified extract 
had been used in all the ELISA analysis that the hybridoma clone may be producing an 
antibody to one of these contaminating proteins.
The only way to confirm the nature of the antibody that the hybridoma was 
producing was to fully characterise the antibody using in this case mammalian in vitro 
systems. Before the in vitro characterisation of the isotype class of the antibody that the 
clones were producing was identified. This was done using a standard isotyping 
procedure, which is based on a sandwich capture ELISA technique. This confirmed that 
all o f the clones were producing one isotype of antibody only and all the same class of 
antibody. The antibody was shown to be of the IgGl isotype, which is the most 
abundant class in serum constituting about 80% of the total serum immunoglobulin. In 
addition it also confirmed that the final clones were monoclonal as each one was only 
producing one isotype specific antibody.
For the mammalian in vitro studies the supernatant was simply removed form 
the growing cells and used in experimental studies. The hybridoma cells secrete 
antibody into the growth media to a level of approximately 10-100/Jg/ml. This is a fairly 
low level of antibody and there are a number of ways in which this level of antibody can 
be increased. This can include simply concentrating the antibody down using a spin 
concentrator or on a more technical level the production of ascites fluid. Ascites fluid is 
produced by injecting the hybridoma cells into the peritoneal cavity of a 
histocompatible mouse, which then secretes the antibody into the ascites fluid at a much 
higher concentration of l-25mg/ml. Neither of these methods was attempted in this 
study for a number of different reasons. The antibody containing supernatant was used 
in two different types of study, both immunoblot analysis and immunofluorescence 
analysis.
In immunofluorescence studies the overall results were much the same as those 
obtained from the immunoblot experiments. The antibody could not detect endogenous 
levels of HPS 1 protein in COS-7 cells. It however could detect transiently over 
expressed HPS1 protein in these cells labelling the characteristic punctate subcellular 
distribution of the protein. It did give an improved result in terms of comparison with 
the polyclonal HPS1 antibodies used in previous studies. The monoclonal antibody gave 
no nuclear non-specific staining which had been a problem with the polyclonal 
antibodies. Results from Oh and co-workers (Oh et al., 2000) demonstrated that their 
monoclonal antibody could stain endogenous HPS1 protein in fibroblast cells. The
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distribution pattern differed considerably from the results of this study in that the 
antibody showed a cytoplasmic distribution in these particular cells using this antibody 
(Oh et al., 2000). Although the monoclonal antibody produced in this study could not 
detect endogenous protein by immunofluorescence or immunoblotting it did prove 
useful for immunoprecipitation of HPSlp as described in the following chapters.
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Chapter 4.0
Subcellular localisation of wildtype and C-terminal truncated forms of 
HPSlp in cultured cell lines 
4.1 Introduction
The original report into the cloning of the HPS1 gene described a 16-bp 
duplication in the exon 15 found in Puerto Rican patients with no mRNA produced (Oh 
et al., 1996). Other mutations described in this study included a Japanese HPS patient 
with a single-base duplication (adenine) within codon Ala 441 resulting in a frameshift 
distal to this site with termination of a nonsense polypeptide at codon 451. In addition a 
Swiss inbred HPS kindred was identified with a third frameshift at codon Pro 324 due to 
an additional cytosine. This frameshift also resulted in the termination of a nonsense 
polypeptide at codon 451. Further mutations characterised include the T322insC 
mutation reported in families of Italian/German/Ukrainian, Swiss, Irish/German, French 
and Scottish heritage. Finally a T322delC mutation has been identified in German and 
Japanese families and a S396delC mutation in Ukrainian, Dutch/German and 
Irish/English/French/Norwegian (Shotelersuk et al., 1998). All of the HPS1 gene 
mutations so far identified are predicted to result in truncated proteins with portions of 
the C terminus missing. This suggests that the C terminal portion of the protein is 
critical for its function.
Studies in this chapter address whether the distribution of the wildtype HPSlp 
corresponds to any previously characterised subcellular compartments and whether the 
mutant HPSlp protein expression pattern differs with respect to that o f the wildtype 
protein in both non-melanocytic and melanocytic cell lines.
4.2 Localisation of HPSlp by immunofluorescence in non-melanocytic 
transfected cell lines
4.2.1 Dual localisation with various markers in transiently transfected cells
To characterise the subcellular localisation of the transiently expressed HPS1 
protein dual labelling studies were carried out. Transiently transfected COS-7 cells were 
stained for the expressed HPS 1 protein and in addition stained with antibodies to 
specific proteins that reside in known subcellular organelles. For this study the 
following antibodies were used; TGN46 a trans Golgi network marker, EEA1 an early
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endosome marker, CD63 a late endosome and lysosome marker and M6PR, which 
cycles between the trans Golgi network and late endosomes, myosin Va an actin motor 
protein, and clathrin a vesicle coat protein. The images obtained from these dual 
labelling studies are shown in Figure 4.1.
As can be seen in Figure 4.1a CD63 characteristically stains quite large 
punctate structures, presumably late endosomes and lysosomes. However no 
colocalisation (yellow overlap) between lysosomes and the HPS1 protein was observed 
in this image. This suggested that under these conditions HPS1 wasn’t present in the 
same structures as CD63. No colocalisation was observed with M6PR, EEA-1 or 
TGN46. Interestingly the trans-Go\gL network did appear to have undergone a 
morphological change in the transfected cells. Instead of the characteristic ring like 
structure the TGN appeared to break up into much smaller vesicular structures seen in 
image (d). This could be the result of the transient expression of the HPS1 protein 
having a function at the level of the TGN or could simply be due to a non-specific effect 
of overexpression resulting in the alteration of TGN morphology. This phenomenon 
was not observed in the untransfected cells on the same slide. No colocalisation was 
observed with the actin motor protein myosin Va (e), which mainly showed a cytosolic 
distribution pattern. The clathrin heavy chain antibody showed the characteristic 
clathrin localisation pattern of tubulovesicular structures in proximity to the Golgi stack 
as well as scattered peripheral foci throughout the rest of the cell. As can be observed in 
the featured image (f) there was some degree of colocalisation between HPS1 and 
clathrin (yellow overlap) exclusively in the juxtanuclear area of the cell. No overlap at 
all was observed between the peripheral foci of both proteins.
These colocalisation experiments were repeated a number of times with similar 
results. Therefore the transiently expressed HPS1 protein did not appear to colocalise to 
any great extent with known subcellular markers including the lysosomal marker CD63 
in non-melanocytic cells. As described previously the transient overexpression of this 
protein may have resulted in it being mislocalized from its usual subcellular location so 
this was addressed by a further series of experiments.
4.2.2 Dual localisation with various markers in the stable cell line
The expression of the HPS1 protein in these stably expressing cells appeared to 
be unaltered compared to the expression pattern observed in transiently transfected 
COS-7 cells. Dual labelling studies were performed on clone 36 cells using various
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Figure 4 .1 Subcellular localisation o f  transiently expressed HPS 1 protein.
COS-7 untransfected cells (a-f) or COS-7 cell transiently transfected with a C terminal HA epitope tagged HPS1 construct 
(g-l) were processed for immunofluorescence analysis using a rat monoclonal HA epitope tag antibody in addition to 
monoclonal antibodies to cither (a) & (g) Cl>63, (c) & (i) EHA-I or clathnn (f) & (I) or polyclonal antibodies to either 
(b) & (h) mannosc 6 phosphate rcepctor. (d) & (j) TGN 46 or (c) & (k) myosin Va. Samples (a), (b), (d), (f), (g), (h), (j) 
and (I) were fixed and pcrmcabiliscd in methanol, (c) and (k) in parafiromaldehydc and methanol and (c) and (i) in 
paraformaldehyde and triton.
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subcellular marker antibodies to assess if there was any change in its subcellular 
localisation. The results obtained from these dual labelling experiments are shown in 
Figure 4.2. No colocalisation was observed with any structures containing CD63 (a). No 
colocalisation was observed with M6PR though there was some concentration in HPS1 
in the perinuclear area near to increased levels of M6PR protein (b). No colocalisation 
was observed with the early endosome marker EEA1, which showed discrete punctate 
vesicles throughout the cell. The morphology of the structures were unaffected by the 
increased expression of HPS 1 by comparison with non-expressing cells in the 
population (c). No colocalisation was observed with the trans Golgi network marker, 
TGN46 (d). The TGN itself did still appear to be broken up from its usual ring-like 
morphology. This suggests that this change is probably due to the overexpression of the 
HPS1 protein and not simply a general problem of transient over expression of protein.
4.3 Immunofluorescence detection of HPSlp in the melanocytic cell 
lines, melan-a, Mell64 and MeWo
4.3.1 Detection of endogenous H PSlp
Melan-a cells are murine immortalised pigmented melanocyte cells. During the 
studies on the melan-a cells they were maintained at all times in phenylthiocarbamide 
which reduced the levels of pigmentation in the cells to aid immunofluorescence 
analysis which can be hindered by the pigmentation. Firstly, attempts were made to try 
to localise endogenous HPS1 protein in these cell using the polyclonal antisera to the 
HPS1 protein. A variety of conditions were tested for immunofluorescence analysis 
using all six polyclonal antisera. Alterations were made to the fixation, 
permeabilisation, blocking conditions, and antibody dilutions but all of these changes 
proved ineffective. None of the six HPSlp polyclonal antisera could detect endogenous 
HPS1 protein in melan-a cells. This may have been due to the melan-a cells being a 
murine cell line whereas all the HPS1 antisera were generated against human peptide or 
protein
Further analyses were performed in an additional melanoma cell line which 
became available as part of a collaboration. These were Mel 164 human immortalized 
melanoma cells, which unlike melan-a cells had only low levels o f melanin in them. No 
addition information about the nature of these cells and the reason for their seemingly 






Figure 4.2 Subcellular localisaton of HPS 1 protein in COS-7 cells stably expressing HA tagged HPS1 
protein.
COS-7 cells stably expressing a C terminal HA epitope tagged form of HPS 1 protein were 
processed for immunofluorescence analysis. The cells were stained using a rat monoclonal 
antibody to the HA epitope tag and in addition to monoclonal antibodies to either (a) CD63 or 
(c) EEA1 or polyclonal antibodies to either (b) man nose 6 phosphate receptor or (d) TGN46.
Samples (a), (b) and (d) were fixed and permeabilised in methanol and sample (c) in 
paraformaldehyde and triton xlOO.
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using the polyclonal antibodies to the HPS1 protein and the final serum from mouse 2, 
which was obtained during the generation of a monoclonal antibody to the HPS1 
protein. Neither the polyclonal or anti-HPSl mouse serum could detect endogenous 
levels of HPS 1 protein in this particular cell type using immunofluorescence analysis. A 
number of conditions were varied but the HPSlp antisera could not detect protein in this 
cell line. This could be due simply to the antibodies not being sensitive enough to detect 
low levels of this protein.
Studies were performed using a final melanoma cell line to try to establish the 
subcellular localisation of endogenous HPS1 protein and to confirm the observations 
made in the Me 164 cell line. MeWo are human malignant melanoma cells derived from 
skin, which have a fibroblast-like morphology. The cells were stated as producing 
melanin but upon light microscopic analysis they weren’t as dark and pigmented as the 
melan-a utilised previously. An attempt was made to try to increase the melanin 
production of this cell line by treating the cells with alpha melanocyte stimulating 
hormone over two weeks but no increase in pigmentation of these cells was observed. 
Immunofluorescence analysis was performed on these adherent cells to establish if any 
of the available reagents could detect endogenous levels of the HPS1 protein in this 
particular cell line. The immunofluorescence analysis was performed using all of the 
polyclonal antibodies to the HPS1 protein, the final serum from mouse 2, which was 
immunized to generate a monoclonal antibody to the HPS1 protein and finally the 
supernatant from the hybridoma clones known to be producing a monoclonal antibody 
to the HPS1 protein. All of these reagents were tested under a variety of conditions. 
Using all of these reagents and all of the conditions tested none of the reagents could 
detect endogenous levels of the HPS1 protein in these melanoma cells.
4.3.2 Detection of HPSlp in transfected melanocyte cell lines
As an alternative method for detecting the subcellular localisation of HPS 1 
protein in these melanocyte cell lines was transient transfections using both of the pMH 
HPS1 and pHM6 HPS1 mammalian expression constructs. In addition, a positive 
control construct was utilised to check for transfection efficiency and as a general 
positive control for the transfection experiments. This construct is a mammalian 
expression vector, which contains the EGFP fused to the lysosomal protein CD63. This 
construct usually yields very high transfection efficiencies and can be easily detected 
with no immunofluorescence processing requires.
131
The primary method of transfection attempted in these melan-a cells was 
electroporation. Both HPS1 constructs and the CD63 GFP construct were transiently 
transfected into the melan-a cells and the cells incubated overnight to allow for protein 
expression to occur. The cells were processed and observed on the confocal microscope. 
From this initial study no transfected cells could be observed with any of the constructs 
even the positive control suggesting that this transfection technique was probably 
unsuitable for use with this particular cell type. Electroporation also gave very low if 
any transfection in Mel 164 and MeWo cells.
The melan-a cells were transiently transfected using either Fugene™ or 
Effectene™ transfection reagents. Various conditions were used with each reagent to 
maximise the transfection rate, these conditions included varying the amount of DNA 
used and the amount of the actual reagent. Using these conditions transfected cells were 
observed using the positive control construct and the HPS1 constructs. In addition 
reasonable transfection efficiencies in both Mel 164 and MeWo cells using both the 
control and HA mammalian expression constructs. All three cell lines were transiently 
transfected with the pMH HPS1 mammalian expression construct and processed for 
immunofluorescence analysis using the monoclonal epitope tag antibody. The results of 
this immunofluorescence analysis are shown in Figure 4.3.
The protein mainly showed a punctate distribution pattern with small vesicles 
distributed throughout the cytosol. This punctate distribution was consistent in all 
transfected cells observed and was consistent when the experiment was repeated. The 
punctate structures were observed throughout the cytosol including towards the 
periphery of the cell. Consistent with the results observed in COS-7 cells some 
transfected cells did show an increased concentration of the expressed protein around 
the perinuclear area of the cell. This may be correlated to the level of expression of the 
HPS1 protein as this increased perinuclear concentration was prominently present in 
cells expressing a high level of the HPS1 protein and to a lesser degree in cells 
expressing a lower level of the HPS1 protein. Amongst the few cells that were 
transfected there did appear to be some variation in this distribution pattern and it was 
not as consistent as the results observed with the COS-7 cell transfections. In some of 
the melan-a cells the HPS1 protein did appear to have a more cytoplasmic distribution 
with punctate spots still present throughout the cell. The other melanocyte cells had a 
much more characteristic punctate distribution pattern more closely resembling that
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Figure 4.3 Immunofluorescence analysis of transiently expressed HPS I protein in COS-7 and 
melanocytic cells.
COS-7, melan-a, mell64 and MeWo cells were tansiently transfected using the pMH HPS1 
mammalian expression construct. The cells were fixed and permeabilised in paraformaldehyde and 
processed for immunofluorescence analysis using the HPUD 1:2 polyclonal antibody and Texas red 
conjugated secondary' antibody (COS-7) or a monoclonal antibody against the HA epitope tag and 
either an FITC conjugated secondary antibody (melan-a and mell64) or TRITC conugated secondary 
antibody (MeWo).
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observed in the COS-7 cells with some cells having an additional perinuclear 
concentration of the expressed protein.
Under all conditions tested the melan-a cells gave a very low transfection 
efficiency making image analysis very difficult. The incubation time was also extended 
after the transfection reaction itself from a standard overnight incubation up to 48 hours, 
to establish if  this particular cell line required extended incubation times but this gave 
no improvement in the results obtained. An alternative method was employed, from a 
paper by Huizing and co-workers, (Huizing et al, 2001), for the transfection of 
melanocytes. This method involved a standard transfection procedure followed by a 72- 
hour incubation. The cells were then transferred to media containing a selective 
antibiotic, in this case it was G418, and incubation continued for a further 3 days. The 
media was replaced with non-selective media for a further five-day incubation. This 
experiment was attempted a number of times and at no stage were any cells produced 
over expressing the HPS1 protein. Consequently further analysis was restricted to the 
Mel 164 and MeWo cell lines
4.3.3 Colocalisation studies using myosin Va, AP-3, and actin on Mell64 and 
MeWo
Dual labelling studies were carried out in Mel 164 and MeWo cells transiently 
over expressing the HPS1 protein to establish its subcellular location. Three subcellular 
marker antibodies of interest were used in this study. These were selected as they all had 
previously stained their endogenous proteins in Mel 164 cells to a good standard with 
very little background staining. Mel64 cells were transiently transfected using a lipid 
based transfection reagent, Genejuice™, under the conditions that gave the highest 
transfection efficiency. The transfected cells were labelled with the HA epitope 
antibody as well as an antibody to either to myosin Va, an actin motor protein, AP-3, 
the adaptor protein complex or actin, the peripheral filamentous network. The results of 
this colocalisation study are shown in Figure 4.4.
Colocalisation studies using the myosin Va antibody gave very interesting 
results. Myosin Va is localised to the microtubule organising centre and in punctate 
structures throughout the cytosol in confluent cells (Lionne et al., 2001). This pattern of 
distribution was partially observed in the transiently transfected Mel 164 cells but no 
MTOC was visible in any of the cells, shown in Figure 4.4. This pattern was observed 
in both transfected cells and non-transfected cells on the same coverslip suggesting that
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Figure 4.4 Colocalisation studies of the HPS1 protein in Mel 164 melanoma cells.
Mel 164 cells were transiently transfected with the pMH I IPS1 mammalian expression construct.
The cells were processed for immunofluorescence analysis using a monoclonal antibody to the HA 
epitope tag in addition either a polyclonal myosin Va antibody (top 3 imagcs),a polyclonal AP-3 
antibody (middle 3 images) or a polyclonal actin antibody (bottom 3 images). The single subcellular 
marker images are shown in (a), (d) and (g). the transient HPS1 protein is show n in images (b), (e) 
and (h) and merged images of both are shown in images (c), (0  and (i). All samples were fixed and 
pcrmeabiliscd in paraformaldehyde and methanol.
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the overexpression of HPS 1 in no way affected the distribution of endogenous myosin 
Va protein. A merged image of the distribution patterns of both HPS1 and myosin Va 
showed very interesting results. There was a high degree of overlap between the two 
proteins around the perinuclear area of the cell. A number of punctate structures were 
observed where HPS1 and myosin Va clearly overlapped resulting in a yellow colour in 
the merged image. Interestingly towards the periphery of the cell up to the plasma 
membrane there was still a considerable amount of myosin Va staining but a lack of any 
expressed HPS1 protein therefore there was no colocalisation in this peripheral region.
In Mel 164 cells both HPSlp and AP-3 appeared to be mainly concentrated in 
the perinuclear area of the cell with only a small number o f peripheral vesicles visible 
which is unlike previous published data (Simpson et al., 1997). There was no overlap 
observed between the two proteins particularly at this perinuclear concentration of AP-3 
protein. The overexpression of the HPS1 protein in these transfected cells had no effect 
on the localisation of the AP-3 protein or the morphology of the AP-3 positive 
structures. This result was concluded by the observation of non-transfected cells on the 
same coverslip as a direct comparison to the transiently expressing cells. It was 
concluded from this study that both the AP-3 and HPS1 proteins resided in very similar 
areas of the cell but there was absolutely no colocalisation between in these Mell64 
cells.
The actin antibody clearly stained the peripheral actin present around the plasma 
membrane throughout the melanoma cells. Transiently expressed HPS1 protein was 
shown to be in punctate structures throughout the cytosol of these me 164 cells but 
mainly around the perinuclear area of the cell. The HPS1 positive structures in no way 
extended to the actin cytoskeletal network around the periphery of the cell and therefore 
there was no colocalisation between these two proteins.
In addition to the dual labelling studies carried out in Mel 164 melanoma cells 
the studies were repeated in the MeWo melanoma cell line. The cells were transiently 
transfected using the Genejuice™ reagent and processed for immunofluorescence 
analysis using the antibody to the HA epitope tag. The cells were then processed for 
immunofluorescence analysis using antibodies to the HA tagged HPS1 protein and 
antibodies to the AP-3 protein complex, actin and myosin Va. Images of representative 
cells are shown in Figure 4.5.
The AP-3 antibody gave a rather unusual staining pattern that deviated from 
previous published data (Lionne et al., 1997). There was very little perinuclear
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Figure 4.5 Colocalisation studies of HPS1 protein in MeWo melanoma cells.
MeWo cells were transiently transfected using the pMH HPS1 expression constuct and 
processed for immunofluoresecenee analysis using a HA monoclonal antibody to the 
transiently overexpressed protein, images (b), (e), and (h) and either polyclonal anitbodies 
to, AP-3 (a), actin (d), or myosin Va (g). The merged images are shown in (c), (f), (i) and (1) 
with any colocalisation between the two protein observed as yellow fluorescence. All 
samples were fixed and permeabilised in paraformaldehyde an methanol.
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accumulation of the AP-3 protein and AP-3 positive vesicles throughout the cytosol 
were much larger than usually observed. Colocalisation studies between over expressed 
HPS1 protein and the adaptor protein complex AP-3, suggested that there was some 
degree o f colocalisation between both proteins particularly in the larger cytosolic 
vesicles in the cell periphery.
The colocalisation studies with the actin antibody gave very conclusive results. 
The punctate structures that the over expressed HPS1 protein was resident in no way 
overlapped with the peripheral actin filamentous network. Some of the punctate HPS1 
positive structures were present towards the periphery of the cell where the actin 
network is but there was no colocalisation between the two proteins. Observation of the 
colocalisation studies of HPS1 with the actin myosin Va protein suggested that there 
probably was no overlap between these two proteins. The antibody to the myosin Va 
gave a fairly diffuse cytosolic distribution pattern. The punctate pattern o f the myosin 
Va appeared not to colocalise to a great extent to the HPS1 protein but the differences in 
the intensity of the staining of the respective proteins made assessing this very difficult.
4.4 Detection of HPSlp in megakaryocytes
In addition to using melanoma cells to identify the subcellular localisation of 
endogenous HPSlp, the mature megakaryocyte cell line, CHRF, was utilised. Mature 
megakaryocytes reside in bone marrow tissue and produce platelets. The CHRF cells 
are semi-adherent and have three morphological states in in vitro culture. These include 
small platelet-like suspension cells, small mononucleated adherent cells and finally 
large polynucleated large adherent cells. All three morphological types are present in 
culture of cells at any one time, however the ratio may vary.
To assess if  any of the polyclonal antibodies to the HPS1 protein could detect 
endogenous HPS1 protein in this cell line the CHRF cells were processed for 
immunofluorescence analysis using the polyclonal HPS1 antisera. The results with 
HPUD2:1 are shown in Figure 4.6. The majority of the cells on the coverslip were 
single fairly small mononucleated cells that did show some fluorescence when stained 
with the HPS1 antisera. The staining pattern was very diffuse and appeared to be 
cytosolic. However the few large multinucleated cells that were present on each 
coverslip did stain very well with these HPS1 antibodies (4.6a). Figure 4.6d shows 
some more slightly smaller CHRF cells stained with the same HPS1 antisera and
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Figure 4.6 Dual labelling analysis of CHRF cells.
CHRF cells were fixed and permeabilised in paraformaldehyde and triton xlOO and processed for 
immunofluorescence analysis using both a polyclonal antibody to the HPS1 protein and a 
monoclonal antibody to the rab27 protein. Representative images of an indiv idual cell, top panel, 
and a group of cells, bottom panel. Single staining patterns with either poly clonal HPUD 2:1 
antibody (a) and(d) or monoclonal rab27 antibody (b) and (e) and the merged images in (c) and (f>. 
Colocalisation is shown by the yellow overlap of the two proteins in the merged images.
imaged at the same magnification as the cell shown in 4.6a The subcellular distribution 
of the endogenous HPS1 protein showed the characteristic small punctate staining 
present throughout the cytosol of the cells. This was a very similar distribution pattern 
to that observed in both fibroblast and melanoma cells, which had been transiently over 
expressing the HPS1 protein. The small HPS1 positive punctate structures radiated out 
throughout the cell towards the periphery and in some cells an accumulation of HPS1 
staining was observed around the plasma membrane. Less than five large polynucleated 
cells were usually present on a coverslip during an average immunofluorescence 
procedure. In an aim to increase this number increased densities of the cells were plated 
onto the coverslips but this only resulted in an increased number of the mononucleated 
cells present and no polynucleated cells being present.
The small GTPase Rab27 protein is present in both melanocyte and platelet cells 
(Chen et al., 1997) and dual labelling studies were carried out in the megakaryocyte 
cells using the anti-Rab27 and HPUD2:1 antibodies. The Rab27a protein appeared to be 
present in small punctate structures that were distributed throughout the cytosol of the 
cell in the large polynucleated cells, which colocalised to a great extent with the HPSlp 
(Figure 4.6b and c) However, there did appear to be an increased concentration of this 
staining around the perinuclear area of the cell and unlike the HPS1 staining there was 
no clearly defined staining at the plasma membrane. There did still remain some non­
specific nucleolar staining in the small mononucleated cells that could not be prevented 
even with changes to the experimental conditions (Figure 4.6e and f).
Attempts were made to try to increase the number of these polynucleated cells 
present on the coverslips to enable further immunofluorescence analysis. Firstly the 
glass coverslips were coated with poly-L-lysine to enhance the number of cells that 
adhered to the glass coverslips. The cells were plated at high density onto these 
coverslips and the immunofluorescence analysis was repeated. The poly-L-lysine coated 
coverslips did result in an increased number of the CHRF cells being present on them 
but they were all of the small mononucleated morphology and therefore did not result in 
a satisfactory images being obtained.
Information was located that confirmed that treating CHRF cells with 1 x 10 8 
mol/L phorbol 12-myristate 13 acetate (PMA) leads to the induction o f multinucleation 
and hyperploidy in these cells with up to 80% of the cells enlarging and approximately 
35% of the cells having two or more nuclei. The cells were treated with PMA at this 
suggested concentration overnight and then processed for immunofluorescence analysis
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as previously described. After the PMA treatment the cells were observed at the light 
microscope level to assess the effect the agent had on the CHRF cells. A large number 
of the CHRF cells had adhered to the coverslip with a wide variation in the size of cells. 
However upon close inspection only 10-20 cells per coverslip were equivalent in size to 
the cells, which had resulted in the previous images being obtained. These treated cells 
were processed for immunofluorescence analysis using a range of different antibodies. 
Using the HPS1 polyclonal antibodies only a small number of cells stained well and 
gave the same punctate staining observed previously. However the PMA seemed to 
have a dramatic effect on the Rab27a results as no cells stained with this antibody at all 
including the larger cells even under the same experimental conditions as utilised 
previously. This result made colocalisation studies impossible in these PMA treated 
cells.
4.5 Detection of HPSlp in the membrane fraction of stably transfected 
COS-7 cells
Due to the punctate nature of the staining pattern for most of the 
immunofluorescence experiments, an additional series of experiments was set up to 
assess whether the HPS1 protein was membrane associated or cytosolic using the COS- 
7 cells stably over expressing the HPS1 protein. Since none of the antibodies appeared 
to detect endogenous protein on immunoblots, whole cell lysates were prepares from 
COS-7 cells and clone 36 cells over expressing HPS1 protein. The lysates were 
centrifuged at 100,000g to yield a membranous pellet fraction and a cytosolic fraction. 
These fractions were used in immunoblot analysis probing with the HA monoclonal 








Figure 4.7 Fractionation of COS-7 cells and COS-7 cells stably expressing HPS1 
protein. Whole cell lysates were prepared and centrifuged at 100,000g to yield a pellet 
and cytosol fraction. Immunoblot results from each fraction using 1/500 diluted 
monoclonal HA epitope antibody lane (a) COS-7 cytosol, (b) COS-7 pellet, (c) COS-7 
HA HPS1 stable cytosol, (d) COS-7 HA HPS1 stable pellet. The 79kDa HPS1 protein is 
exclusively partitioned into the pellet fraction after centrifugation.
The results from the fractionation demonstrate that the expressed HPS1 protein 
is exclusively partitioned into the pellet fraction after centrifugation. This suggests that 
the HPS 1 protein is probably membrane associated. As a positive control for the 
reliability of the fractionation procedure, the immunoblots were also probed with a 
mannose 6-phosphate receptor antibody as it is known to be exclusively membrane 
associated. The cytosol and membrane fractions were first analysed by SDS-PAGE 
analysis to confirm that different proteins were isolated in each fraction. The results 











Figure 4.8 SDS-PAGE analysis and coomassie blue staining of fractionation samples (a) 
COS-7 cytosol, (b) COS-7 pellet, (c) COS-7 HA HPS1 cytosol and (d) COS-7 HA 
HPS1 pellet. Various bands of protein can be observed in both different fractions from 
each cell line.
The SDS-PAGE analysis of the different fractions illustrated that a range of 
different proteins were present in both fractions after centrifugation. It was assumed that 
this pellet fraction probably contained various membrane components and possibly 
cytoskeletal elements such as microtubules and actin filaments. The immunoblot 
analysis using the positive control mannose 6-phosphate receptor antibody against both 
the cytosolic and membraneous fractions are shown in Figure 4.9
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Figure 4.9 Immunoblot analysis of 100,000g fractions from COS-7 cells and COS-7 
HPS1 stably expressing cells probed with 1/5000 diluted polyclonal antibody to M6PR. 
Lane (a) is COS-7 cytosol fraction, lane (b) COS-7 pellet fraction, lane (c) COS-7 HA 
HPS1 stable cytosol, (d) COS-7 HA HPS1 stable pellet. The 215kDa M6PR protein can 
be seen exclusively partitioned into the pellet fractions of both the different cell types.
The positive control immunoblot demonstrated that known membrane associated 
proteins were exclusively partitioned in the pellet fraction after this centrifugation.
An attempt was made to try to remove the HPS 1 protein from is probable 
membrane association using a both a carbonate or triton X I14 wash. This method had 
been utilised by Oh and co-workers (Oh et al., 2000) to demonstrate that HPS1 was 
peripherally associated with membranes in melanocytic cells. A carbonate wash has a 
high salt concentration to dissociate any proteins that are membrane associated, whilst a 
triton X I14 detergent wash should remove all proteins including integral membrane 
proteins. The treatments were carried out on the pelleted fractions of HPS 1 stable 
expressing COS-7 cells and the resultant supernatants and pellets were analysed by 
immunoblot analysis using the monoclonal anti-HA epitope antibody. The results from 









Figure 4.10 Immunoblot analysis of cytosol and pellet fractions using a 1/500 diluted 
monoclonal epitope antibody after carbonate and triton X I14 treatments. Lanes (a) and 
(b) are resultant carbonate treatment cytosol and pellet fractions respectively. Lanes (c) 
and (d) are resultant detergent treatment cytosol and pellet fractions respectively.
Figure 4.10 shows that the HPS1 protein was present in the pellet fraction after 
both treatments suggesting it was not removed from the membrane by either of the 
washing techniques. Control experiments were performed with the mannose 6 
phosphate receptor which is an integral membrane protein. This experiment 
demonstrated only a partial but visible transfer of the M6PR protein into the cytosol 
fraction after triton X I14 treatment (data not shown). This suggested that the protocol 
used for this procedure was probably not removing all protein from the membranes as 
anticipated.
4.6 Effects of truncated HPSlp on subcellular distribution
4.6.1 Generation of mammalian expression vectors encoding HPSlp C-terminal 
truncations
In order to compare results from immunofluorescence immunoblotting of the 
transient over expression of the full-length HPS 1 protein with that of the mutant protein, 
a similar mammalian expression construct that contained C terminal truncation mutants 
of the HPS 1 gene were generated. The C terminal portion of the HPS 1 protein is known 
to be critical to its function from patient genetic data. All mutations identified in the 
HPS 1 gene so far reveal that all the mutations result in C terminal truncations of the
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HPS1 protein. It was hypothesised therefore that this C terminal portion of the HPS1 
protein might have a role in the subcellular localisation of the protein. The mammalian 
expression constructs would allow overexpression of C terminal truncated forms of the 
HPS 1 protein to look at any changes in the distribution of the protein compared to 
wildtype protein.
These constructs were generated using a PCR based approach and would result 
in the expression of human HPS1 protein mutated in such a way as to result in the 
complete absence of either the last 45 amino acids from the C terminus and termed 
AC45 or the last 205 amino acids from the C terminus and termed AC205.
To generate both constructs primers were designed to the appropriate position 
within the full length coding sequence of the human wildtype HPS1 sequence. The 
forward primers used were the same as those used to generate the full-length HPS1 
mammalian expression construct. Reverse primers were designed to regions within the 
HPS 1 gene, which would result in the production of a cDNA of the HPS 1 gene lacking 
sections of the C terminus. The primers were used in a PCR reaction with the pMH 
HPS 1 full length sequence as the template to generate the cDNA inserts corresponding 
to these truncated forms of the HPS 1 gene. The results of the PCR reactions using these 
primers are shown in Figure 4.11.
Figure 4.11 Products of the PCR reaction to generate truncated cDNAs of the HPS1 
gene for insertion into a mammalian expression vector. Lane 1 shows the product of the 
reaction to generate the cDNA required for the production of the AC205 HPS1 
construct. Lane 2 shows the product o f the reaction to generate the cDNA required for 
the production of the AC45 HPS 1 construct.
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The PCR reaction was successful with both sets of primers utilised in a PCR 
reaction producing one major product at the expected size. The primers for the AC205 
construct produced a single product at 1.5kb and the primers for the AC45 construct 
produced a single product at approximately 1.8kb. For consistency, the same expression 
vector used, pMH, as for expression of the full-length protein. The PCR products and 
the pMH vector were digested using the restriction endonucleases Hind III and Kpnl, 
and the products used in a ligation reaction. Plasmid DNA was extracted from resultant 
transformants and used in a diagnostic restriction digest to assess if any of the clones 
contained the construct of interest. No transformants were obtained for the AC45 
construct but a number for the AC205 were obtained and analysed. The diagnostic 




Figure 4.12 Diagnostic restriction digest on potential pMH AC205 HPS1 constructs. 
Lane 1 clone 8 undigested, lane 2 clone 8 digested Hind III and Kpn I, lane 3 clone 8 
digested Hind III and Bam HI. Lane 4 clone 11 undigested, lane 5 clone 11 digested 
Hind III and Kpn I and lane 6 clone 11 digested Hind III and Bam HI.
The diagnostic digests on two of the potential pMH AC205 HPS1 constructs 
shown is Figure 4.12 yielded the expected products. Both clones 8 and 11 when 
digested with either Hind III or Kpn I or Hind III and Bam HI gave the two expected 
products at 1.5kb and 5.4kb. The 1.5kb product was the AC205 HPS1 cDNA and the 
5.4kb product was the pMH mammalian expression vector. Clone 11 was selected to be 
carried forward and a larger scale plasmid DNA preparation was performed. The 
construct was also sequenced to confirm the exact nature o f it (data not shown) before it 
was utilised in further experiments.
1 2 3 4 5 6
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Due to the pMH A45 HPS 1 construct not yielding any transformants the 
procedure was repeated to try to obtain this construct. The same primers were utilised in 
another PCR reaction with the experimental conditions replicated as used before. The 





Figure 4.13 PCR products of the reaction to generate a cDNA insert for the production 
of the pMH AC45 HPS 1 construct. Lanes 1 and 2 contain the products of the PCR 
reaction clearly showing the 1.8kb cDNA product expected from this reaction.
The PCR product produced was of the expected size of approximately 1.8kb. 
This product was digested with the restriction enzymes Hind III and Kpn I and ligated 
into the Hind III and Kpn I sites of the pMH vector. The ligation reaction was used to 
transform competent XL-1 blue E.Coli cells and plasmid DNA was extracted for use in 
diagnostic restriction digests. The products of these diagnostic digests on the plasmid 
DNA from one such clone is shown in Figure 4.14.
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Figure 4.14 Diagnostic digest products from potential pMH AC45 HPS1 constructs. 
Lane 1, clone 5 undigested, lane 2, clone 5 digested with Hind III and Kpnl, lane 3, 
clone 5 digested with Hind III and Bam HI and lane 4, clone 5 digested with Bam HI.
Figure 4.14 shows that clone 5 appeared to give the correct sized fragments after 
the diagnostic digests. The expected product sized were 5.4kb and 2kb after the Hind 
III/Kpn I digest, 5.9kb and 1.3kb after the Hind III/Bam HI digest and a single product 
at 7.4kb after the Bam HI only digest. The construct was sequenced and additional 
stocks of this plasmid DNA were prepared.
4.6.2 Transient overexpression of truncated forms of HPS1 protein in COS-7 cells
COS-7 cells were transiently transfected with both the pMH AC205 
HPS 1 construct and the pMH AC45 HPS 1 construct. The transiently transfected cells 
were incubated overnight and then processed for immunofluorescence analysis using the 
HPS 1 polyclonal antibody that was generated using a peptide present in the N terminus 
of the HPS1 protein. Two representative cells expressing either the AC205 truncation or 
the AC45 truncation mutant proteins are shown in Figure 4.15.
Both of the constructs when transiently over expressed in COS-7 cells produced 
a protein product that was recognised by the N-terminal HPS1 polyclonal antibodies in 
immunofluorescence analysis. The results of the subcellular localisation of both of these 
truncated forms of the HPS1 protein were consistent between all the cells, which were 
transiently over expressing the proteins. The truncated proteins showed a very similar if 
not identical subcellular distribution pattern compared to the distribution of full length 
HPS 1 protein in these COS-7 cells. Both truncated proteins showed the characteristic 
punctate staining pattern throughout the cytosol o f the expressing cells. The truncated 
proteins did show a slight increase in aggregation inside the cell but there did still
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HPS1 AC45 HPS1 AC205
Figure 4.15 Immunofluorescence analysis o f  COS-7 cells transiently overexpressing C terminal 
tuncations o f  the HPS1 protein.
COS-7 cells were transiently transfected with either the AC45 or AC205 C terminal truncation 
constructs. The cells were then fixed and permeabilised in paraformaldehyde and triton xlOO 
and processed for immunofluorescence analysis using a polyclonal antibody to the N terminal 
part o f  the HPS1 protein (MPUD 1:2). Image (a) shows the distribution o f  the AC45 truncated 
protein and image (b) the distribution o f  the AC205 protein in these COS-7 cells.
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appear to be an increased accumulation of the protein in the perinuclear area of the cell 
that had also been observed with the full-length wild type HPS1 protein. The punctate 
staining pattern did extend out towards the periphery of the cell in much the same 
manner as the wild type protein. It therefore did appear that the removal of various 
portions of the C terminus of the HPS1 protein appeared to have little effect on the 
subcellular localisation of the protein when they were transiently over expressed in 
COS-7 cells.
4.6.3 Transient overexpression of truncated forms of HPS1 protein in melanocytic 
cells
The pMH AC45 HPS1 and pMH AC205 HPS1 constructs expressed protein in 
COS-7 cells that could be detected by immunofluorescence analysis using a polyclonal 
antibody to the HPS1 protein. Both truncated proteins appeared to show the same 
subcellular distribution pattern in this cell line as the wild type HPS1 protein when 
transiently over expressed. Further studies were carried out to assess if these mutant 
HPS1 proteins when over expressed in cells containing secretory lysosomes still showed 
the same distribution pattern as the wild type HPS1 protein. The studies were carried 
out in two separate melanoma cells lines, melan-a and Mel 164 cells. These cells were 
transiently transfected with both constructs and then processed for immunofluorescence 
analysis using the same polyclonal antibody to the HPS1 protein as utilised in the 
previous studies in COS-7 cells. Representative cells from these analyses are shown in 
Figure 4.16.
Studies were first carried out in the pigmented immortalised murine melan-a 
cells. As was observed in previous studies using this cell line great difficulty was found 
in trying to transiently transfect these particular cells, hence only very few cells were 
transiently transfected in each experiment. However a small number of transiently 
transfected cells with both the AC45 HPS1 and AC205 HPS1 constructs were observed. 
There was also no apparent difference in the transfection efficiency between the two 
constructs so equal numbers of images were obtained for each construct. Two 
representative cells transiently over expressing both truncated forms of the HPS1 
protein are shown in Figure 4.16 a and b. Both of the constructs appeared to show 
similar distribution patterns of the expressed proteins. Both proteins showed a punctate 
distribution pattern with some increased perinuclear staining. This pattern of protein 
distribution was not radically different to the distribution of wildtype protein in this
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Figure 4.16 Imunofluoresccnce analysis o f  truncated HPS1 in melanoma cells 
Meloma. melan-a and Mel 164 cells were transiently tranfected with either the AC45 or AC205 
C terminal HPS1 constructs. The cells were fixed and pcrmeabilised in paraformaldehyde and 
triton xlOO and processed for immunofluorescence analysis using a polyclonal antibody to the 
HPS I protein (H PUD 1:2). Images o f  the localisation o f  both truncated proteins are shown in 
melan-a cells (a) and (b), and in Mel 164 cells (c) and (d). Image (e) shows a higher magnification 
image o f  a Mel 164 cell overxpressing the AC205 protein.
particular cell line. Some cells over expressing the AC205 protein did appear to contain 
a much smaller number of larger punctate structures than observed with the full-length 
protein.
Transient overexpression studies were also performed in the Mell64 melanoma 
cell line, which had in previous studies proved more amenable to transfection and 
immunofluorescence analyses. The Me 164 cells were transiently transfected with both 
truncation expression constructs and processed for immunofluorescence analysis. Two 
representative cells expressing these proteins are shown in Figure 4.16. When 
transiently transfected into these cells both constructs resulted in the over expressed of 
the truncated proteins that could be detected by the HPS1 polyclonal antibody by 
immunofluorescence analysis. A significant number of transfected cells were observed 
for each experiment undertaken which made obtaining images of representative cells 
fairly straightforward. Both truncated proteins appeared to have a similar subcellular 
distribution pattern to each other and to the wildtype HPS1 protein when expressed in 
these melanoma cells. Both truncated proteins showed a punctate distribution 
throughout the cytosol of the transfected cells. The small punctate structures extended 
throughout the cell towards its periphery. There did also appear to be an increased 
concentration of the protein around the perinuclear area of the cell, which was apparent 
with both the AC45 HPS1 and AC205 HPS1 truncated proteins. The absence of the C 
terminal portion of the HPS1 in each of the truncated proteins did not appear to 
radically change the distribution of the HPS1 protein when transiently over expressed in 
these melanocytic cells. This was concluded by comparisons of the subcellular 
distribution of full-length wildtype HPS1 protein when transiently over expressed in this 
same cell line. Increased non-specific nuclear staining of the cells was observed in this 
study but was unavoidable even with changes in experimental conditions.
An interesting observation was noted in this study of the transient expression of 
the truncated proteins that is illustrated in image (e) on Figure 4.16. When high 
magnification and increased zoom was utilised to observe the Mel 164 cells transiently 
over expressing the truncated HPS1 proteins a specific subcellular localisation pattern 
was observed. The small fluorescence punctate structures throughout the cell appear to 
be present along specific “tracks” within the internal structure of the cell and in some 
cases these actually resembled tubular networks. So further analysis was performed on 
this phenomenon as described in Chapter 5.0.
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4.7 Discussion
Immunofluorescence analysis studies in this chapter were performed with the 
aim of trying to define the subcellular localisation of both wildtype and truncation 
mutants of the HPS1 protein both in mammalian cells containing secretory lysosomes 
such as melanocytes and COS-7 cells transiently and stably over expressing the protein. 
Direct comparison could then be made between the subcellular localisation of the HPS1 
protein in cells known to contain secretory lysosomes and those, which do not contain 
any. The first cells containing secretory lysosomes utilised in this study were mouse 
melan-a melanocyte cells. These cells are heavily pigmented containing a large amount 
of melanin pigment when observed at the light microscope level. This particular cell 
line has been used extensively in a variety of studies concerning the characterisation and 
biogenesis of melanosomes.
Initial experiments focused on trying to detect endogenous HPS1 protein in 
these cells by immunofluorescence analysis using the polyclonal antibodies to the HPS1 
protein. Under a variety of conditions tested none of these antibodies were able to detect 
the endogenous HPS1 protein. This was not entirely unexpected, as the polyclonal 
antibodies were generated using antigens from the human HPS1 protein. Other 
published studies had failed to detect endogenous levels of HPS 1 protein by 
immunofluorescence analysis (Dell* Angelica et al., 2000b) but additional work by Oh 
and co-workers demonstrated a monoclonal antibody that could detect endogenous 
levels of HPS 1 protein in human fibroblasts (Oh et al., 2000). It was suspected that this 
was due entirely to a combination of the quality of antibody used to detect the protein 
and also the fact that the HPS1 protein is expressed at low levels, even in melanoma and 
melanocyte cells where it was functionally important.
As an alternative method to studying the endogenous localisation of the HPS1 
protein transient overexpression of the protein was carried out in this melanocyte cell 
line. A variety of transfection methods were utilised in an attempt to obtain consistent 
transient overexpression and immunofluorescence analysis of this protein in these cells. 
Under all transfection conditions used very low if  any transiently over expressing cells 
were observed hence only a very low number of images of the over expressed protein 
were observed. Methods used by researchers in other studies on these cells were 
employed but did not improve the result. It was suspected that the passage number of 
the melan-a cells, which was 27 or 28 when these studies were carried out, might have
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been the limiting factor resulting in the transfection difficulties. Images of the over 
expressed HPS1 protein were obtained and showed that in these cells the protein 
maintained the small punctate distribution observed previously in the COS-7 cells. This 
suggested that in both cell types the HPS1 protein was both partially cytosolic and 
resident in small punctate structures throughout the cytosol. Due to the low transfection 
efficiencies in these melan-a cells no dual labelling studies could be carried out
Work by Oh and co-workers showed that they could readily detect HPS1 protein 
in FME melanoma cells where a large part of the protein was concentrated in the 
perinuclear area of the cell and appeared to correspond with early-stage melanosomes. It 
was suggested from this study that HPS1 specifically associated with early stage 
melanosomes being formed in the perinuclear region but not with end-stage 
melanosomes in the cytoplasmic dendrites of the cell (Oh et al., 2000). Analysis of 
COS-7 cells stably over expressing lower levels of the HPS1 protein did appear to 
support the localisation pattern observed in the transiently over expressing cells. The 
characteristic punctate pattern was certainly observed in this study as well as the 
perinuclear increased concentration of the HPS1 protein. Studies by Dell* Angelica and 
co-workers (Dell’ Angelica et al., 2000b) demonstrated than when a His tagged 
HPS 1 protein was over expressed in M l fibroblasts the protein demonstrated a mainly 
cytosolic distribution pattern. Close inspection of the image did reveal a somewhat 
cytosolic distribution pattern with increased levels of perinuclear accumulation o f the 
HPS1 protein.
Due to the transfection difficulties any colocalisation studies in these cells were 
very limited so an additional melanoma cell line was employed for this purpose. The 
melanoma cell line Mel 164 was selected. They were observed to be unpigmented or 
contained very low levels melanin pigment compared to the melan-a cells so would 
potentially be useful in immunofluorescence experiments since a lower level of pigment 
should not interfere with the fluorescence generated by the secondary antibodies. 
Attempts were made to localise endogenous HPS1 protein in this cell line using 
immunofluorescence analysis techniques. As previously described a number of 
conditions were varied but as was the case with the melan-a cells, the polyclonal 
antibodies to the HPS1 protein were unable to detect endogenous levels o f protein in 
this particular cell line. The only conclusion drawn from this was it was probably a 
combination of the specificity of these particular antibodies and the levels of HPS 1 
protein expression in these human melanoma cells. As an alternative method for
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detecting the subcellular localisation of the HPS1 protein in these cells containing 
secretory lysosomes they were transiently transfected using a mammalian expression 
construct. A variety of different reagents were utilised to try to transiently transfect 
these melanoma cells. These cells gave a much better transfection efficiency under a 
variety of conditions tested. The same pattern of distribution of the transiently over 
expressed HPS1 protein was observed in these Mel 164 as seen in both the COS-7 and 
melan-a cells. The protein was present in small punctate structures throughout the 
cytosol of the cell with a characteristic increase in concentration of the protein around 
the perinuclear area of the cell. It was therefore concluded that the transient 
overexpression of the HPS1 protein using this mammalian expression construct resulted 
in the same distribution of over expressed protein within the cells whether they 
contained secretory lysosomes or not.
This result was consistent with the subcellular localisation observed by Oh and 
co-workers (Oh et al., 2000) but was slightly contradictory compared to the result of 
Dell* Angelica and co-workers (Dell’ Angelica et al., 2000b). One explanation for this 
contradiction with the results of Dell’ Angelica may be due to differences in the 
mammalian expression construct and cell line used. In that particular study HPS1 was 
transiently over expressed in both HeLa and M l melanoma cells using a pcDNA3.1 
HisA vector containing the HPS1 sequence. The expression pattern in that study does 
resemble a similar pattern to that observed in this study but it is clearly more punctate 
and not as cytosolic as the images obtained from that study.
The advantageous transfection efficiencies produced in the Mel 164 cell type 
enabled more detailed dual labelling studies to be carried out. Colocalisation studies 
using an antibody to the actin motor protein myosin Va seemed to show some 
colocalisation between this protein and the HPS1 protein around the perinuclear area of 
the cell. There was however no colocalisation towards the periphery of the cell and 
myosin Va could clearly be observed extending further towards the plasma membrane 
than HPS1 in the same cell. Myosin Va is a dimeric molecular motor present on actin 
filaments and is required for the peripheral accumulation of melanosomes in 
melanocytes via an interaction with the two proteins melanophilin and Rab27 (Fukuda 
et al., 2002). Previous studies have clearly show myosin Va localised to the microtubule 
organising centre and in punctate structures in confluent cells. It was these punctate 
structures; around the perinuclear area that colocalisation with the HPS1 protein was 
observed. This suggests that the HPS1 protein may be associated with early
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melanosomes in melanoma cells in conjunction with myosin Va. In addition it suggests 
that since HPS 1 wasn’t associated with myosin Va in the most peripheral part of the cell 
it probably isn’t associated with late stage melanosomes. In addition if not associated 
with Myosin Va it would not play a role in the peripheral retention of melanosomes. 
Peripheral retention of melanosomes is critical for their transfer into keratinocytes and 
the complex containing Myosin Va essential to this process. The proteins Rab27 and 
melanophilin were also key components of this complex (Nagashima et al., 2002).
The utilisation of this cell line also enabled colocalisation studies between HPS1 
and the AP-3 adaptor protein complex. Both proteins appear to be important in 
melanosome biogenesis and/or function and appear closely linked. This evidence came 
from the finding that some patients with Hermansky-Pudlak syndrome did not have a 
mutation in the HPS1 gene but they did in fact have a mutation in one of the subunits of 
the AP-3 complex (Dell’ Angelica et al., 1999). AP-3 is a known component of the 
cellular machinery that mediates signal dependent sorting o f integral membrane proteins 
within the endocytic and late secretory pathway (Hirst and Robinson, 1998). Null allele 
mutations of the j83A subunit of the AP-3 complex resulted in the mis-sorting of both 
lysosomal and melanosomal proteins. Lysosomal proteins, for example CD63, were 
mis-sorted to the cell surface and melanosomal proteins, such as tyrosinase were mis- 
sorted to non-endosomal vesicles structures (Yang et al., 2000). The subcellular 
localisation of the AP-3 complex is in punctate distribution throughout the cytosol with 
an increased perinuclear concentration of the protein (Simpson et al., 1997). 
Colocalisation experiments carried out between transiently expressed HPS1 protein and 
the AP-3 protein complex in Mel 164 cells demonstrated that there was no colocalisation 
between the two proteins in either the punctate structures throughout the cytosol or in 
the perinuclear area of the cell where both proteins appeared to show increased 
concentrations.
This result was not entirely unexpected and confirmed previous published data 
demonstrating that when over expressed the HPS1 protein did not affect the subcellular 
distribution of the AP-3 adaptor protein complex (Dell’ Angelica et al., 2000b). In 
addition this study showed that there was also no direct interaction between the HPS1 
protein and the AP-3 adaptor protein complex by immunoprecipitation analysis. Data 
from this study and previous published data strongly argue against a critical role for the 
HPS1 protein in AP-3 dependent sorting pathways. They therefore participate in the 
biogenesis or function of lysosome-related organelles via distinct mechanisms.
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Colocalisation analysis in Mel 164 was also extended to look for any 
colocalisation of HPS 1 with the actin cytoskeletal network as melanosome peripheral 
retention is dependent on the actin cytoskeleton. The antibody used to stain the actin 
network showed the characteristic filamentous staining pattern around the periphery of 
the cell corresponding to the peripheral actin network underlying the plasma membrane. 
None of the punctate structures positive for the HPS1 protein colocalised in any way 
with this peripheral cytoskeletal network. Confirming that HPS1 was not functioning at 
the very periphery of the cell in association with the actin cytoskeleton. Previous 
published studies had confirmed the role of the myosin Va protein at this location in its 
role in the peripheral retention of melanosomes (Wu et al., 1997). Clearly the HPS1 
protein was not present in this location so is therefore unlikely to play any part in this 
process.
An additional cell line was utilised to try to observe endogenous HPS1 protein in 
a cell line containing secretory lysosomes. The human MeWo melanoma cell line was 
utilised. This particular cell line had a fibroblast-like morphology and like the Mel 164 
cells appeared at the light microscope level to have a very low melanin pigment content. 
Attempts to increase the level of melanin pigmentation using melanocyte-stimulating 
hormone were unsuccessful. The cells were relatively small compared to the COS-7 cell 
line but did have a characteristic fibroblast morphology with dendritic projections.
Using the polyclonal antibodies against the HPS1 protein in immunofluorescence 
analyses to try to detect endogenous levels of HPS 1 protein in these cells was 
unsuccessful. The transient overexpression of the HPS1 protein resulted in the 
characteristic punctate distribution throughout the cell with an increased protein 
concentration around the perinuclear area. Colocalisation studies of the HPS1 protein 
were repeated in this cell line. The transiently expressed HPS1 protein did not 
colocalise at all with the AP-3 adaptor protein complex confirming the results observed 
in the Mel 164 cells. In addition none of the small HPS1 positive punctate structures 
colocalised with the actin cytoskeleton.
Myosin Va had shown some colocalisation with the HPS1 protein in previous 
colocalisation studies. The HPS1 protein did express very well in these MeWo cells 
yielding high levels of protein expression by immunofluorescence analysis. 
Colocalisation studies with the myosin Va antibody suggested there was some 
colocalisation with the HPS1 towards the perinuclear area of the cell but not the in the 
cell periphery.
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In addition to the analysis in melanoma cells the HPS1 protein is known to be 
functionally important in platelet dense granule biogenesis from analysis of patients 
with Hermansky-Pudlak syndrome type 1 (White, 1985). The CHRF mature 
megakaryocyte cell line was selected for these studies due to it being semi-adherent 
making it amenable for immunofluorescence analysis. Patients with mutations in the 
HPS1 protein have characteristic blood clotting problems due to the presence o f dense 
granules within platelets being devoid of their contents (Witkop et al., 1987). Analysis 
of immature megakaryocytes revealed that dense granules appear at a very early stage 
of megakaryocyte maturation. The dense granule components become segregated from 
other secretion granule contents in the multivesicular body. Lysosomes are present in 
these cells but appear to be formed very early in maturation and are more heterogenous 
in composition than either alpha or dense granules (Youssefian and Cramer, 2000). For 
platelet activity granule contents must be transferred to the cell exterior without loss of 
cytoplasm. The organelles become concentrated in the cell centre inside rings of 
microtubules. Internal contractions break the rings and drive out the secreted contents 
(White et al., 1985). This process is dependent on microtubules but is not as well 
characterised as the microtubule dependent movement of melanosomes to the cell 
exterior.
The CHRF cells have three characteristic morphological states present in tissue 
culture including small suspension cells, single adherent mononuclear cells and large 
adherent polynucleated cells which give rise to platelets. No previous published studies 
have looked at the localisation or function of the HPS1 protein in either platelets or 
mature megakaryocytes. Immunofluorescence analysis using the polyclonal antibodies 
to the HPS1 protein in these CHRF cells revealed that they could detect endogenous 
levels of the HPS1 protein in the large polynucleated cells. The HPS1 protein showed a 
characteristic punctate distribution throughout the large cell particularly towards the 
periphery and plasma membrane region of the cell. These punctate structures were small 
and appeared very similar to the distribution pattern observed upon transient over 
expression of the HPS1 protein in the various tissues tested. The antibodies detected no 
endogenous protein in the small adherent mononucleated cells, which may be due to 
their small nature and apparent dense internal contents. Very few large polynucleated 
cells were present on each coverslip and their relative abundance appeared to be related 
to the total number of cells on the coverslip. The cells were treated with PMA to try to 
increase the relative number of large cells but this merely increased the total number of
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adherent cells on the coverslip and had a detrimental effect on the immunofluorescence 
analysis using the HPS1 polyclonal antibodies.
A number of other antibodies were tested for endogenous immunofluorescence 
analysis to enable colocalisation studies to be undertaken. Only the Rab27 antibody 
gave a consistent detection of endogenous protein in the large polynucleated cells. This 
antibody had usually given poor results in immunofluorescence analysis in other cell 
lines tested. The staining pattern produced by this antibody was remarkable similar to 
the subcellular distribution of the HPS1 protein with a punctate pattern throughout the 
cytosol. Colocalisation studies were performed with both antibodies and a very high 
degree if  not total colocalisation between the HPS1 and Rab27 proteins apparent. The 
HPS1 protein did extend further out towards the periphery of the cell up to the plasma 
membrane but this was the only noticeable difference between the staining patterns.
This result suggested at this stage of development in the mature megakaryocyte 
both the HPS1 and Rab27 proteins colocalised. The exact site of this colocalisation 
could not be further defined but it was hypothesised that it could possibly be dense 
granules or multivesicular bodies, which give rise to dense granules. The role of the 
Rab27a protein in platelet dense granule function has not be studied but it could 
possibly be similar to a role that of the melanosome in the peripheral retention of 
organelles such as the dense granule at the site of platelet production in the mature 
megakaryocyte. It is suspected that both the HPS1 and Rab27 antibodies were able to 
detect endogenous protein in this cell type and not other lines due to the apparent high 
density of both proteins in these punctate structures throughout the megakaryocyte. The 
function of both proteins in the formation of platelet organelles specifically the dense 
granule remains to be elucidated.
Studies were performed in this research to assess the importance of the C 
terminal portion of the HPS1 protein in terms of its subcellular localisation. Genetic 
analysis o f patients with Hermansky-Pudlak syndrome 1 revealed the present of a 
number of point mutations present in the HPS1 gene when it was first cloned (Oh et al., 
1996). There are currently a total of twelve frameshifts mutations in the HPS1 gene so 
far identified from patients. The first three to be fully characterised were the Puerto 
Rican mutation resulting in a 204 C terminal amino acid truncation, the Japanese 
mutation resulting in a 259 C terminal amino acid truncation and finally the Swiss 
mutation resulting in a 376 C terminal amino acid truncation. The different mutations 
exhibit different levels of severity in terms of the phenotype of the Hermansky-Pudlak
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syndrome (Oh et al., 1996). Patients with the Puerto Rican mutation exhibit the most 
severe phenotype of the syndrome. This genetic information suggests the C terminal 
portion of the HPS1 protein is important to the proteins function and or localisation but 
with no clearly defined protein motifs in this region its functional role remains 
unknown.
Mammalian expression constructs containing two different C terminal truncation 
mutants of the HPS1 gene were generated by a PCR based approach to study the 
possible role of this C terminal portion of the HPS1 protein. The constructs were both 
expressed in COS-7 and the subcellular distribution of these truncated proteins viewed 
using immunofluorescence analysis with the polyclonal antibodies to the N terminal 
portion of the HPS1 protein. In this COS-7 cell line, which contains no secretory 
lysosomes, the over expressed truncated protein showed a punctate distribution 
throughout the cytosol of the expressing cells. The expressed protein did appear to 
aggregate together more readily than the wildtype protein with a number of large 
punctate structures within the expressing cells. There did however remain an increased 
concentration of the expressed protein in the perinuclear area of the cell. There was 
however no difference in the distribution of the two truncated proteins compared to each 
other in this cell line. When over expressed in COS-7 cells both truncated proteins 
appeared to show a very similar protein distribution pattern to the wildtype protein with 
a slightly increased tendency for the protein to aggregate into larger punctate structures. 
It can be speculated that these aggregated structures may be BLOC-3 complexes or 
parts there of. HPS1 and HPS4 are components of this ~500kDa membrane associated 
complex in melanoma cells. HPS1 but not HPS4 is also resident in a cytosolic complex 
of ~200kDa termed BLOC-5 (Chiang et al., 2003).
In a small number of Mel 164 cells expressing the AC205 truncated protein, 
analysed at high magnification, it did appear that the truncated protein was present in a 
tubular-type distribution reminiscent of part of the cytoskeletal network of the cell. 
Further colocalisation studies would be required to confirm or disprove this possible 
colocalisation theory. These studies suggested that removing the C terminal o f the 
HPS1 protein may cause the protein to aggregate together to a greater extent than when 
the wildtype protein is expressed. Removing the C terminal of the protein appeared not 
to have a dramatic effect on the subcellular localisation of the protein when expressed in 
either melanocytic or non-melanocytic cells. Therefore the C terminal is probably not 
directly involved in the localisation of the HPS1 protein but it may have a role for
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example in the functioning of the protein. This may be related to the formation of the 
BLOC-3, 500kDa complex in melanoma cells, which was characterised in a number of 
recent published studies (Oh et al., 2000;).
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Chapter 5.0
Association of HPSlp with microtubules
5.1 Introduction
Melanosomes are transferred from their site of origin in the perikaryon to the 
tips of melanocyte dendrites and eventually into the surrounding keratinocytes. Like all 
membrane-bound organelles, the transport of melanosomes is mediated by the net sum 
of centripetal and centrifugal cytoskeletal forces acting upon them. Two major 
cytoskeletal macromolecular polymers, actin filaments and microtubules direct 
intracellular movement of organelles in cells. Actin filaments are composed of actin 
monomers and microtubule filaments of ce/3-tubulin dimers. Organelles are shuttled 
along actin filaments and microtubules by members of three major families of 
adenosine triphosphatase chemokinetic motor proteins, dyneins (Hirokawa et al, 1998), 
kinesins (Hirokawa et al, 1998) and myosins (Mermall et al, 1998). Centrifugal 
organelle movements, away from the cell body are driven mainly by kinesin, whereas 
centripetal or backwards movement is driven by cytoplasmic dynein (Gelfand and 
Scholey, 1992).
Normal human melanocytes express high levels of kinesin and 
ultrastructurally kinesin molecules are closely associated with melanosomes. Antisense 
oligonucleotides decreased kinesin protein levels and inhibited the bi-directional 
movement of the melanosomes promoting their backward movement (Hara et al., 2000). 
Cytoplasmic dynein was confirmed as being expressed in melanocytes using reverse 
transcriptase polymerase chain reaction and immunoblotting. Melanocyte cultures 
treated with dynein antisense oligonucleotides showed a strong anterograde transport of 
melanosomes from the cell body into the dendrites. This confirmed cytoplasmic dynein 
participates in retrograde melanosomal transport in human melanocytes (Byers et al., 
2000).
Investigations were performed to assess whether the Hermansky-Pudlak 
syndrome 1 protein was associated with melanosomes and specifically microtubule 
filaments and associated microtubule motor proteins, which are crucial to the transport 
of melanosomes within human melanocyte cells.
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5.2 Colocalisation of HPS1 and 0-tubulin by immunofluorescence
5.2.1 COS-7 Transients
Previous data from COS-7 cells over expressing HPS1 protein appeared to 
suggest that the protein was partially cytosolic, aggregated and present in small punctate 
structures throughout the cytosol of the cell. Close inspection suggested that the 
punctate structures were not randomly orientated but appeared to be present along 
networks through the cell reminiscent of a cytoskeletal element. Analysis of this 
phenomenon was expanded to see if  the expressed HPS1 protein was truly associated 
with a cytoskeletal element within the cells.
To assess this possible cytoskeletal association hypothesis, COS-7 cells were 
transiently transfected with the pMH HPS1 mammalian expression construct and then 
processed for immunofluorescence analysis using both an anti-HA epitope antibody to 
the expressed HA tagged HPS1 protein and an anti- 0 tubulin antibody to detect 
microtubule filaments. The cells were viewed on the confocal microscope and the 
results of this study are shown in Figure 5.1. Three representative cells are shown 
including higher magnification images of certain areas of the cells to enable more 
detailed analysis.
Inspection of the images suggested that as demonstrated previously the over 
expressed HPS1 protein showed a characteristic punctate pattern of subcellular 
distribution observed in these COS-7 cells. The small punctate structures radiated out 
throughout the cytosol of the cell and appeared to show a non-random distribution 
pattern. The HPS1 punctate structures were present towards the periphery of the cell but 
not actually at the plasma membrane. The 0 tubulin antibody stained the microtubule 
filaments throughout the cell with particular dense clusters around the plasma 
membrane and towards the periphery of the cell. Close examination of the merged 
images in which both staining patterns were visible revealed that the punctate HPS1 
positive structures appeared to line up along specific microtubule filaments within the 
cell. This was most obvious towards the periphery of the cell due to the two discrete 
structures being easily distinguished. Obtaining images of lengths of microtubules was 
challenging due to a single plane of focus obtained using the confocal microscope.
To aid analysis high magnification images were obtained that are also illustrated 
in Figure 5.1. It appeared from these studies that the small punctate structures did 








Figure 5.1 Colocalisation o f  transiently overexpressed HPS1 protein with microtubules in 
COS-7 cells.
COS-7 cells were transiently transfected using the pMH HPS1 mammalian expression construct, 
fixed and permeabilised in methanol and processed for immunofluorescence analysis using a 
polyclonal HPUD 2:1 anti-HPSl antibody and a monoclonal anti- (5 tubulin antibody. The top 
panel shows the staining pattern o f  (5 tubulin (a), HPS1 (b) and the merged image o f  both (c). 
Images (d) and (e) show additional images o f  the colocalisation o f  the tw o proteins with 
increased magnification o f  areas o f  each cell in (f) and (g).
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number of punctate HPS1 positive structures lining up along the same stretch of a 
microtubule. In some cases the colocalisation was very high with significant portions of 
yellow overlap visible on a merged image suggesting a high degree of colocalisation 
between the two proteins.
The experiment was repeated a number of times using either the anti-HA or the 
anti-HPS 1 polyclonal antibodies to detect the over expressed HPS1 protein. The final 
results obtained were the same each time but the HPS1 polyclonal antibodies gave a 
higher background non-specific staining pattern, which made the analysis more 
difficult.
5.2.2 COS-7 stables
Attempts were made to repeat the experiment in the COS-7 cells stably over 
expressing the HPS1 protein to see if  the punctate structures also appeared to associate 
with microtubule filaments. The clone 36 COS-7 cells stably over expressing the HPS1 
protein were processed for immunofluorescence analysis using an anti-HA epitope 
antibody to detect the stably expressed HPS1 protein and an anti-/? tubulin antibody to 
detect the microtubule network. The results from this study are shown in Figure 5.2, 
which includes three representative cells and high magnification images from portions 
of two of these cells.
The results in this study were much the same as observed for the COS-7 cells 
transiently over expressing the HPS1 protein. The stably expressing HPS1 protein 
showed the characteristic punctate distribution that had previously been observed with 
this cell line. On close examination a number of these HPS1 positive structures 
appeared in very close association with the microtubule network present throughout the 
cell. The HPS1 protein was not present around the nucleus of the cell or right at the 
plasma membrane so there was no colocalisation in either of these areas of the cell. In 
other areas of the cell a number of HPS1 positive punctate structures could be observed 
lining up along the same microtubule filament. A significant number of cells did also 
show a very high degree of colocalisation between the HPS1 and /? tubulin proteins 
characterised by the intense yellow overlap observed on the merged images. A 
representative cell showing this high-level colocalisation is illustrated at the top of 
Figure 5.2. It can be seen in the high magnification images obtained that the punctate 
HPS1 structures associated with the microtubule network of these HPS1 stably
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3 P S 1  t u b u l i nt u b u l i n
Figure 5.2 Colocalisation o f  stably expressed HPS1 protein with microtubules in COS-7 cells 
stably overexpressing the HPS1 protein.
Clone 36 cells were fixed and permeabilised in methanol and processed for immunofluorescence 
analysis using a polyclonal HPUD 2:1 anti-UPS 1 antibody and a monoclonal anti- (5 tubulin 
antibody. The top panel shows the staining pattern o f  [3 tubulin (a), HPS1 (b) and the merged 
image o f  both in (c). Images (d) and (e) show additional images o f  the colocalisation o f  the two 
proteins with increased magnification o f  areas o f  each cell shown in (f) and (g).
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expressing cells. In addition to these studies in COS-7 cells further analyses in 
mammalian cells containing secretory lysosomes was performed.
5.2.3 MelI64 and MeWo melanoma cells
The cell lines selected for this study were the unpigmented melanoma 
cell line, Mel 164, which had previously given a high transfection efficiency with the 
pMH HPS1 mammalian expression construct, and the MeWo human melanoma cell 
line. Both melanoma cell lines were transiently transfected using the pMH HPS1 
mammalian expression construct and processed for immunofluorescence analysis using 
an anti-HA antibody to detect the transiently over expressed HPS1 protein and an anti-/? 
tubulin antibody to detect the microtubule network. Representative images from this 
study in M ell64 cells are shown in Figure 5.3.
When transiently over expressed in these cells, the HPS1 protein showed a 
punctate pattern o f distribution and in addition there appeared to be an increased 
concentration of the expressed protein around the perinuclear area o f the cell. This 
localisation is shown in the two cells illustrated in Figure 5.3. There did appear to be a 
close association between the HPS1 protein and the microtubule filaments in the cells. 
High magnification images of portions of the cells were obtained with particular focus 
around the base of dendritic processes of the cell where visualisation and the 
localisation of the HPS1 and (3 tubulin was well defined. It was apparent form these 
high magnification images that the HPS1 positive punctate structures did associate with 
microtubule filaments. The microtubule networks were very tightly clustered in these 
regions o f the cell but the punctate HPS1 structures were observed in large numbers 
around the filaments in these regions. Very few microtubule filaments were observed 
around the perinuclear area of the cell in which to assess the colocalisation, where 
increased concentrations of the HPS1 protein were found. It was suspected that this was 
merely due to the imaging techniques used; the antibody specificity and the fact that the 
cells had a much greater depth in this area compared to the dendritic processes.
In addition to the studies in the unpigmented Mel 164 melanoma cells further 
studies were carried out in the pigmented MeWo human malignant melanoma cell line. 
The cells were transiently transfected using the pMH HPS1 mammalian expression 
construct and processed for immunofluorescence analysis using and anti-HPSl and an 
anti- /? tubulin antibody. The results from these studies are shown in Figure 5.4.
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Figure 5.3 Colocalisation o f  transiently overexpressed HPS1 protein with nucrotubules in 
m ell6 4  melanoma cells.
Mel 164 cells were transiently transfected with the pMH HPS1 mammalian expression  
construct, fixed and permeabilised in methanol and processed for immunofluorescence 
analysis using a rat monoclonal anti-HA epitope anitbody and a mouse monclonal 
anti-(i tubulin anibody. The top panel shows the staining pattern o f  the |5 tubulin (a), HPS, (b) 
and the merged imge o f  both (c). Image (d) shows the expression pattern o f  both in an 






Figure 5.4 Colocalisation o f  transiently overexpressed HPS1 protein with microtubules in 
MeWo melanoma cells.
M ewo cells were transiently transfected using the pMH HPSl mammalian expression  
construct, fixed and permeahilised in methanol and processed for immunofluorescence 
analysis using a polyclonal HPIJD 2.1 anti-HPSl antibody and a monoclonal anti-p tubulin 
antibody. The top panel shows the staining pattern o f  p tubulin (a), HPSl (b) and the merged 
image o f  both (c) Images (d) and (e) show additional cells illustrating the colocalisation  
between the tw o proteins. Increased magnification o f  areas o f  these cells is show n in (f) and (g).
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Three representative cells are shown in this image including two higher magnification 
images obtained from portions of two the cells shown. The transiently over expressed 
HPSl protein illustrated the characteristic punctate pattern of distribution that is 
observed in both COS-7 and melanoma cell lines. The /3 tubulin antibody stained the 
microtubule network within the cell including the microtubule organising centre, which 
had not been previously observed in any of the other cell types analysed.
The small punctate HPSl positive structures associated closely with microtubule 
filaments within the cell. This was particularly noticeable towards the base of dendrites 
of the cell where there was an abundance of microtubules that could be visualised in a 
single plane of focus. A number of the punctate HPSl structures associated with a 
single microtubule filament. No colocalisation was observed between the microtubule 
organising centre and the over expressed HPSl protein. There was also no association 
around the perinuclear area of the cell. There was in some cases a very high level of 
colocalisation between the two proteins in very brightly fluorescing regions along 
dendrites and towards their periphery. This is shown in Figure 5.4 in two of the 
represented cells. These dendritic areas were very narrow and contained very large 
amounts of microtubule filaments which extended all the way to the extreme tip of the 
dendrite process. A significant number of HPSl positive punctate structures were 
present in these regions in some cases extending towards the extreme tip of the structure 
and these colocalised with the microtubules. These results confirmed all of the previous 
observed results in the various other cell lines analysed. In melanoma cells containing 
dendrites the HPSl positive structures often colocalised very highly with microtubules 
within these narrow structures.
5.3 Subcellular fractionation
Previous studies had shown that the HPSl protein was membrane associated 
when both transiently and stably over expressed in COS-7 cells. Western blot analysis 
of cytosolic and pellet fractions demonstrated that the HPSl protein was exclusively 
partitioned into the membrane pellet fraction in this study. The actual composition of 
this fraction was not determined in that study and it was suspected that this fraction 
might contain cytoskeletal elements in addition to membranous components. The 
contents of the membranous pellet were characterised by immunoblot analysis o f the 
pellet and cytosol fractions using an antibody to the microtubule protein /3-tubulin to
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assess i f  either o f  the resultant membrane or cytosol fractions contained microtubules. 
The results o f  this immunoblot experiment including the im m unoblot show ing the 
membrane association o f  the H P Sl protein are shown in Figure 5.5.











Figure 5.5 Part I Fractionation o f  CO S-7 cells and CO S-7 cells stably expressing H P Sl 
protein. W hole cell lysates were prepared from both cell types and centrifuged at 
100,000g to yield a pellet and cytosol fraction. Immunoblot results from each fraction 
using a m onoclonal H A epitope antibody diluted 1/500 lane (a) C O S-7 cytosol, (b) 
CO S-7 pellet, (c) COS-7 H A  H P S l stable cytosol, (d) CO S-7 H A  H P S l stable pellet. 
The 79kDa H P S l protein is exclu sively  partitioned into the pellet fraction after 
centrifugation. Part II immunoblot analysis o f  cytosol (a) and pellet (b) fractions from 
CO S-7 cells stably expressing H P S l protein probed with a m onoclonal antibody to /? 
tubulin diluted 1/1000. Virtually all o f  the /3 tubulin protein w as partitioned into the 
pellet fraction.
The results outlined in Figure 5.5 suggest that cytoskeletal elem ents as w ell as 
membranes were extracted into the pellet after the fractionation procedure. This im plies 
that H P S 1 m ay be associated with membranes or cytoskeletal elem ents or both. A  small 
portion o f  the /3 tubulin protein was partitioned into the cytosolic fraction but the vast 
majority w as associated with the membrane fraction. It w as suspected that as the
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fractions were prepared at low temperatures this might have caused some of the 
microtubule filaments to depolymerise resulting in the presence of some of the (3 tubulin 
protein in the cytosolic fraction.
5.4 Effects of perturbing microtubules on HPSl localisation in 
transiently transfected COS-7 cells
In order to assess if  the punctate HPSl positive structures were directly 
interacting with microtubule filaments analysis using microtubule interfering agents was 
carried out. COS-7 fibroblast cells were transiently transfected using the pMH HPSl 
mammalian expression construct and then treated with one of three microtubule 
interfering drugs. The agents used were nocodazole or vincristine, which are both 
microtubule disrupting agents, or paclitaxel which is a microtubule stabilising agent.
The cells were then processed for immunofluorescence analysis using both anti-HA 
epitope and anti- tubulin antibodies to assess the localisation of both proteins in these 
treated cells. The results o f this study are shown in Figure 5.6.
The over expressed HPSl protein was present in small punctate structures 
throughout the cytosol of the COS-7 fibroblasts. The punctate HPSl positive structures 
appeared very closely associated with microtubule filaments. Observation of the drug 
treated cells revealed a dramatic change in the distribution of both proteins. After 
nocodazole treatment the microtubule filaments were completely depolymerised and a 
very diffuse almost cytosolic pattern of (3 tubulin protein was apparent throughout the 
COS-7 cells. The intensity of the staining acquired with the tubulin antibody after the 
nocodazole treatment was much reduced suggesting that virtually all o f the j8 tubulin 
had depolymerised and formed a very diffuse pool of protein within the cytosol of the 
cells. The effect on the subcellular localisation of the HPSl protein was equally 
dramatic as there were no longer HPSl positive punctate structures within the cells. The 
protein had redistributed into a much more diffuse pool of what appeared to be cytosolic 
protein. The level of fluorescence observed with the HPSl antibody was much reduced 
than that of the untreated controls suggesting the protein had changed to a diffuse 
probably cytosolic distribution within the cells. Interestingly there was some apparent 
colocalisation between the HPSl and tubulin proteins after nocodazole treatment 





t u b u l i n
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Figure 5.6 Effect o f  microtubule interfering drugs on the subcellular localisation o f  the HPSl 
protein in transiently overexpressing COS-7 cells.
COS-7 cells were transiently transfected with the pMH H PSl mammalian expression construct. 
They were then treated with either Vincristine (b), Nocodazole (c) or Paclitaxel (d), fixed and 
permeabilised in methanol and then processed for immunofluorescence analysis using a rat 
monolonal anti-HA epitope antibody and a mouse monoclonal anti-|3 tubulin antibody. An 
untreated control cell stained with both antibodies is shown in image (a).
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The experiment was repeated with another microtubule interfering chemical, 
vincristine. This drug also had a dramatic effect on the subcellular localisation of the /? 
tubulin protein. The action of the chemical severely disrupted the microtubule 
filamentous network resulting in all the /? tubulin protein being redistributed to a diffuse 
cytosolic pattern within the treated cells. A very dramatic effect was also observed upon 
the localisation of the over expressed HPSl protein after the vincristine treatment. 
Absolutely no HPSl punctate structures could be observed in these treated cells and it 
appeared as if the over expressed HPSl protein had redistributed to a diffuse cytosolic 
localisation. As previously observed in the nocodazole treated cells there did appear to 
be some colocalisation between the HPSl and /3 tubulin proteins towards the perinuclear 
area of the cells.
Finally HPSl over expressing COS-7 cells were treated with a microtubule 
stabilising chemical, paclitaxel. Immunofluorescence analysis of cells treated with this 
chemical revealed a very different result from the previous results with both nocodazole 
and vincristine. Observation of the /3 tubulin staining pattern after treatment revealed 
that the microtubule network was present throughout the cells and towards the periphery 
of the cells a very large dense network of microtubule filaments was present. These 
filaments gave a very strong fluorescence signal compared to untreated cells. The 
microtubules were also present in very large numbers densely packed into any dendritic 
processes that were present in the observed cells. All of the /3 tubulin staining appeared 
to be associated with this filaments and no cytosolic staining was observed anywhere 
within the cell. The HPSl protein also gave a very distinctive distribution pattern in 
these treated cells. A large number of punctate HPSl positive structures were present 
throughout the cytosol of the cell. The pattern of distribution of the over expressed 
HPSl protein in these treated cells was very similar to the observed pattern in untreated 
COS-7 fibroblasts. It appeared as if  the punctate HPSl structures were in very close 
association with the microtubule filaments with a number of punctate structures lining 
up along individual microtubule filaments. A number of punctate structures were 
present around the perinuclear area of the cell in which there was no apparent 
microtubule filaments after the paclitaxel treatment. There was however a large number 
of the HPSl punctate structures in association with the microtubules towards the 
periphery of the cell and in the dendritic processes where the microtubule filaments 
were abundant.
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High magnification images were obtained from each individual cell featured in 
Figure 5.6 and they are shown in Figure 5.7. These images illustrate the punctate 
distribution of the HPSl protein in both the untreated and paclitaxel treated cells and 
their apparent association with microtubule filaments. In both the vincristine and 
nocodazole treated cells the subcellular localisation of both the (3 tubulin and HPSl 
proteins was severely disrupted. Both proteins showed a diffuse cytosolic distribution 
pattern with some colocalisation between the two proteins.
5.5 Effects of perturbing microtubules on HPSl localisation in 
transiently transfected Mell64 cells
Previous data had suggested that over expressed HPSl protein in cells 
containing secretory lysosomes had a very similar distribution pattern to that observed 
in COS-7 cells. In this case it also appeared as if  the protein was associated with 
microtubule filaments. To analysis this hypothesis Mel 164 melanoma cells transiently 
over expressing the HPSl protein were treated with the same microtubule interfering 
drugs described previously and processed for immunofluorescence analysis using both 
anti-HA epitope and anti-/? tubulin antibodies. The results of this study are shown in 
Figure 5.8.
In the untreated cell the transiently over expressed HPSl protein was localised 
in small punctate structures throughout the cytosol of the cell. The punctate structures 
were present throughout the cytosol with an increased concentration of the HPSl 
protein present in the perinuclear area of the cell. These punctate structures were present 
in the melanoma cell in both the periphery and towards the plasma membrane region of 
the cell. The /? tubulin protein was present in characteristic microtubule filaments 
throughout these untreated cells. The microtubule filaments were particularly 
concentrated around the base and within any dendritic processes that were present in 
these cells. It did appear that the HPSl positive structures were associated with 
microtubule filaments towards the periphery of the cell as had been observed 
previously.
Vincristine chemical treatment of the cells had a dramatic effect of the 
subcellular localisation of both the HPSl and /? tubulin proteins when observed by 
immunofluorescence analysis. The /? tubulin protein was localised in a diffuse 
cytoplasmic distribution throughout the Mel 164 cells. The HPSl protein was no longer
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Figure 5.7 High magnification images illustrating the effect of microtubule interfering 
drugs on the subcellular localisation of the HPSl protein in transiently over expressing 
COS-7 cells.
COS-7 cells were transiently tranfected with the pMH HPSl mammalian expression 
construct. They were then untreated (a) or treated with either Vincristine (b),
Nocodazole (c) or Paclitaxel (d). fixed and permeabilised in methanol and then processed 
for immunofluorescence analysis using both a rat monocloanl anti-HA epitope antibody 
and mouse monoclonal anti-(i tubulin antibody. Cells were visualised and high 




Figure 5.8 Effect of microtubule interfering drugs on the subcellular localisation of the HPSl 
protein in transiently overexpressing mell64 melanoma cells.
Mel 164 melanoma cells were tansiently tansfected with the pMH HPSl mammalian 
expression construct, t hey were then treated with either Vincristine (b),
Nocodazole (c) or Paclitaxel (d), fixed and permeabilised in methanol and then processed for 
immunofluorescence analysis using both a rat monoclonal anti-HA epitope antibody and a 
mouse monoclonal anti- (5 tubulin antibody. An untreated control cell stained with both 
antibodies is shown in image (a).
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present in small punctate structures throughout the cytosol. A large portion of the HPSl 
protein was now in a diffuse cytoplasmic distribution pattern. In some areas of the cell 
colocalisation of the HPSl and /? tubulin proteins was observed. In addition to this a 
significant amount o f the HPSl protein present appeared to aggregate into a small 
number of larger punctate structures throughout the cell. Aggregated HPSl protein of 
this sort had never been previously observed in Mel 164 cells.
Treatment with the nocodazole agent had a similar effect on the subcellular 
localisation of the HPSl protein in Mel 164 cells as the treatment with vincristine. Some 
of the HPSl protein was now in a diffuse cytoplasmic distribution pattern but a 
significant amount had aggregated into larger punctate structures than those present in 
untreated cells. These larger structures were present throughout the cell but the majority 
were present in the periphery of the cell around the plasma membrane. The exact 
subcellular localisation of the structures was however unknown. No colocalisation was 
observed between the HPSl and /3 tubulin proteins in these nocodazole treated cells.
Treatment with paclitaxel had a similar effect in transiently transfected 
Mel 164 cells as had been observed in COS-7 cells. The over expressed HPSl protein 
was localised in small punctate structures throughout the cytosol in a similar manner to 
the observed distribution pattern in untreated cells. The action of this chemical agent 
had resulted in an enhanced amount of microtubule filaments being present throughout 
the cell particularly in the peripheral regions of the cell and in dendritic processes. The 
punctate HPSl positive structures appeared to colocalise with the microtubule filaments 
with several areas o f the cell showing high levels of colocalisation between the two 
proteins.
5.6 Effects of perturbing microtubules on HPSl localisation in 
transiently transfected MeWo cells
To confirm the observed data on the effect of microtubule interfering drugs on 
the subcellular localisation of the HPSl protein in both COS-7 fibroblasts and Mell64 
melanoma cells, further studies were carried out in MeWo melanoma cells. These cells 
were known to be pigmented unlike the Mel 164 cells and therefore might yield different 
results in this study. These melanoma cells were transiently transfected with the pMH 
HPSl mammalian expression construct and either left untreated or were treated with 
vincristine, nocodazole or paclitaxel. The cells were then processed for
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immunofluorescence analysis using both an anti-HA epitope antibody and an anti-/? 
tubulin antibody. The cells were observed and resultant images obtained from this study 
are shown in Figure 5.9.
Untreated cells showed the characteristic distribution of over expressed HPSl 
in these MeWo melanoma cells. The over expressed HPSl protein was present in small 
punctate structures throughout the cytosol of the cell with an enhanced concentration of 
the protein around the perinuclear area of the cell. Close observation confirmed that the 
HPSl positive punctate structures appeared to associate with the microtubule filaments 
and this was particularly noticeable in the dendritic processes of transiently over 
expressing cells and is illustrated in Figure 5.9.
Treatment of the MeWo cells with vincristine dramatically changed the 
subcellular distributions of both HPSl and /3 tubulin proteins. Microtubule filaments 
were completely absent from the cells and the /? tubulin protein was now mainly 
distributed in a diffuse cytosolic pattern throughout the cell. There was an increase level 
of the tubulin protein around the perinuclear area of the cell. Some of the (3 tubulin 
protein was also present in a number of small punctate structures throughout the cell. 
The effect of vincristine on the subcellular distribution of the HPSl protein was equally 
as dramatic. The over expressed protein was no longer present in small punctate 
structures within the cell. The protein was now completely diffuse and cytosolic 
throughout the cell. There was an increased level of the HPSl protein in the perinuclear 
area of the cell but apart from this it was simply present in the cytoplasm of the cell. 
There were areas of colocalisation between the HPSl and (3 tubulin proteins particularly 
in the perinuclear area of the cell and to a small extent in the cytosol.
Treatment with the microtubule interfering drug nocodazole had a very similar 
effect on the subcellular localisation of both /? tubulin and HPSl as had been observed 
with vincristine. Absolutely no microtubule filaments remained after treatment with the 
/3 tubulin protein completely redistributed to a diffuse cytosolic pattern. There was a 
small increase in the concentration of the protein around the perinuclear area o f the cell. 
The HPSl protein was also drastically redistributed upon treatment from its usual small 
punctate pattern o f distribution to a very diffuse and cytosolic subcellular localisation in 
much the same way as the /? tubulin protein. No punctate structures containing the HPSl 
protein were present anywhere within the cell. There did appear to be a small area of 
colocalisation between the HPSl and (3 tubulin proteins in the perinuclear area o f the
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Figure 5.9 Fflfect of microtubule disrupting drugs on the subcellular localisaton of the HPSl 
protein in transiently overexpressing MeWo melanoma cells.
Me Wo cells were transiently transfected with the pMH HPSl mammalian expression construct. 
They were then treated with either Vincristine (b), Nocodazole (c) or Paclitaxel (d) fixed and 
permeabilised in methanol and then processed for immunofluorescence analysis using both a rat 
monoclonal anti-HA epitope antibody and a mouse monoclonal anti-(i tubulin antibody. An 
untreated control cell stained with both antibodies is shown in image (a).
MeWo cell but the exact subcellular localisation of this region remains to be 
determined.
Treatment with the microtubule stabilising agent paclitaxel yielded very 
interesting results in these MeWo cells transiently over expressing the HPSl protein. 
The over expressed HPSl protein was present in small punctate structures distributed 
throughout the cytosol of the cell including towards the periphery of the cell near to the 
plasma membrane. All of the /3 tubulin protein was present within microtubule filaments 
and no cytoplasmic protein was observed. There was a significant level of colocalisation 
between the punctate HPSl structures and the network of microtubule filaments present 
within the MeWo cell. This was easily observed on the merged image shown by the 
yellow fluorescence overlap. However the punctate HPSl positive structures did extend 
further towards the plasma membrane region of the cell where there was only a few 
microtubule filaments present in these treated cells.
5.7 Immunoprecipitation of HPSl and probing for associated proteins
Previous studies suggested that the HPSl protein was part of a 500kDa complex 
in melanocyte cells and part o f a 200kDa complex in non-melanocytic cells (Oh et al., 
2000). In an attempt to identify proteins that could be interacting with the HPSl protein 
in both cell types immunoprecipitation analysis was performed. In preliminary studies a 
protocol was adapted from literature provided by Santa Cruz Biotechnology, Inc. 
California, USA, for the immunoprecipitation analysis. Initial immunoprecipitation 
studies were carried out using unlabelled whole cell lysates from clone 36 COS-7 cells 
stably over expressing the HPSl protein. In addition COS-7 untransfected cells were 
utilised as a negative control. Protein A beads were coated with either an anti-HA, anti- 
0 tubulin or anti-clathrin antibodies. After the lysates were incubated with the beads 
they were washed and boiled before the immunoprecipitants were analysed by SDS- 







Figure 5.10 Immunoprecipitation analysis of COS-7 and clone 36 cells stably 
expressing whole cell lysates using anti-HA coated protein A beads. Precipitants were 
analysed by immunoblot analysis using the same monoclonal anti-HA epitope antibody 
diluted 1/500. Lane (a) COS-7 whole cell lysates, (b) Clone 36 whole cell lysates, (c) 
COS-7 immunoprecipitants and (d) Clone 36 immunoprecipitants.
Very little if any over expressed HPSl protein was observed in the clone 36 
whole cell lysates suggesting the cells were not expressing a lot of protein or simply too 
little protein was loaded into each lane of the gel. Due to this low level of protein over 
expression it was not unsurprising that no HPS1 protein was detected in the 
immunoprecipitation. All that was detected on the immunoblot was the antibody 
unreduced heavy and light protein chains at 50 and lOOkDa.
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Figure 5.11 Immunoprecipitation analysis of COS-7 and clone 36 stably expressing 
whole cell lysates and anti-clathrin coated protein A beads. Precipitants were analysed 
by both SDS-PAGE analysis followed by coomassie blue staining and immunoblot 
analysis using a monoclonal anti-clathrin antibody diluted 1/1000. Lane (a) COS-7 
precipitants (b) clone 36 precipitants, (c) COS-7 precipitants and (d) clone 36 
precipitants.
The clathrin positive control immunoprecipitation was successful. When the 
precipitants were analysed by SDS-PAGE and coomassie blue staining very little 
protein was observed on the gel except for the reduced antibody protein chains at 
50kDa. However when the precipitants were analysed by immunoblot analysis using the 
clathrin antibody the precipitated clathrin protein at 192 kDa could be observed in the 
COS-7 cell lysate sample. This result confirmed that the immunoprecipitation had been 
successful and the clathrin protein had been extracted from the whole cell lysates using 
this method. No clathrin protein was precipitated from the clone 36 whole cell lysate 
sample, which it was suspected might not have contained enough protein for the 
experiment to have been successful.
In was speculated that the immunoprecipitation using the HA antibody may have 
been unsuccessful due to the fact that the antibody itself was a rat monoclonal antibody. 
Rat antibodies have a fairly low specific affinity for protein A, which may have reduced 
the binding capacity o f the coated beads and therefore could explain why no HPS1 
protein was precipitated during the experiment. An additional HA antibody was 
available for this study but it was not a high specific antibody as used in all previous 
studies. It was however a mouse monoclonal antibody which are known to have a much 
higher affinity to protein A. The antibody was used in a repeat experiment as described
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above. The precipitants were analysed by immunoblot analysis using the same HA 
antibody. The antibody itself gave a very high non-specific background on immunoblot 
analysis and no identifiable band at 79kDa was visible (data not shown).
The protocol for the immunoprecipitation was varied to try to enhance the amount of 
protein precipitated. The method was obtained from Dr G. Banting’s laboratory, 
University of Bristol and contained minor modifications on the previously utilised 
technique. The studies were repeated in much the same way as previously described. 
COS-7 and clone 36 stably over expressing HPSl protein were utilised with protein A 
beads coated with either an anti-HA antibody, an anti-HPSl polyclonal antibody or an 
anti-clathrin antibody as a positive control. The immunoprecipitants were analysed by 
both SDS-PAGE and immunoblot analysis. Upon SDS-PAGE analysis and staining 
with coomassie blue dye no obvious protein bands were visible on the gel at all. The 




Figure 5.12 Immunoprecipitation using COS-7 cells and COS-7 cells stably over 
expressing the HPSl protein (clone 36) and a monoclonal anti-HA antibody, polyclonal 
anti HPSl antibody or monoclonal anti-clathrin antibody. Lane (a) clone 36 lysate and 
HPSl antibody, (b) clone 36 lysate and HA antibody, (c) COS-7 lysate and HPSl 
antibody, (d) COS-7 lysate and HA antibody and (e) COS-7 lysate and clathrin 
antibody.
The immunoblot contained a band at 192kDa observed in the clathrin 
immunoprecipitation sample. However no protein band was observed at 79kDa in any 
of the immunoprecipitants using the whole cell lysate from the cells stably over
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expressing the HPS1 protein. It was speculated that this might possibly be due to the 
fact that these cells only contained a low level of HPS 1 protein, which was proving to 
be undetectable using the immunoprecipitation and immunoblot procedures in this 
study. An alterative method to address this would be to utilise whole cell lysates 
prepared from transiently over expressing COS-7 cells, which are known to express 
HPS 1 protein at high levels, which is easily detectable by immunoblot analysis.
The experiment was repeated using the same protocol but this time whole cell 
lysates from COS-7 fibroblasts transiently transfected with the pMH HPSl mammalian 
expression construct. The lysates were used in immunoprecipitations using protein A 
beads coated with all of the anti-HPSl polyclonal antibodies. The resultant precipitants 
were analysed by immunoblot analysis using 1/500 diluted monoclonal anti-HA epitope 
tag antibody. The image of the blot obtained is shown in Figure 5.13.
Figure 5.13 Immunoprecipitation of whole cell lysates from COS-7 cells transiently 
over expressing the HPSl protein. Protein A beads were coupled to the following HPSl 
polyclonal antibodies, (a) HPUD 1:2, (b) HPUD 2:1, (c) HPUD 2:2, (d) HPUD 4:1 and 
(e) HPUD 4:2.
A positive band at 79kDa was detected by immunoblot analysis using an anti- 
HA epitope antibody against all the immunoprecipitant samples. Utilising a whole cell 
lysate from COS-7 cells over expressing the HPS 1 protein resulted in a much-increased 
amount of HPSl protein being precipitated by the anti-HPSl polyclonal antibodies. As 
no negative control had been included in this particular experiment, the procedure was 
repeated using a negative control to confirm that the HPS 1 protein was indeed being
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precipitated. In addition to the cells transiently over expressing the HPS 1 protein, whole 
cell lysate from COS-7 cells that were not transfected were also used in the study. In 
this repeat experiment only one of the polyclonal antibodies was used in the 
immunoprecipitation procedure. The results of this repeat experiment are shown in 
Figure 5.14.
Figure 5.14 Immunoprecipitation of whole cell lysates from COS-7 cells and COS-7 
cells transiently over expressing HPSl protein, using polyclonal anti-HPUD 2:2 coated 
protein A beads. Lane (a) COS-7 lysate precipitated with HPUD 2:2, (b) COS-7 cells 
over expressing HPSl precipitated with HPUD 2:2. Immunoblot analysis was 
performed using a monoclonal anti-HA antibody diluted 1/500 to detect the HA tagged 
over expressed HPS 1 protein.
Figure 5.14 demonstrated that only the over expressed HPSl protein in the 
transiently transfected COS-7 cells was immunoprecipitated using the HPUD 2:2 
polyclonal antibody. The epitope tagged antibody detected the precipitated product at 
79kDa on the immunoblot. No bands were observed in the COS-7 untransfected lysate 
sample suggesting that the HPS 1 protein could only be immunoprecipitated from cells 
expressing a high level of this protein. A number of protein bands were observed below 
50kDa that corresponded to the protein chains of the antibody used in the 
immunoprecipitation procedure. This study was repeated using the same antibody and 
conditions with various other whole cell lysates to assess if HPS 1 protein could be 
immunoprecipitated from these samples. Whole cell lysates were prepared from a 







addition lysates from the mature megakaryocyte, CHRF cell line. At no stage was it 
apparent that the HPS1 polyclonal antibodies could precipitate endogenous levels of 
HPS1 protein from these cell lines and for the precipitated material to be detected by 
immunoblot analysis (data not shown).
Extensive studies were carried out on the immunoprecipitated material using 
SDS-PAGE analysis. The aim of these studies was to try to identify the HPS1 protein 
itself on the gel and to also identify any other protein bands corresponding to unknown 
proteins that had been immunoprecipitated with the HPS1 protein. These unknown 
proteins may be directly interacting with the HPS1 protein. Unfortunately all studies 
carried out on immunoprecipitated samples that were analysed by SDS-PAGE analysis 
and coomassie blue staining yielded very little information. This technique was simply 
not specific enough to allow detection of very low levels of protein in the resultant 
immunoprecipitation reaction. An alternative method of detection was employed to try 
to enhance any protein bands that were present on the SDS-PAGE gel. The gels 
containing the immunoprecipitation samples were stained using silver stain, which had 
a much-increased sensitivity for detecting proteins than coomassie blue dye.
The immunoprecipitation reactions were repeated exactly as outlined in the 
previous experiment except instead of analysing the samples by immunoblotting the 
samples were analysed by SDS-PAGE followed by silver staining. Unfortunately so 
little protein was present within the gels that the gels had to be exposed to the silver 
stain for an extended period of time before any protein became visible. This resulted in 
the gels having a very high background making imaging of the gels very difficult. 
Under general observation no differences were observed in the pattern of protein bands 
in the negative control COS-7 sample and the sample from COS-7 cells transiently over 
expressing the HPS1 protein.
In an attempt to try to enhance the amount of protein being precipitated in these 
experiments an alternative method of sample preparation was used to increase the 
relative amount of HPS1 protein in the reaction. Previous basic fractionation 
experiments identified that after whole cell lysate from COS-7 cells transiently over 
expressing HPS1 protein was centrifuged at 100,000xg the HPS1 protein was 
exclusively partitioned into the pellet fraction. This fractionation procedure would be 
utilised to try to enhance the amount of HPS1 protein being precipitated. The whole cell 
lysate from both negative control COS-7 cells and the transiently over expressing COS- 
7 cells was centrifuged as described and the two separate fractions used in an
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immunoprecipitation reaction using protein A beads coated with anti-HA antibody. All 
precipitants were analysed by immunoblot analysis using the same monoclonal anti-HA 





Figure 5.15 Immunoprecipitation utilising supernatant and pellet fractions after a 
100,000xg centrifugation of both COS-7 and COS-7 transiently over expressing HPS1 
whole cell lysates. The immunoprecipitation was carried using protein A beads coated 
with a monoclonal anti-HA or polyclonal anti-HPSl antibody. Lane (a) COS-7 
supernatant, HA antibody, (b) COS-7 pellet, HA antibody, (c) COS-7 pMH HPS1 
supernatant, HA antibody, (d) COS-7 pMH HPS1 pellet, HA antibody and (e) COS-7 
pMH HPS 1 pellet, HPS antibody.
No protein bands were apparent in any o f the COS-7 untransfected lysate 
immunoprecipitant samples. The results for the transiently transfected lysate were both 
surprising and unexpected. The HA antibody coated protein A beads precipitated the 
transiently over expressed HPS 1 protein from both the supernatant and pellet fractions. 
However the amount of HPS 1 protein immunoprecipitated from each sample was 
different to that anticipated. Only a very small amount of the HPS 1 protein had been 
extracted from the pellet fraction even though this fraction contained virtually all of the 
transiently over expressed HPS 1 protein. In comparison the amount of protein 
precipitated from the supernatant sample was much larger even though the relative 
amount of HPS 1 protein in this fraction was much reduced. The amount extracted from
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the supernatant fraction was equivalent to the usual amount of HPS 1 protein 
immunoprecipitated using this same technique and whole cell lysate instead of 
fractionated sample. This result suggested that the HPS1 protein was more readily 
immunoprecipitated from the soluble supernatant than from the pellet fraction.
This result also explained why only a relatively small amount of protein was yielded 
from the immunoprecipitation studies making identifying interacting proteins difficult. 
Further immunoblot analysis was performed on the immunoprecipitants extracted using 
this method. The samples were immunoblotted with a range of antibodies to see if any 
of these proteins were pulled down along with the over expressed HPS1 suggesting a 
direct protein interaction. Antibodies included in this study included AP-3, Rab27 and (3 
tubulin. None of these studies suggested that any of these three proteins were being 
immunoprecipitated along with HPS1 (data not shown). It was suspected that the reason 
for this might be in part due to the very small amount of HPS 1 protein that was being 
extracted in these studies. Alternative methods were employed to try to investigate this 
further.
5.8 Identification of interacting proteins
An alternative technique was employed to identify proteins interacting directly 
with the HPS1 protein using immunoprecipitation. Due to only a small amount of HPS 1 
protein being extracted reverse immunoprecipitation studies were used as an alternative. 
Protein A beads would be coated with an antibody to a particular protein that could be 
possibly interacting with the HPS1 protein. The immunoprecipitation would be 
continued using whole cell lysate from COS-7 cells transiently over expressing HPS1 
protein. The samples would then be immunoblotted to establish if in addition to the 
recognised protein HPS1 was also immunoprecipitated. Four antibodies against the 
following proteins, Rab27,/? tubulin, AP-3, and actin were used in a preliminary study. 
The immunoprecipitants were immunoblotted using the monoclonal anti-HA antibody 









Figure 5.16 Immunoprecipitation reaction using various antibodies and whole cell lysate 
from COS-7 cells transiently over expressing HPS 1 protein. Protein A beads bound to 
(a) normal mouse serum, (b) monoclonal anti-Rab27 antibody, (c) monoclonal anti-/? 
tubulin antibody, (d) polyclonal anti-AP-3 antibody and (e) polyclonal anti-actin 
antibody.
Figure 5.16 demonstrated that with the AP-3 and actin antibodies and normal 
mouse serum no HA tagged HPS 1 protein was immunoprecipitated. Only the antibody 
protein chains were observed at 50kDa and below. However with both the Rab27 and (3 
tubulin antibodies it did appear that there was some protein extracted in this 
immunoprecipitation that the anti-HA antibody specifically bound to on 
immunoblotting. This protein band was much larger than the expected 79kDa for the 
HPS1 protein. The experiment was repeated to establish if the HPS1 protein was being 
pulled down in a large complex that was difficult to reduce. The results of this repeated 
experiment are shown in Figure 5.17. In addition to the four antibodies used in the 
previous experiment an anti-myosin Va antibody was also included in this study. In 
addition to this after the immunoprecipitation reaction the beads were incubated with 
SDS-PAGE sample buffer containing 2-mercaptoethanol for lOmins at room 







Figure 5.17 Reverse immunoprecipitation with a range of antibodies and whole cell 
lysate from COS-7 cells transiently over expressing the HPS 1 protein. Protein A beads 
coated with lane (a) Normal mouse serum, (b) polyclonal anti-actin antibody, (c) 
polyclonal anti-AP-3 antibody, (d) monoclonal anti-/3 tubulin antibody, (e) monoclonal 
anti-Rab27 antibody and (f) polyclonal anti-myosin Va antibody. The 75kDa band in all 
lanes shows the unreduced heavy and light chains of the antibodies used to coat the 
protein A beads that in this experiment were not reduced.
Figure 5.17 illustrates that all of the antibodies tested did not appear to 
immunoprecipitate the HPS 1 protein via a direct interaction with the proteins tested. 
This was not entirely unexpected with proteins such as actin and AP-3, which had 
previously shown no colocalisation with the HPS 1 in extensive immunofluorescence 
analyses. There did however appear to be a single band at approximately lOOkDa in the 
/? tubulin sample that was detected by immunoblot analysis using the anti-HA epitope 
antibody. This band was not at the expected molecular weight o f 79kDa for the HPS1 
protein. Control immunoblot analyses were performed with all of the antibodies tested 
to confirm that they were indeed immunoprecipitating the expected proteins and in all 
cases this proved to be conclusive (data not shown). SDS-PAGE and silver staining was 
performed on two of the reverse immunoprecipitation samples to assess if the lOOkDa 
band observed in the /3 tubulin sample with the anti-HA antibody could be a positive 
result and also to look for any additional proteins that were being immunoprecipitated in 
this reaction. The results of this silver staining are shown in Figure 5.18.
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Figure 5.18 Silver staining of reverse immunoprecipitation reaction using COS-7 pMH 
HPS1 whole cell lysate. Protein A beads were coated with (a) normal mouse serum, (b) 
polyclonal anti-AP-3 antibody and (c) monoclonal anti-/? tubulin antibody. The 
precipitated products were analysed by SDS-PAGE analysis followed by silver staining 
of the resultant gels.
Figure 5.18 demonstrated the precipitated protein products using whole cell 
lysate from COS-7 cell transiently over expressing the HPS1 protein in conjunction 
with protein A beads coated with antibodies to both the /? subunit AP-3 complex and /? 
tubulin protein. Close inspection revealed that the 1 OOkDa band present in the tubulin 
immunoprecipitate was by far the most abundant protein in this reaction. As it was the 
incorrect molecular weight to be the HPS 1 protein this suggests that is was likely that 
the anti-HA and/or the secondary anti-rat horse radish peroxidase antibodies were cross 
reacting with this protein band upon immunoblot analysis. This suggests that the HPS 1 
protein was not being immunoprecipitated with /? tubulin and was therefore unlikely to 
be directly interacting with this protein.
An additional reagent was available to confirm this theory and this was to utilise 
the monoclonal antibody to the HPS1 protein that had been generated for this study. To 
confirm that this monoclonal antibody was suitable for analysing immunoprecipitants 
using immunoblot analysis a control experiment was set up. Protein A beads were 
coated with the monoclonal anti-HA antibody and incubated in an immunoprecipitation 
reaction with either COS-7 whole cell lysate or COS-7 whole cell lysate from cells 
transiently over expressing the HPS 1 protein. The immunoprecipitated products were
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boiled from the protein A beads and were then analysed by immunoblot analysis using 
the monoclonal antibody against the HPS 1 protein. The results o f this control 





Figure 5.19 Immunoprecipitation reaction using monoclonal anti-HA coated protein A 
beads and COS-7 and COS-7 transiently over expressing HPS 1 whole cell lysates. All 
samples were immunoblotted using an anti-HPSl monoclonal antibody. Lane (a) COS-7 
whole cell lysate and lane (b), COS-7 transiently over expressing HPS 1 protein whole 
cell lysate.
This control immunoprecipitation revealed that the anti-HA antibody could 
precipitate out the transiently over expressed HPS 1 protein from the whole cell lysate 
and that this protein could be easily and cleanly detected by immunoblotting with the 
monoclonal anti-HPS 1 antibody. No background crossreactivity was observed except to 
the antibody protein chains at around 50kDa, which had been removed from the protein 
A beads during the boiling reaction. Due to the absence of background on 
immunoblotting this antibody was utilised for the same procedure on additional reverse 
immunoprecipitation reactions. Protein A beads were coupled to a range of antibodies 
that reacted against specific proteins that it was suspected may be directly interacting 
with the HPS 1 protein. These beads were used in an immunoprecipitation reaction and 
the resultant samples were analysed by immunoblot analysis. The immunoblot analysis 
was carried out using a monoclonal antibody against the HPS 1 protein and the results of 




Figure 5.20 Reverse immunoprecipitations using monoclonal anti-HA antibody and 
whole cell lysate from COS-7 cells transiently over expressing HPS 1 protein. Protein A 
beads were coupled to the following antibodies (a) polyclonal anti-actin, (b) polyclonal 
anti-AP-3, (c) monoclonal anti-/? tubulin, (d) monoclonal anti-Rab27 and (e) polyclonal 
myosin Va and then incubated with the whole cell lysate. All immunoprecipitants were 
analysed by immunoblot analysis using neat supernatant from a hybridoma producing a 
monoclonal antibody against the HPS1 protein.
Using all of the antibodies tested no HPS1 protein was immunoprecipitated in 
conjunction with the antibodies and therefore proteins tested. A high amount of over 
expressed HPS 1 protein was confirmed to be present in the whole cell lysate before it 
was utilised in the immunoprecipitation reaction. This result also confirmed that 
previous studies using the /? tubulin antibody that seemed to suggest that HPS 1 was 
immunoprecipitated in conjunction with the /? tubulin protein was in fact an artefact 
anticipated. Therefore in conclusion using this method, actin, AP-3, rab27, myosin Va 
and /? tubulin proteins appeared from this data not to directly interact with the HPS 1 
protein in COS-7 cells transiently over expressing the HPS 1 protein.
5.9 Immunoprecipitation of labelled cell lysate for detection of 
interacting proteins
A final alternative method was utilised to identify the unknown proteins that 
could possibly be directly interacting with the HPS 1 protein. Studies had shown that the 
HPS 1 protein could be immunoprecipitated cleanly from a COS-7 transiently over 
expressing whole cell lysate but that additional proteins being precipitated along side
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this could not be identified. One of the reasons for this is that simply not enough protein 
was being immunoprecipitated to allow identification of additional proteins being 
pulled down using the immunoblot detection technique. A method was used to increase 
the sensitivity of detection and a widely used standard technique for 
immunoprecipitation reactions. This involves biosynthetic radiolabelling of the cells 
used to produce the whole cell lysate and the use of this lysate in the 
immunoprecipitation procedure. Me Wo melanoma cells were transiently transfected 
using the pMH HPS1 mammalian expression construct and incubated over night. In 
addition untransfected MeWo cells were grown up as negative controls for the 
immunoprecipitation reaction. The cells were biosynthetically labelled using 100/xCi of 
Trans35S-Label before the whole cell lysate from these cells was prepared in the usual 
way. The lysates were incubated with protein A beads that had been coated with anti- 
HA epitope antibody. The immunoprecipitation reaction was continued as outlined 
previously and the precipitants were analysed by SDS-PAGE analysis. The resultant gel 
was dried down and imaged on a phosphoimager. The results of this analysis are shown 
in Figure 5.21.
Figure 5.21 Immunoprecipitation reaction using biosynthetically labelled whole cell 
lysate. MeWo cells and MeWo cell transiently over expressing HPS1 were radiolabelled 
and used in an immunoprecipitation reaction with protein A beads coated with a 
monoclonal anti-HA antibody. Lane (a) whole cell lysate from radiolabelled MeWo 
cells (b) immunoprecipitation using MeWo whole cell lysate and (c) 
immunoprecipitation using MeWo whole cell lysate from cells transiently over 
expressing the HPS 1 protein.
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The positive control sample showing biosynthetically labelled MeWo whole cell 
lysates has a large array of proteins present at a range of different molecular weights 
and all o f these proteins were radiolabelled and were detected by the phosphoimager. As 
expected no bands were observed in the negative control sample as the HA antibody 
should not immunoprecipitate any proteins from the MeWo whole cell lysate. No 
background bands were visible on the image demonstrating that no random proteins 
were sticking to the protein A beads indiscriminately. The final sample did not give the 
result anticipated. The anti-HA antibody immunoprecipitated the transiently over 
expressed HA tagged HPS1 protein from the MeWo whole cell lysate shown by the 
clear band at the expected molecular weight of 79kDa. However the observed protein 
band wasn’t very intense even after a prolonged exposure time and on close 
examination no other protein bands could be observed in this sample on the image. This 
suggests that no other proteins were being immunoprecipitated with the HPS1 protein in 
this reaction.
5.10 Discussion
Experimental studies outlined in this chapter confirmed the previous subcellular 
localisation data for the HPS1 protein when it is transiently over expressed in COS-7 
cells. The protein was present in the cytosol, aggregated and in a large number of 
punctate structures that were present throughout the cytosol of the cell. Studies 
suggested that these punctate structures were associated with a cytoskeletal element 
within the cell of which actin filaments were discounted due to previous 
immunofluorescence analysis. Dual labelling immunofluorescence studies were carried 
out to look for a possible association of the HPS1 punctate structures with microtubule 
filaments. Analysis revealed that whilst a high level of colocalisation between the HPS1 
and /? tubulin proteins was not present there did appear to be a close association between 
the two proteins. Analysis revealed the HPS1 positive punctate structures were laying 
along clearly defined pathways within the cell and these appeared to be associated with 
distinct microtubule filaments. Representing these observations using confocal 
microscopy proved challenging due to only one plane of focus being imaged at any one 
time making obtaining images of long lengths of microtubule filaments difficult. The 
experiment was repeated on a number of occasions and a significant number o f images 
obtained to represent the apparent observed association. No such association between
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HPS1 and microtubules had been previously described mainly as earlier data had 
demonstrated a mainly cytosolic distribution pattern of the HPS1 protein in M l 
fibroblast cells (Dell* Angelica et al., 2000).
Data for this association was collected from COS-7 cells that were transiently 
over expressing the HPS1 protein. As a control for this analysis the studies were 
repeated in the COS-7 cells that stably expressed the HPS1 protein. The distribution 
pattern always remained the same in these cells transiently over expressing the HPS1 
protein. The protein was still resident in these punctate structures throughout the cell. 
The level of expressed protein tended to be less in the stably expressing cells but the 
number of punctate structures appeared from observations to be very similar. As the 
actual distribution was not dramatically different from the observed distribution pattern 
of the HPS1 protein when transiently over expressed in the same cells it was theorised 
that again in these cells the HPS1 protein would appear to associate with microtubules. 
This did prove to be the case with a number of the HPS1 positive punctate structures 
appearing to be associated with a single microtubule filament. These results were 
consistent but the studies were performed in COS-7, which do not contain lysosome- 
like organelles. This distribution pattern of the transiently over expressed HPS1 protein 
had been observed in cells that did contain these organelles and equivalent studies were 
performed in these cells.
Firstly the studies were repeated in Mel 164 unpigmented melanoma cells that 
were obtained as part of a collaboration. The Mel 164 cells were obtained from a cancer 
biology research group and these cells had not been previously used to study the 
biogenesis of melanosomes in melanocyte cells. The cells themselves appeared at the 
light microscope level to be either non-pigmented or containing very low levels of 
melanin pigment. The exact reason for this lack of pigmentation was unknown and 
could be due to a number of factors. Obviously this did have a bearing on this particular 
study as it may be related to the biogenesis or protein targeting to the melanosome 
organelle itself. An extensive literature research revealed the previous publications in 
which this cell line had been utilised, in all cases these studies were related to cancer 
biology and in no way correlated with melanosome biogenesis. With this point in mind 
the studies into the association of the HPS1 protein with microtubules was extended 
using these Mel 164 cells. Transient over expression of the HPS1 protein resulted in the 
same punctate subcellular distribution pattern. Close observation of dual labelled cells 
revealed that in these Mel 164 cells the punctate structures in which the HPS1 protein
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was present did appear to associate with microtubule filaments in much the same way as 
had been observed in the COS-7 cells.
Due to the apparent lack of pigmentation in these cells and the implication that 
this could have with regard to the localisation of the HPS1 protein these studies were 
repeated in an additional melanoma cell line. The MeWo fibroblast-like melanoma cells 
were utilised, as they are known to contain melanin pigment and have been used in a 
select number of studies into secretory lysosome biogenesis and function. Again the 
transient over expression of the HPS1 protein resulted in a distribution pattern identical 
to the previously observed pattern. Dual labelling studies revealed a close association of 
the HPS1 punctate structures with microtubule filaments particularly towards the 
periphery of the cell.
Previous published biochemical data confirmed that the HPS1 protein is part of 
a ubiquitous cytosolic complex and in cells containing secretory lysosomes is 
transiently and specifically associated with membrane components of early 
organellogenesis (Oh et al., 2000). This study supports these findings from basic 
fractionation studies that were carried out. When transiently over expressed the HPS1 
protein is present in punctate structures and using basic fractionation studies it was 
confirmed that all o f this HPS1 protein was present in the pellet fractionation. Analysis 
of this pellet fraction demonstrated that it contained both membraneous and cytoskeletal 
elements. The finding that endogenous HPS1 protein colocalised with the known 
melanosome associated protein Rab27 in mature megakaryocytes also supported this 
evidence. The exact role of the Rab27 in this cell line was unknown but it was 
hypothesised that it might play a similar role in secretory lysosome peripheral retention 
or biogenesis in much the same way as its role in melanosome biogenesis (Bahadoran et 
al., 2001, Hume et al., 2001). All of this data together suggests that the HPS1 protein is 
associated with components of the early secretory lysosome biogenesis and this 
particular role in a functionally related pathway but independent of the adaptor protein 
complex AP-3.
The role of microtubule filaments is well known at the level of facilitating long- 
range movements within mammalian cells including the movement of whole organelles. 
Very few studies have looked at the role of microtubule filaments with regard to the 
movement of melanosomes and premelanosome structures. The previous publications in 
this area have mainly focused on the microtubule motor protein kinesin, which was 
shown to colocalise with melanosomes in melanocytes (Vancoillie et al., 2000). The
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motor protein and microtubules were shown to be functional important in the bi­
directional long range movement of melanosomes towards the periphery of the cell 
(Hara et al., 2000) where they are retained by the Rab27, melanophilin, myosin Va 
complex in association with actin peripheral networks (Nagashima et al., 2002). This 
confirmed the possibility that the HPS1 protein may be present in punctate structures 
associated with microtubule filaments.
A well-established technique to assess the association of particular structures 
with microtubules is the utilisation of microtubule disrupting agents and to determine 
the effect that these agents have on the subcellular localisation of the structures of 
interest. Studies were carried out to assess the association of the HPS1 punctate 
structures with microtubules both in fibroblasts and melanoma cells. The chemical 
agents used in this study, which disrupt microtubule filaments, were nocodazole, 
vincristine and paclitaxel.
Nocodazole is a synthetic compound chemically unrelated to other microtubule- 
disintegrating alkaloids. Investigations into the mechanism of its activity led to the 
finding that the compound showed a highly specific anti-microtubular activity inducing 
the total disappearance of microtubules from mammalian cells in culture (Samson et al., 
1979). The activity and ensuing biological effects were identical to those produced by 
anti-microtubular alkaloids including alteration of cell shape, loss of directional cell 
movement, loss of ordered subcellular organelle movements, randomisation of 
subcellular organelle topography and destruction of the mitotic spindle with ensuing 
mitotic block (DeBrabander et al., 1976). The cell biology effects were identical within 
a large dose-range (0.04-100/ig/ml). Subsequently it was shown that nocodazole inhibits 
the polymerisation of tubulin in vitro in a dose dependent manner and it shares the same 
binding site on the tubulin molecule with colchicines (Hoebeke et al., 1976). The 
antimicrotubular activity was easily reversible as nocodazole is easily removed from its 
binding site.
Vincristine is a member of the Vinca alkaloid chemicals, which are also 
antimicrotubular agents mediated by the interaction of these drugs with tubulin and/or 
microtubules. The interaction may take the form of the following: 1) diminished 
microtubule dynamics by suppressing dynamic instability at both ends of the 
microtubule thus increasing the time spent in the “resting state”; 2) inhibition of 
microtubule assembly or promotion of disassembly at intermediate concentrations and 
at higher concentrations the formation of spirals, tubules with splayed ends, paracrystals
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and other aggregates (Erickson et al., 1975). In all cases normal microtubule function is 
compromised. Vinca alkaloids can bind to dimeric tubulin, to microtubule ends and to 
certain aggregates formed by self-association of tubulin. Indirect evidence points to the 
binding of vincristine to the (3 monomer of tubulin thus having major effects on the 
cross linking of specific SH groups on /3 tubulin with the bifunctional N, W-ethylene 
bis(iodoacetamide). Similarly vincristine inhibits the hydrolysis of the exchangeable 
GTP bound to /? tubulin (Downing, 2000).
Paclitaxel is an antimitotic drug that also enhances the polymerisation of 
tubulin. In mammalian cells incubation with paclitaxel results in the formation o f stable 
bundles of microtubules that are resistant to depolymerization by for example cold 
temperature or dilution. In vitro, in the presence of paclitaxel, tubulin will polymerise in 
the absence of GTP, which under normal conditions is an absolute requirement for 
polymerisation. In contrast to vincristine, which binds to the tubulin dimer, paclitaxel 
has a binding site on the microtubule polymer. Paclitaxel binds to microtubules 
specifically and reversibly with a stoichiometry, relative to the tubulin heterodimer, 
approaching one. Analysis of the binding site o f paclitaxel revealed the chemical bound 
to the (3 tubulin monomer (Rao et al, 1995).
When either COS-7 or melanoma cells were treated with these chemical agents 
during this study they had a dramatic effect on the structure of microtubules. The effect 
of these drugs on the subcellular localisation of the HPS1 protein has never before been 
analysed. In experiments in this study both nocodazole and vincristine severely affected 
the integral structure of microtubule filaments resulting in all of the microtubules 
depolymerising. No filaments were observed in any treated cells and the /? tubulin 
protein was present in a diffuse distribution throughout the cytosol of the cell. Upon 
paclitaxel treatment of the cells microtubule stabilisation was observed. This resulted in 
a vast array of microtubule filaments being present in the cell particularly towards the 
periphery around the plasma membrane region. Observation of the transiently over 
expressed HPS1 protein in these treated cells revealed some interesting findings.
In both COS-7 and melanoma cells over expressing the HPS1 protein, when 
treated with either nocodazole or vincristine, the HPS1 protein was redistributed from 
the small punctate structures it was usually present in. When all of the microtubules 
were depolymerised the protein was no longer present in these punctate structures but 
showed a diffuse distribution pattern throughout the cytosol much the same as the 
observed distribution pattern o f the 0 tubulin protein. The level of fluorescence for both
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proteins was much lower due to their diffuse distribution patterns but in some areas 
there did appear to be some colocalisation between the HPS1 and /3 tubulin proteins. In 
addition to this in melanoma cells some of the HPS1 protein did appear to aggregate 
together even at low levels of protein expression upon treatment with this 
depolymerising agents. This type of aggregation had never before been observed in any 
of the cell types utilised with this type of protein expression.
In both COS-7 and melanoma cells over expressing HPS1, when treated with 
paclitaxel the effect on the HPS1 localisation was not as dramatic as the observed result 
with the microtubule depolymerising agents. The HPS1 protein remained present in 
small punctate structures that were present throughout the cell but were particularly 
concentrated on the large number of microtubule filaments in the periphery o f the cell. 
These punctate structures were noticeable against the dense filament networks and again 
it was apparent that a number o f punctate structures could be observed lining up along 
the same microtubule filament. The punctate structures extended towards the periphery 
of the cell and were even observed in dendritic processes. These immunofluorescence 
analysis results appeared to suggest that indeed the punctate structures were associated 
with the microtubule network within the cell and upon depolymerisation of this network 
the HPS1 protein was no longer present in punctate structures but had been redistributed 
to the cytosol of the cell.
Previous data from this study and other publications suggested that the HPS1 
protein might be present in subcellular structures involved in the early stages of 
secretory lysosome biogenesis (Oh et al, 2000). If this is correct evidence form 
microtubule interfering agents suggests that these structures are associated and 
dependent on the microtubule network within the cell for their structure and movement. 
Studies on the movement of melanosomes within melanocytes confirmed that 
microtubules filaments mediated their bi-directional movements (Wu et al., 1998) and 
that the microtubule motor protein kinesin was crucial in the anterograde movement of 
the organelle (Hara et al, 2000). Data presented in this study suggests that the HPS1 
protein in present in punctate structures that associate with microtubule filaments and 
previous immunofluorescence analysis confirmed a degree of colocalisation between 
over expressed HPS1 protein and the microtubule motor protein kinesin. In addition to 
this work, it has been proved that lytic granules in T cells exhibit kinesin dependent 
motility on microtubules in vitro confirming the results observed with melanosomes 
(Burkhardt et al 1993).
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Attempts were made to try to confirm the redistribution of the HPS1 protein 
observed in immunofluorescence analysis using basic fractionation experiments. 
Previously in untreated cell all of the HPS1 protein was present in the pellet fraction 
after a 100,000xg centrifugation in which both membranes and cytoskeletal elements 
were also shown to be present. Cells were pre-treated with nocodazole prior to the 
fractionation to assess the drugs effect on the fractionation pattern o f both HPS1 and /3 
tubulin. Evidence from these experiments suggested that the nocodazole treatment was 
not actually depolymerising the microtubule filaments to any great extent with no 
alteration in the fractionation pattern of the /3 tubulin protein observed. An older batch 
of the chemical was used in this study, which had yielded unconvincing 
immunofluorescence data with regard to the depolymerisation No firm conclusions 
could be drawn from these experiments and in hindsight utilising vincristine may have 
been a better option.
Previous research by Oh and co-workers (Oh et al., 2000) using cytoplasmic 
fractionation by gel filtration followed by immunoblotting of human lymphoblastoid 
cells revealed that the HPS1 protein was part of a 200kDa complex. When repeated with 
FME melanoma cells the HPS1 protein was demonstrated to be part of a complex 
greater than 500kDa. These results suggest that the HPS1 protein was clearly associated 
with a number of other proteins both in lymphoblastoid and melanoma cells. None of 
the proteins that the HPS1 protein associates with in mammalian cells have yet been 
identified and only a small number have been shown not to directly interact with HPS1, 
one of these being the AP-3 complex. Analysis from this study confirmed that there was 
no colocalisation between the HPS1 and AP-3 using immunofluorescence analysis 
supporting the fact that a direct interaction between these two proteins is very unlikely. 
In an attempt to try to identify proteins that directly interact with the HPS1 protein 
immunoprecipitation analysis was utilised with both fibroblasts and melanoma cells.
Ideally endogenous levels of HPS 1 protein would be extracted from the whole 
cell lysates of cells of interest. However none of the polyclonal or monoclonal 
antibodies against the HPS1 protein could immunoprecipitate the HPS1 protein from a 
variety of whole cell lysates tested including Mell64, MeWo and CHRF cells. It was 
postulated that the reason for this was due to the very low abundance of the HPS1 
protein in mammalian cells and in addition the specificity of the antibodies used in this 
study. Previous published data showed that to immunoprecipitate endogenous HPS1 
protein an elaborate immunoprecipitation recapture procedure was required confirming
203
the results observed in this experiment (Dell’ Angelica et al., 2000). During the initial 
procedures using this technique a clathrin heavy chain antibody was used as a positive 
control. After modifications to the experimental technique transiently over expressed 
HPS1 protein could be immunoprecipitated from COS-7 fibroblasts transiently over 
expressing HPS 1 using both polyclonal antibodies to the HPS1 protein and a monoclonal 
antibody to the epitope tag present on the over expressed protein.
Only small amounts of the HPS1 protein could be immunoprecipitated from 
whole cell lysates of transiently over expressing cells. It was initially suspected that the 
reason for this was due to the antibody specificity and the technique used in the 
experiment. A number of modifications were made but no increase in the amount of 
protein immunoprecipitated was observed. Due to only small amounts of protein being 
pulled down the methods used to detect any possible proteins being immunoprecipitated 
alongside the HPS1 protein were inadequate. Utilising immunoblotting, SDS-PAGE 
analysis with coomassie blue or silver staining did not reveal any interacting proteins. 
The reason for this result became apparent when basic fractionation of the whole cell 
lysate was carried out prior to the immunoprecipitation reaction. Again the transiently 
over expressed HPS1 protein was exclusively distributed in the pellet fraction after a 
100,000xg centrifugation of whole cell lysates from transiently over expressing COS-7 
cells. It was assumed that utilising this pellet fraction in the immunoprecipitation 
reaction would vastly increase the amount of HPS 1 protein that was extracted during the 
precipitation thereby increasing the chances of identifying an interacting protein. 
However this hypothesis proved to be totally incorrect, when analysed virtually no 
HPS1 protein was immunoprecipitated from the pellet fraction and only a small amount 
of HPS 1 protein was extracted from the supernatant fraction. The level of protein 
extracted from the supernatant fraction was equivalent to the usual amount of protein 
extracted during one of these procedures.
This fractionation reaction confirmed that only the HPS1 protein present in the 
supernatant was able to be immunoprecipitated and it was assumed that this protein was 
a small proportion of the total present in any one cell and was actually cytosolic rather 
than membrane or cytoskeletal associated. This result suggested that the HPS1 protein 
in the pellet fraction was not available for immunoprecipitation. This may be due to a 
number of reasons including that the HPS1 protein was buried in a very large protein 
complex, or even associated with microtubule filaments that could not be extracted 
using this technique. The portions of the protein to which the antibodies recognised may
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also have been buried within other proteins preventing the proteins extraction. It is 
known from previous publications that the membrane associated form of the HPS1 
protein is associated with up to 420kDa of additional proteins. It is assumed in this 
study that any cytosolic forms of the HPS1 protein are probably associated with very 
few other proteins. This finding of the extraction of the cytosolic form of HPS 1 
probably suggests that very few other proteins are directly interacting with the HPS1 
protein in this cytosolic state meaning that there is unlikely to be any additional 
interacting proteins present with it. This explains the apparent lack of any interacting 
proteins being immunoprecipitated in these reactions or it may simply be that the 
method used in this study not sensitive enough for the low abundance HPS1 protein.
An alternative method was employed to try to identify interacting proteins 
utilising antibodies to various proteins to assess if  in addition to these protein HPS1 was 
immunoprecipitated alongside confirming a direct interaction. Initially it did appear that 
the tubulin antibody was immunoprecipitating the HPS1 protein alongside tubulin 
but after further investigation and alterations to the method this proved to be incorrect. 
This anomalous results were mainly the result o f inconsistencies with regard to the full 
removal of material form the protein A beads and in addition the full reduction o f the 
immunoprecipitated material. None of the antibodies tested resulted in the 
immunoprecipitation o f the HPS1 protein suggesting that AP-3, actin, myosin Va, rab27 
or jS tubulin were not directly interacting with the HPS1 protein but no firm conclusions 
could be drawn from this study due to the nature of the HPS1 protein being precipitated 
and the fact that no positive control was available to confirm that the experiments were 
working as planned. The possible utilisation of an alternative system to 
immunoprecipitation such as a yeast two-hybrid analysis to identify proteins interacting 
with the HPS1 protein may have yielded better results. In addition to this with regard to 
the possible interaction of the HPS protein with microtubules it may have been 
advantageous to use an in vitro microtubule polymerisation technique to generate 
microtubule filaments to use in pull down experiments instead o f an antibody based 
system.
To address the question of the effect of the sensitivity of detection of this system 
on the results obtained an alternative method of detection was used. A standard method 
used in immunoprecipitation reactions incorporates the radiolabelling of proteins prior 
to the immunoprecipitation reaction. Cells are first starved in methionine and cysteine 
free media prior to the addition of 35S labelled methionine and cysteine, which are
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incorporated into proteins. Radioactivity is detected at the final stage of the 
immunoprecipitation reaction using a phosphoimager in this study. A standard 
immunoprecipitation reaction was carried out using whole cell lysate from COS-7 cells 
that were transiently over expressing the HPS1 protein and had been radiolabelled. The 
immunoprecipitants were analysed by SDS-PAGE analysis before being exposed on the 
phosphoimager. It was anticipated that this method would enhance the detection of any 
proteins that were immunoprecipitated with the HPS1 protein. Again upon observation 
of the resultant image only the radiolabelled HPS1 protein was visible suggesting that 
only the cytosolic HPS1 protein was being precipitated at very low levels. No other 
proteins were observed in the reaction. It was therefore confirmed that not merely the 
result of the amount of the HPS1 protein but the actual nature of the localisation of the 
HPS1 protein appeared to be the crucial factor in the determination of proteins directly 
interacting with the HPS1 protein.
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6.0 Conclusions
Characterisation of the polyclonal antisera generated against the human 
HPS1 protein, received as part of a collaboration was completed. The polyclonal 
antisera were unable to detect endogenous levels of the HPS1 protein in a variety 
of cell lines tested by immunofluorescence analysis. It was speculated that the 
levels of HPS 1 protein in these cell lines was low and the affinity of the HPS1 
antibodies was not sufficient to detect the endogenous protein using this 
technique. Immunoblot analysis with the antisera did reveal a significant band at 
90kDa in the Panc-1 pancreatic cell line, although symptoms of pancreatic 
abnormalities are not reported in patients with Hermansky Pudlak syndrome type 
1, thus the 90 kDa band detected by the anti-human HPS1 polyclonal antisera 
could represent an additional isoform of HPS 1 which has a potential role in 
pancreatic cell function.
A monoclonal antibody against the human HPS1 protein was generated in 
this study using recombinant human HPS1 protein expressed in bacterial cells.
All of the recombinant protein produced was insoluble, and therefore it was 
purified from bacterial inclusion bodies. The insoluble nature of the protein may 
be due its hydrophobic regions facilitating the formation of insoluble protein 
aggregates. Immunised Balb-c mice produced a high level immune response 
against the HPS1 protein when examined by ELISA analysis. The spleen cells 
from the mice were used to produce antibody-secreting hybridoma clones. One 
clone producing an IgG isotype antibody specific for the HPS1 protein was 
identified following screening. Full characterisation of this antibody revealed that 
like the polyclonal antisera it could not detect endogenous levels of HPS 1 protein 
by immunoblot or immunofluorescence analysis, but it could detect transiently 
overexpressed protein using both techniques.
Transient overexpression and immunofluorescence analysis in both non- 
melanocytic and melanocytic cell lines was performed to assess the subcellular 
localisation of the HPS1 protein. Analysis in both cell lines revealed that the 
protein was partially aggregated, partially cytosolic and present in punctate
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vesicles throughout the cell. In partial agreement with previously published data 
that concluded that the HPS1 protein was mainly cytosolic or concentrated in the 
perinuclear area of the cell, some perinuclear accumulation was also observed. 
Colocalisation studies in both cell lines demonstrated that HPS1 protein did not 
colocalise with EEA-1, TGN-46, M6PR or CD63. In COS-7 cells there was some 
colocalisation with the coat protein clathrin around the perinuclear area o f the 
cell. In addition in melanocytic cells there was some colocalisation with the actin 
motor protein Myosin Va around the perinuclear area of the cell but not towards 
the cell periphery. This suggests that the HPS1 protein is not involved in the 
peripheral retention of melanosomes at the cell periphery in combination with 
Myosin Va. Endogenous levels of HPS1 could be detected by 
immunofluorescence analysis in large polynuclear mature megakaryocyte cells, 
but not mature megakaryocyte in other morphological states. The protein was 
present in punctate vesicles throughout the cell and these vesicles colocalised to a 
large extent with the small GTPase, Rab27. This suggests that these structures 
might be involved in dense granule formation or be dense granules themselves, 
as patients with HPS1 have deficient platelet dense granule function. The role of 
Rab27 protein in platelet function remains uncharacterised.
Studies were performed to investigate the role of the C terminus of the 
HPS1 protein by analysing its subcellular localisation. A number of gene 
mutations studied in HPS1 patients reveal that the C terminus appears to be 
critical for the proteins wildtype function. When truncated forms of the HPS1 
protein were overexpressed in non-melanocytic and melanocytic cells the 
subcellular distribution pattern showed some changes compared to the wildtype 
protein. The truncated protein appeared to be more prone to aggregation 
particularly in the melanocytic cells lines. The HPS1 protein was recently shown 
to be part of the BLOC-3 membrane associated complex with HPS4 in 
melanocytic cells. It is speculated from these truncation studies that the C 
terminus of the HPS1 may play a role in the formation of this complex and its 
membrane association.
Further colocalisation studies in both melanocytic and non-melanocytic 
cell lines revealed that when overexpressed the HPS1 protein present in vesicles
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associated closely with microtubule filaments throughout the cells. Treatment of 
these cells with vincristine and nocodazole, which perturb microtubule filaments, 
redistributed the HPS1 protein from a punctate to a more cytosolic pattern. In 
some instances there was colocalisation between the depolymerised /? tubulin 
protein and HPS1. Putative association between /3 tubulin and HPS1 was further 
supported by treatment with Paclitaxel, which resulted in stabilised microtubule 
filaments and associated punctate HPS1 structures, and association between /3 
tubulin and HPS1 in basic fractionation studies. The HPS1 protein exclusively 
partitioned into the membrane fraction that also contained the /3 tubulin protein. 
Data shown here demonstrating colocalisation between HPS1 and 0 tubulin 
suggests that HPS1 may have a regulatory role in microtubule-mediated 
transport, supporting recent findings (Nazarian et al., 2003) that show the 
microtubule-mediated localisation of lysosomes and late endosomes is dependent 
on the HPS1/HPS4 containing BLOC-3 complex.
Immunoprecipitation studies were carried out to identify proteins that 
were directly interacting with the HPS1 protein in both non-melanocytic and 
melanocytic cells lines. Using a variety of techniques and both polyclonal and 
monoclonal antibodies against the HPS1 protein the antibodies were unable to 
precipitate endogenous HPS1 protein. When transiently over expressed the HPS1 
protein could be precipitated with both HPS1 antibodies but only cytosolic HPS1 
protein appeared to be extracted. No interacting proteins were identified during 
this study, which it is assumed, is due to the affinity of the antibodies used, the 
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